<!DOCTYPE html>
<html lang="en" class="scroll-smooth">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Heamatology - Brain And Scalpel</title>
    <link rel="preload" href="assets/background.jpg" as="image">
    <script src="https://cdn.tailwindcss.com"></script>
    <!-- HLS.js for M3U8 support -->
    <script src="https://cdn.jsdelivr.net/npm/hls.js@latest"></script>
    <style>
        
/* Liquid Glass Morphism Universal Theme - Enhanced */
:root {
  --glass-bg: rgba(0, 0, 0, 0.6);
  --glass-bg-light: rgba(255, 255, 255, 0.1);
  --glass-bg-medium: rgba(255, 255, 255, 0.15);
  --glass-bg-heavy: rgba(255, 255, 255, 0.2);
  --glass-border: rgba(255, 255, 255, 0.2);
  --glass-border-light: rgba(255, 255, 255, 0.1);
  --text-primary: rgba(255, 255, 255, 0.95);
  --text-secondary: rgba(255, 255, 255, 0.7);
  --text-tertiary: rgba(255, 255, 255, 0.5);
  --accent-blue: #60a5fa;
  --accent-purple: #a855f7;
  --accent-green: #34d399;
  --accent-orange: #fb923c;
  --accent-red: #f87171;
  --accent-yellow: #fbbf24;
}

* {
  margin: 0;
  padding: 0;
  box-sizing: border-box;
}

body {
  margin: 0;
  min-height: 100vh;
  font-family: system-ui, -apple-system, BlinkMacSystemFont, 'Segoe UI', sans-serif;
  background: url("assets/background.jpg") center center / cover no-repeat fixed;
  position: relative;
  overflow-x: hidden;
  color: var(--text-primary);
}

body::before {
  content: "";
  position: fixed;
  inset: 0;
  background: rgba(0, 0, 0, 0.4);
  backdrop-filter: blur(10px);
  -webkit-backdrop-filter: blur(10px);
  z-index: -1;
}

/* Glass morphism components */
.glass {
  background: var(--glass-bg);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid var(--glass-border);
  border-radius: 16px;
}

.glass-light {
  background: var(--glass-bg-light);
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid var(--glass-border-light);
  border-radius: 12px;
}

.glass-medium {
  background: var(--glass-bg-medium);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid var(--glass-border);
  border-radius: 16px;
}

.glass-heavy {
  background: var(--glass-bg-heavy);
  backdrop-filter: blur(25px);
  -webkit-backdrop-filter: blur(25px);
  border: 1px solid var(--glass-border);
  border-radius: 20px;
}

.glass-card {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid rgba(255, 255, 255, 0.15);
  border-radius: 20px;
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  box-shadow: 0 8px 32px rgba(0, 0, 0, 0.3);
}

.glass-card:hover {
  transform: translateY(-8px);
  background: rgba(255, 255, 255, 0.12);
  border-color: rgba(255, 255, 255, 0.25);
  box-shadow: 0 20px 60px rgba(0, 0, 0, 0.4);
}

.glass-button {
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.8), rgba(168, 85, 247, 0.8));
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid rgba(255, 255, 255, 0.2);
  border-radius: 12px;
  color: white;
  font-weight: 600;
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  box-shadow: 0 4px 20px rgba(96, 165, 250, 0.3);
  cursor: pointer;
  border: none;
}

.glass-button:hover {
  transform: translateY(-2px);
  box-shadow: 0 8px 30px rgba(96, 165, 250, 0.4);
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.9), rgba(168, 85, 247, 0.9));
}

.glass-button:disabled {
  opacity: 0.5;
  cursor: not-allowed;
  transform: none;
}

.glass-input {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid rgba(255, 255, 255, 0.2);
  border-radius: 12px;
  color: var(--text-primary);
  transition: all 0.3s ease;
}

.glass-input:focus {
  outline: none;
  border-color: var(--accent-blue);
  background: rgba(255, 255, 255, 0.12);
  box-shadow: 0 0 20px rgba(96, 165, 250, 0.3);
}

.glass-input::placeholder {
  color: var(--text-tertiary);
}

/* Performance analysis styles */
.performance-card {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid rgba(255, 255, 255, 0.15);
  border-radius: 20px;
  box-shadow: 0 8px 32px rgba(0, 0, 0, 0.3);
}

.score-circle {
  position: relative;
  width: 150px;
  height: 150px;
  margin: 0 auto;
}

.score-circle svg {
  transform: rotate(-90deg);
}

.score-circle .circle-bg {
  fill: none;
  stroke: rgba(255, 255, 255, 0.1);
  stroke-width: 8;
}

.score-circle .circle-progress {
  fill: none;
  stroke-width: 8;
  stroke-linecap: round;
  transition: stroke-dasharray 2s cubic-bezier(0.4, 0, 0.2, 1);
}

.score-text {
  position: absolute;
  top: 50%;
  left: 50%;
  transform: translate(-50%, -50%);
  text-align: center;
}

/* Review question styles */
.review-question {
  background: rgba(255, 255, 255, 0.05);
  border: 1px solid rgba(255, 255, 255, 0.1);
  border-radius: 16px;
  padding: 20px;
  margin-bottom: 20px;
}

.review-question.correct {
  border-left: 4px solid #22c55e;
}

.review-question.incorrect {
  border-left: 4px solid #ef4444;
}

.review-question.not-attempted {
  border-left: 4px solid #6b7280;
}

/* Gradient backgrounds for accents */
.gradient-blue {
  background: linear-gradient(135deg, var(--accent-blue), #3b82f6);
}

.gradient-purple {
  background: linear-gradient(135deg, var(--accent-purple), #8b5cf6);
}

.gradient-green {
  background: linear-gradient(135deg, var(--accent-green), #10b981);
}

.gradient-orange {
  background: linear-gradient(135deg, var(--accent-orange), #f97316);
}

.gradient-red {
  background: linear-gradient(135deg, var(--accent-red), #ef4444);
}

.gradient-yellow {
  background: linear-gradient(135deg, var(--accent-yellow), #f59e0b);
}

/* Navigation button styles */
.nav-btn-not-attempted {
  background: rgba(255, 255, 255, 0.1);
  border: 1px solid rgba(255, 255, 255, 0.2);
  color: rgba(255, 255, 255, 0.7);
}

.nav-btn-current {
  background: linear-gradient(135deg, var(--accent-blue), #3b82f6);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
  box-shadow: 0 0 20px rgba(96, 165, 250, 0.4);
}

.nav-btn-correct {
  background: linear-gradient(135deg, var(--accent-green), #10b981);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-incorrect {
  background: linear-gradient(135deg, var(--accent-red), #ef4444);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-bookmarked {
  background: linear-gradient(135deg, var(--accent-yellow), #f59e0b);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-marked-review {
  background: linear-gradient(135deg, var(--accent-purple), #8b5cf6);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-answered {
  background: linear-gradient(135deg, #6b7280, #4b5563);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

/* Option button styles - REVISED FOR INLINE FEEDBACK */
.option-button {
  background: rgba(255, 255, 255, 0.05);
  border: 1px solid rgba(255, 255, 255, 0.15);
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  position: relative;
  overflow: hidden;
  width: 100%;
  text-align: left;
  padding: 1rem;
  border-radius: 12px;
  color: var(--text-primary);
  cursor: pointer;
  display: flex;
  align-items: center;
  gap: 1rem;
  font-size: 1rem;
}

.option-button:hover {
  background: rgba(255, 255, 255, 0.1);
  border-color: rgba(96, 165, 250, 0.5);
  transform: translateX(8px);
}

.option-button.selected {
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.3), rgba(59, 130, 246, 0.3));
  border-color: var(--accent-blue);
  transform: translateX(8px);
}

#optionsContainer.answered .option-button:hover {
    transform: translateX(0); /* Disable hover effect after answering */
}

#optionsContainer.answered .option-button {
    cursor: not-allowed;
    pointer-events: none;
}

#optionsContainer.answered .option-button:not(.correct):not(.incorrect) {
    opacity: 0.5;
}

.option-button.correct {
    background: linear-gradient(135deg, #22c55e, #16a34a);
    border-color: #22c55e;
    color: white;
    transform: translateX(0);
}

.option-button.incorrect {
    background: linear-gradient(135deg, #ef4444, #dc2626);
    border-color: #ef4444;
    color: white;
    transform: translateX(0);
}

.option-letter {
  background: rgba(255, 255, 255, 0.1);
  border: 1px solid rgba(255, 255, 255, 0.2);
  transition: all 0.3s ease;
  width: 2.5rem;
  height: 2.5rem;
  border-radius: 50%;
  display: flex;
  align-items: center;
  justify-content: center;
  font-weight: bold;
  color: var(--text-primary);
  flex-shrink: 0;
}

.option-button.selected .option-letter {
  background: var(--accent-blue);
  border-color: var(--accent-blue);
  color: white;
}

.option-button.correct .option-letter, .option-button.incorrect .option-letter {
    background: rgba(255, 255, 255, 0.2);
    border-color: rgba(255, 255, 255, 0.3);
}

.option-text {
  flex: 1;
  font-size: 1rem;
  line-height: 1.5;
}

/* Stats bar responsive grid */
.stats-grid {
  display: grid;
  grid-template-columns: repeat(5, 1fr);
  gap: 1rem;
  align-items: center;
  justify-items: center;
}

@media (max-width: 768px) {
  .stats-grid {
    grid-template-columns: repeat(3, 1fr);
    gap: 0.5rem;
  }
  
  .stats-grid > div:nth-child(4),
  .stats-grid > div:nth-child(5) {
    grid-column: span 1;
  }
}

@media (max-width: 480px) {
  .stats-grid {
    grid-template-columns: repeat(2, 1fr);
  }
  
  .stats-grid > div:last-child {
    grid-column: span 2;
    justify-self: center;
  }
}

/* Animations */
@keyframes float {
  0%, 100% { transform: translateY(0px); }
  50% { transform: translateY(-20px); }
}

@keyframes pulse-glow {
  0%, 100% { box-shadow: 0 0 20px rgba(96, 165, 250, 0.3); }
  50% { box-shadow: 0 0 40px rgba(96, 165, 250, 0.6); }
}

@keyframes checkmark {
  0% { transform: scale(0) rotate(0deg); }
  50% { transform: scale(0.8) rotate(180deg); }
  100% { transform: scale(1) rotate(360deg); }
}

@keyframes cross {
  0% { transform: scale(0) rotate(0deg); }
  50% { transform: scale(0.8) rotate(90deg); }
  100% { transform: scale(1) rotate(180deg); }
}

.animate-float {
  animation: float 6s ease-in-out infinite;
}

.animate-pulse-glow {
  animation: pulse-glow 2s ease-in-out infinite;
}

.animate-checkmark {
  animation: checkmark 0.6s cubic-bezier(0.4, 0, 0.2, 1);
}

.animate-cross {
  animation: cross 0.6s cubic-bezier(0.4, 0, 0.2, 1);
}

/* Custom scrollbar */
::-webkit-scrollbar {
  width: 8px;
}

::-webkit-scrollbar-track {
  background: rgba(255, 255, 255, 0.05);
  border-radius: 4px;
}

::-webkit-scrollbar-thumb {
  background: rgba(255, 255, 255, 0.2);
  border-radius: 4px;
}

::-webkit-scrollbar-thumb:hover {
  background: rgba(255, 255, 255, 0.3);
}

/* Responsive utilities */
@media (max-width: 768px) {
  .glass-card {
    border-radius: 16px;
  }
  
  .glass {
    border-radius: 12px;
  }
}

    </style>
</head>
<body>
    <!-- Mode Selection Modal -->
    <div id="modeModal" class="fixed inset-0 bg-black bg-opacity-70 flex items-center justify-center z-50 backdrop-blur-sm">
        <div class="glass-heavy p-8 max-w-md w-full mx-4 shadow-2xl">
            <h2 class="text-2xl font-bold text-white mb-6 text-center">Choose Study Mode</h2>
            
            <div class="space-y-4">
                <button onclick="selectMode('study')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Study Mode</h3>
                            <p class="text-sm text-white text-opacity-70">Interactive learning with immediate feedback</p>
                        </div>
                        <div class="gradient-blue w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path d="M9 12l2 2 4-4m6 2a9 9 0 11-18 0 9 9 0 0118 0z"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('test')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Test Mode</h3>
                            <p class="text-sm text-white text-opacity-70">Practice test with performance analysis at end</p>
                        </div>
                        <div class="gradient-purple w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path d="M9 2a1 1 0 000 2h2a1 1 0 100-2H9z"></path>
                                <path fill-rule="evenodd" d="M4 5a2 2 0 012-2v1a1 1 0 001 1h6a1 1 0 001-1V3a2 2 0 012 2v6a2 2 0 01-2 2H6a2 2 0 01-2-2V5zm3 4a1 1 0 000 2h.01a1 1 0 100-2H7zm3 0a1 1 0 000 2h3a1 1 0 100-2h-3z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('timed_study')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Timed Study</h3>
                            <p class="text-sm text-white text-opacity-70">Study with time pressure and immediate feedback</p>
                        </div>
                        <div class="gradient-green w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path fill-rule="evenodd" d="M10 18a8 8 0 100-16 8 8 0 000 16zm1-12a1 1 0 10-2 0v4a1 1 0 00.293.707l2.828 2.829a1 1 0 101.415-1.415L11 9.586V6z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('timed_exam')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Timed Exam</h3>
                            <p class="text-sm text-white text-opacity-70">Real exam simulation with strict timing</p>
                        </div>
                        <div class="gradient-red w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path fill-rule="evenodd" d="M12.395 2.553a1 1 0 00-1.45-.385c-.345.23-.614.558-.822.88-.214.33-.403.713-.57 1.116-.334.804-.614 1.768-.84 2.734a31.365 31.365 0 00-.613 3.58 2.64 2.64 0 01-.945-1.067c-.328-.68-.398-1.534-.398-2.654A1 1 0 005.05 6.05 6.981 6.981 0 003 11a7 7 0 1011.95-4.95c-.592-.591-.98-.985-1.348-1.467-.363-.476-.724-1.063-1.207-2.03z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
            </div>
        </div>
    </div>

    <!-- Performance Analysis Modal -->
    <div id="performanceModal" class="hidden fixed inset-0 bg-black bg-opacity-80 flex items-center justify-center z-50 backdrop-blur-sm">
        <div class="glass-heavy p-8 max-w-4xl w-full mx-4 shadow-2xl max-h-[90vh] overflow-y-auto">
            <div class="flex items-center justify-between mb-8">
                <h2 class="text-3xl font-bold text-white">Performance Analysis</h2>
                <button onclick="closePerformanceModal()" class="glass-light p-2 rounded-lg text-white hover:bg-white hover:bg-opacity-20">
                    <svg class="w-6 h-6" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M4.293 4.293a1 1 0 011.414 0L10 8.586l4.293-4.293a1 1 0 111.414 1.414L11.414 10l4.293 4.293a1 1 0 01-1.414 1.414L10 11.414l-4.293 4.293a1 1 0 01-1.414-1.414L8.586 10 4.293 5.707a1 1 0 010-1.414z" clip-rule="evenodd"></path>
                    </svg>
                </button>
            </div>
            
            <!-- Score Overview -->
            <div class="grid grid-cols-1 md:grid-cols-3 gap-6 mb-8">
                <div class="performance-card p-6 text-center">
                    <div class="score-circle mb-4">
                        <svg width="150" height="150" class="mx-auto">
                            <circle class="circle-bg" cx="75" cy="75" r="65"></circle>
                            <circle id="scoreCircle" class="circle-progress" cx="75" cy="75" r="65" stroke="#22c55e" stroke-dasharray="0 408"></circle>
                        </svg>
                        <div class="score-text">
                            <div class="text-3xl font-bold text-white" id="accuracyScore">0%</div>
                            <div class="text-sm text-white text-opacity-70">Accuracy</div>
                        </div>
                    </div>
                </div>
                
                <div class="performance-card p-6">
                    <h3 class="text-lg font-bold text-white mb-4 text-center">Results Summary</h3>
                    <div class="space-y-3">
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Total Questions:</span>
                            <span class="text-white font-semibold" id="totalQuestionsResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-green-400">Correct:</span>
                            <span class="text-green-400 font-semibold" id="correctResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-red-400">Incorrect:</span>
                            <span class="text-red-400 font-semibold" id="incorrectResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-gray-400">Not Attempted:</span>
                            <span class="text-gray-400 font-semibold" id="notAttemptedResult">0</span>
                        </div>
                    </div>
                </div>
                
                <div class="performance-card p-6">
                    <h3 class="text-lg font-bold text-white mb-4 text-center">Time Analysis</h3>
                    <div class="space-y-3">
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Total Time:</span>
                            <span class="text-white font-semibold" id="totalTimeResult">0:00</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Avg per Question:</span>
                            <span class="text-white font-semibold" id="avgTimeResult">0:00</span>
                        </div>
                    </div>
                </div>
            </div>
            
            <!-- Action Buttons -->
            <div class="flex justify-center space-x-4 mb-8">
                <button onclick="reviewQuestions()" class="glass-button px-8 py-3 text-lg">
                    Review All Questions
                </button>
                <button onclick="retakeQuiz()" class="glass-light px-8 py-3 text-lg text-white hover:bg-white hover:bg-opacity-20">
                    Retake Quiz
                </button>
            </div>
            
            <!-- Question Review Section -->
            <div id="questionReviewSection" class="hidden">
                <h3 class="text-2xl font-bold text-white mb-6">Question Review</h3>
                <div id="reviewQuestionsContainer">
                    <!-- Review questions will be populated here -->
                </div>
            </div>
        </div>
    </div>

    <!-- Header -->
    <header class="glass sticky top-0 z-40 mb-6">
        <div class="container mx-auto px-6 py-4">
            <div class="flex items-center justify-between">
                <div class="flex items-center space-x-4">
                    <button onclick="goBack()" class="glass-light px-4 py-2 text-white hover:bg-white hover:bg-opacity-20 transition-all duration-300 flex items-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                            <path fill-rule="evenodd" d="M9.707 16.707a1 1 0 01-1.414 0l-6-6a1 1 0 010-1.414l6-6a1 1 0 011.414 1.414L5.414 9H17a1 1 0 110 2H5.414l4.293 4.293a1 1 0 010 1.414z" clip-rule="evenodd"></path>
                        </svg>
                        Back
                    </button>
                    <div id="quizHierarchy" class="text-sm text-white text-opacity-60">
                        Cerebellum / qBank / Pathology
                    </div>
                </div>
                
                <div class="flex items-center space-x-4">
                    <div class="glass-light px-3 py-1 text-sm text-white">
                        Question <span id="currentQuestion">1</span> of <span id="totalQuestions">125</span>
                    </div>
                    
                    <!-- Timer -->
                    <div id="timerContainer" class="hidden gradient-red px-3 py-1 text-sm text-white font-bold animate-pulse-glow">
                        <span id="timeDisplay">2:00</span>
                    </div>
                </div>
            </div>
        </div>
    </header>

    <!-- Progress Bar -->
    <div class="w-full h-1 bg-black bg-opacity-30 mb-6">
        <div id="progressBar" class="h-1 gradient-blue transition-all duration-500 ease-out" style="width: 0%"></div>
    </div>

    <!-- Stats Bar - Show only in study modes -->
    <div id="statsBar" class="glass-light mb-8">
        <div class="container mx-auto px-6 py-4">
            <div class="stats-grid">
                <div class="text-center">
                    <div class="text-lg font-bold text-green-400" id="correctCount">0</div>
                    <div class="text-xs text-white text-opacity-60">Correct</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-red-400" id="incorrectCount">0</div>
                    <div class="text-xs text-white text-opacity-60">Incorrect</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-blue-400" id="totalAttempted">0</div>
                    <div class="text-xs text-white text-opacity-60">Attempted</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-purple-400" id="accuracy">0%</div>
                    <div class="text-xs text-white text-opacity-60">Accuracy</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-orange-400" id="timeSpent">0:00</div>
                    <div class="text-xs text-white text-opacity-60">Time</div>
                </div>
            </div>
        </div>
    </div>

    <div class="flex container mx-auto px-6 gap-8">
        <!-- Question Navigation Sidebar -->
        <div class="w-80 glass p-6 h-fit sticky top-24">
            <h3 class="text-lg font-bold text-white mb-4">Question Navigator</h3>
            <div id="questionNav" class="grid grid-cols-5 gap-2 mb-6">
                <!-- Question numbers will be populated here -->
            </div>
            
            <div class="space-y-3 text-xs">
                <h4 class="text-sm font-medium text-white text-opacity-80 mb-3">Legend</h4>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-not-attempted rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Not Attempted</span>
                </div>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-current rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Current</span>
                </div>
                <div id="studyModeLegend" class="space-y-2">
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-correct rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Correct</span>
                    </div>
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-incorrect rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Incorrect</span>
                    </div>
                </div>
                <div id="testModeLegend" class="hidden space-y-2">
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-answered rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Answered</span>
                    </div>
                </div>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-bookmarked rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Bookmarked</span>
                </div>
                <div id="testModeReviewLegend" class="hidden items-center">
                    <div class="w-6 h-6 nav-btn-marked-review rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Marked for Review</span>
                </div>
            </div>
            
            <!-- Submit Quiz Button for test modes -->
            <div id="submitSection" class="hidden mt-6">
                <button onclick="submitQuiz()" class="glass-button w-full py-3 text-lg font-bold">
                    Submit Quiz
                </button>
            </div>
        </div>

        <!-- Main Quiz Interface -->
        <div class="flex-1 max-w-4xl">
            <div class="glass-card p-8 lg:p-12 mb-8 relative">
                <!-- Question Text -->
                <div id="questionText" class="text-xl lg:text-2xl leading-relaxed text-white mb-8">
                    Loading question...
                </div>

                <!-- Question Media -->
                <div id="questionMedia" class="mb-8"></div>

                <!-- Options -->
                <div id="optionsContainer" class="space-y-3 mb-8">
                    <!-- Options will be inserted here -->
                </div>

                <!-- Solution Display (only for study modes) -->
                <div id="solutionContainer" class="hidden glass-light p-6 border-l-4 border-green-400">
                    <h3 class="text-lg font-bold text-green-400 mb-3 flex items-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                            <path fill-rule="evenodd" d="M18 10a8 8 0 11-16 0 8 8 0 0116 0zm-7-4a1 1 0 11-2 0 1 1 0 012 0zM9 9a1 1 0 000 2v3a1 1 0 001 1h1a1 1 0 100-2v-3a1 1 0 00-1-1H9z" clip-rule="evenodd"></path>
                        </svg>
                        Explanation
                    </h3>
                    <div id="solutionText" class="text-white text-opacity-90 leading-relaxed mb-4"></div>
                    <!-- Explanation Video -->
                    <div id="solutionVideo" class="hidden">
                        <video id="explanationVideoPlayer" class="w-full rounded-lg" controls>
                            Your browser does not support the video tag.
                        </video>
                    </div>
                </div>
            </div>

            <!-- Controls -->
            <div class="flex justify-between items-center mb-8">
                <button onclick="previousQuestion()" id="prevBtn" class="glass-button px-6 py-3 flex items-center disabled:opacity-50 disabled:cursor-not-allowed">
                    <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M12.707 5.293a1 1 0 010 1.414L9.414 10l3.293 3.293a1 1 0 01-1.414 1.414l-4-4a1 1 0 010-1.414l4-4a1 1 0 011.414 0z" clip-rule="evenodd"></path>
                    </svg>
                    Previous
                </button>
                
                <div class="flex justify-center flex-grow">
                    <button onclick="toggleBookmark()" id="bookmarkBtn" class="glass-light px-6 py-3 text-white hover:bg-yellow-500 hover:bg-opacity-20 transition-all duration-300 flex items-center">
                        <svg class="w-5 h-5 mr-2" id="bookmarkIcon" fill="currentColor" viewBox="0 0 20 20">
                            <path d="M5 4a2 2 0 012-2h6a2 2 0 012 2v14l-5-2.5L5 18V4z"></path>
                        </svg>
                        <span id="bookmarkText">Bookmark</span>
                    </button>
                    
                    <button onclick="toggleMarkForReview()" id="markReviewBtn" class="hidden glass-light px-6 py-3 text-white hover:bg-purple-500 hover:bg-opacity-20 transition-all duration-300 flex items-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                           <path fill-rule="evenodd" d="M5 2a2 2 0 00-2 2v12a2 2 0 002 2h10a2 2 0 002-2V4a2 2 0 00-2-2H5zm0 2h10v12H5V4z" clip-rule="evenodd" />
                           <path d="M12.586 6.586a2 2 0 10-2.828 2.828l-3 3a2 2 0 102.828-2.828l3-3z" />
                        </svg>
                        <span id="markReviewText">Mark for Review</span>
                    </button>
                </div>
                
                <button onclick="nextQuestion()" class="glass-button px-6 py-3 flex items-center">
                    Next
                    <svg class="w-5 h-5 ml-2" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M7.293 14.707a1 1 0 010-1.414L10.586 10 7.293 6.707a1 1 0 011.414-1.414l4 4a1 1 0 010 1.414l-4 4a1 1 0 01-1.414 0z" clip-rule="evenodd"></path>
                    </svg>
                </button>
            </div>
        </div>
    </div>

    <script>
        let questionsData = [
  {
    "id": 14257,
    "choices": [
      {
        "id": 56989,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Acid hematin method</span></p>"
      },
      {
        "id": 56990,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Alkali hematin method</span></p>"
      },
      {
        "id": 56991,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Cyanmethemoglobin method</span></p>"
      },
      {
        "id": 56992,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Any of the above</span>\u200b\u200b\u200b\u200b\u200b\u200b</p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt;\">The best method for estimation of hemoglobin concentration in blood is:</span></p>",
    "unique_key": "Q4564548",
    "question_audio": null,
    "question_video": null,
    "map_id": 31894,
    "difficulty_level": "difficult",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C. Cyanmethemoglobin method</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The c<strong>yanmethemoglobin </strong>method is considered th<strong>e gold standard for hemoglobin measurement</strong>. <strong>Hemoglobin </strong>is converted to <strong>cyanmethemoglobin</strong>, which has a <strong>stable color, </strong>using a solution containing <strong>potassium cyanide and potassium ferricyanide. </strong>This method provides <strong>accurate and reliable measurements </strong>and is less susceptible to interference from turbidity.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. The acid hematin</strong> method involves converting<strong> hemoglobin to acid hematin </strong>using an <strong>acidic solution</strong>. This method is<strong> less frequently </strong>used due to its<strong> lower specificity and sensitivity </strong>compared to other methods.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Similar to the acid hematin</strong> method, the <strong>alkali hematin </strong>method involves the<strong> conversion of hemoglobin to alkali hematin </strong>using an<strong> alkaline solution</strong>. It is also not commonly used in clinical practice because it can be less accurate and is affected by turbidity caused by the presence of other substances in the blood.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Educational Objective:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Methods to estimate hemoglobin:</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_iGkA07R.png\" width=\"1340\" height=\"569\"></p>",
    "correct_choice_id": 56991,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "InvestigationBased"
    ]
  },
  {
    "id": 15403,
    "choices": [
      {
        "id": 61572,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lack of H, A and B antigen on RBCs </span></span></p>"
      },
      {
        "id": 61573,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lack of H, A and B substance in saliva </span></span></p>"
      },
      {
        "id": 61574,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lack of antigens of several blood group systems </span></span></p>"
      },
      {
        "id": 61575,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">H, A and B antibody will always be present in se&shy;rum </span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"background-color:white\"><span style=\"color:#0d0d0d\">A 30-year-old male requires a blood transfusion after a severe car accident. He is known to have the Bombay phenotype. Prior to the transfusion, his blood sample is sent to the laboratory for compatibility testing. Based on his blood group, which of the following statements is incorrect?</span></span> </span></span></span></p>",
    "unique_key": "Q3552180",
    "question_audio": null,
    "question_video": null,
    "map_id": 31892,
    "difficulty_level": "difficult",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><span style=\"color:black\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Lack of antigens of several blood group systems</span></strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">Option C: </span></span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">People with<strong> Bombay phenotype (rarest blood </strong>group in the <strong>world) </strong>express <strong>no A, B or H antigens on the red blood cells. </strong>These are <strong>homozygous </strong>for the silent <strong>h allele </strong>(being represented h). So, these antigens are<strong> not present </strong>in the <strong>saliva </strong>also. As the <strong>antigens are not expressed, </strong>so, the<strong> H, A and B antibody </strong>will always be present in<strong> serum</strong>. </span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">ABO antigens are present not only on the<strong> red blood cells </strong>abut also on the<strong> other blood cells</strong>, in most body fluids (<strong>except CSF</strong>),<strong> cell membrane of tissues </strong>such as <strong>intestine, urothelium and vascular endothelium</strong>. </span></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">He lacks antigens from multiple blood group systems:</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\"> This statement is<strong> incorrect</strong>. Individuals with the <strong>Bombay phenotype </strong>only lack <strong>antigens </strong>in the <strong>ABO blood group system </strong>specifically related to <strong>A, B, and H antigens. </strong>They<strong> do not lack antigens </strong>from other <strong>blood group systems</strong>.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">Explanation:</span></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">Option A. His red blood cells lack H, A, and B antigens:</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\"> This statement is<strong> correct. </strong>Individuals with the Bombay blood group<strong> do not express A, B, or H antigens on their red blood cells </strong>due to a homozygous mutation in the H gene <strong>(hh genotype).</strong></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">Option B. His saliva does not contain H, A, and B substances:</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\"> This statement is<strong> correct. </strong>The lack of H antigen also affects the presence of these <strong>antigens in body fluids</strong>, including<strong> saliva</strong>, because the <strong>H antigen is a precursor for A and B antigen synthesis.</strong></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">Option D. His serum contains antibodies against H, A, and B antigens:</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\"> This statement is <strong>correct</strong>. Because individuals with the Bombay phenotype<strong> do not express A, B, or H antigens on their red blood cells</strong>, they will form<strong> antibodies against </strong>these antigens if <strong>exposed.</strong></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">Educational Objective:</span></span></u></strong>&nbsp; </span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">Individuals with the Bombay phenotype lack A, B, and H antigens on their red blood cells and in their saliva, and their serum contains antibodies against these antigens. </span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><span style=\"color:black\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Wintrobe&rsquo;s hematology 12th/635-6</span></strong></span></span></span></p>",
    "correct_choice_id": 61574,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual"
    ]
  },
  {
    "id": 15415,
    "choices": [
      {
        "id": 61620,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">It was the first blood group system to be discovered </span></span></span></span></p>"
      },
      {
        "id": 61621,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">It has four different blood group A, B, AB, O (H) </span></span></span></span></p>"
      },
      {
        "id": 61622,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">ABO (H) antigens are present in most body tissues and fluids </span></span></span></span></p>"
      },
      {
        "id": 61623,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><span style=\"color:black\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">ABO (H) antibodies are invariably present in plasma when persons RBC lack the corresponding antigen</span></span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Although more than 400 blood groups have been identified, the ABO blood system re-mains the most important in clinical medicine because:</span></span></span></span></p>",
    "unique_key": "Q3801944",
    "question_audio": null,
    "question_video": null,
    "map_id": 31896,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ans. D) ABO (H) antibodies are invariably present in plasma when persons RBC lacks the corresponding antigen </span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><span style=\"color:black\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><span style=\"color:black\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">In clinical transfusion practice the<strong> ABO blood groups </strong>are the most important and can never be ignored in <strong>red cell transfusion, </strong>because individuals, who genetically <strong>lack any antigen, </strong>have <strong>antibodies against the red cell types </strong>that they have<strong> not inher&shy;ited</strong>. These <strong>antibodies can destroy red cells rapidly in circulation. </strong></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><span style=\"color:black\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">The same is <strong>not </strong>the case with other<strong> blood groups </strong>where <strong>antibodies are formed </strong>only after exposure to the<strong> sensitive antigen (Preformed antibodies are absent</strong>). </span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">Educational Objective:</span></span></u></strong> </span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">The presence of naturally occurring <strong>antibodies </strong>in individuals <strong>against ABO antigens </strong>they<strong> do not possess on their red blood cells </strong>is the critical factor that can<strong> lead to hemolytic reactions </strong>if <strong>incompatible blood </strong>is transfused.</span></span></span></span></p>",
    "correct_choice_id": 61623,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual"
    ]
  },
  {
    "id": 15416,
    "choices": [
      {
        "id": 61624,
        "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fucose</span></span></p>"
      },
      {
        "id": 61625,
        "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Deoxyribose</span></span></p>"
      },
      {
        "id": 61626,
        "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ribulose</span></span></p>"
      },
      {
        "id": 61627,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ribose</span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Carbohydrate present in blood group substance is:</span></span></span></p>",
    "unique_key": "Q8794279",
    "question_audio": null,
    "question_video": null,
    "map_id": 31897,
    "difficulty_level": "difficult",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ans. A) Fucose </span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">Option A:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">Fucose is a <strong>monosaccharide </strong>that is added to the<strong> precursor substance on red blood cells </strong>to form the <strong>H antigen</strong>. Individuals with the <strong>O blood group </strong>have the<strong> H antigen on their red blood cells </strong>without further modification</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">The first blood group antigen system was <strong>ABO and is the most important in transfusion medicine</strong>. The major blood groups of this system are <strong>A, B, AB, and O</strong>. <strong>H sub&shy;stance </strong>is the <strong>immediate precursor </strong>on which the <strong>A and B antigens </strong>are added. This<strong> H substance </strong>is formed by the </span><strong>addition of fucose </strong>to the <strong>glycolipid or glycoprotein back&shy;bone</strong>. The subsequent addition of<strong> N-acetyl galactosamine creates </strong>the A antigen, while the addition&nbsp;</span></span></span><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">of<strong> galactose produces the B antigen</strong>. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><span style=\"color:black\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">Option B. Deoxyribose:</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\"> Deoxyribose is a <strong>sugar found in DNA</strong>, not associated with the ABO blood group antigens.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">Option C. Ribulose:</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\"> Ribulose is a<strong> pentose sugar </strong>involved in metabolic pathways, like the<strong> pentose phosphate pathway, </strong>but it is not related to blood group antigen formation.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">Option D. Ribose:</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\"> Ribose is a<strong> sugar component of RNA </strong>and is not involved in the structure of ABO blood group antigens.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">Educational Objective:</span></span></u></strong> </span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\"><strong>Fucose </strong>is added to the<strong> glycolipid or glycoprotein backbone </strong>of red blood cells to form the<strong> H antigen. </strong></span></span></span></span></p>",
    "correct_choice_id": 61624,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual"
    ]
  },
  {
    "id": 15436,
    "choices": [
      {
        "id": 61704,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lacks H-antigen</span></span></span></p>"
      },
      {
        "id": 61705,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lacks A-antigen</span></span></span></p>"
      },
      {
        "id": 61706,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lacks B antigen </span></span></span></p>"
      },
      {
        "id": 61707,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">All of the above</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is true about h/h blood group?</span></span></span></p>",
    "unique_key": "Q3144879",
    "question_audio": null,
    "question_video": null,
    "map_id": 31893,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) All of the above </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>h/h blood group </strong>is the other name of <strong>Bombay blood group</strong>. It is characterized by<strong> absence of H, A and B anti&shy;gen </strong>expression on the <strong>surface of red cells</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">Educational objective: </span></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">The<strong> h/h blood group (Bombay blood group) </strong>is characterized by the <strong>absence of the H antigen, A antigen, and B antigen on the surface of red blood cells</strong>.</span></span></span></span></p>",
    "correct_choice_id": 61707,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 15448,
    "choices": [
      {
        "id": 61752,
        "text": "<p>1</p>"
      },
      {
        "id": 61753,
        "text": "<p>9</p>"
      },
      {
        "id": 61754,
        "text": "<p>19</p>"
      },
      {
        "id": 61755,
        "text": "<p>13</p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A medical student is reviewing the chromosomal locations of blood group antigens. When considering the Rh blood group system, including the Rh antigen, which of the following chromosomes houses the relevant genes?</span></span></span></p>",
    "unique_key": "Q2225390",
    "question_audio": null,
    "question_video": null,
    "map_id": 31898,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) 1 </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><span style=\"color:black\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><span style=\"color:black\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The<strong> Rh blood group </strong>system involves <strong>two genes, RHD and RHCE, </strong>which are located on<strong> chromosome 1</strong>. The specific chromosomal location for the <strong>Rh antigen is on chromosome 1</strong>.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><span style=\"color:black\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective: </span></u></strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><span style=\"color:black\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>gene for Rh antigen </strong>is present on <strong>chromosome 1.</strong></span></span></span></span></p>",
    "correct_choice_id": 61752,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "InvestigationBased"
    ]
  },
  {
    "id": 14278,
    "choices": [
      {
        "id": 57073,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">TIBC &uarr; </span></span></span></p>"
      },
      {
        "id": 57074,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">S. Iron &uarr;</span></span></span></p>"
      },
      {
        "id": 57075,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">BM iron &darr;</span></span></span></p>"
      },
      {
        "id": 57076,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">S. ferritin &uarr;</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 58-year-old man with a history of rheumatoid arthritis presents with fatigue and exertional dyspnea. Laboratory tests show a mild anemia with a hemoglobin of 10 g/dL. Further workup reveals the following: serum ferritin is elevated, total iron-binding capacity (TIBC) is decreased, serum iron is reduced, and transferrin saturation percentage is decreased. Which laboratory finding is most characteristic of the anemia of chronic disease?</span></span></span></p>",
    "unique_key": "Q2594472",
    "question_audio": null,
    "question_video": null,
    "map_id": 31891,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><em><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D. S. ferritin &uarr; </span></em></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Anemia of chronic disease </strong>is characterized by <strong>increased serum ferritin levels, decreased Total Iron Binding Capacity (TIBC), reduced serum iron, and a decreased percentage saturation of transferrin.</strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Serum ferritin </strong>is an <strong>acute-phase reactant </strong>and can be <strong>increased in anemia of chronic disease</strong>, reflecting the <strong>body&#39;s iron stores </strong>which are sequestered due to<strong> inflammatory cytokines.</strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. TIBC is typically</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong> increased </strong>due to the body&#39;s attempt to<strong> increase iron binding capacity </strong>in response to<strong> low iron stores</strong>, which is not the case in anemia of chronic disease.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Anemia of chronic disease</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> typically presents with <strong>decreased serum iron due to sequestration of iron </strong>within <strong>macrophages and hepatocytes</strong>.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. In anemia of chronic disease</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">, bone marrow<strong> iron stores </strong>are usually <strong>normal or increased</strong>, not decreased.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong> </span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The most characteristic laboratory finding in <strong>anemia of chronic disease </strong>is<strong> increased serum ferritin, </strong>reflecting <strong>sequestered iron stores </strong>that are not available for<strong> effective erythropoiesis despite the body </strong>having <strong>adequate or increased total iron.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Robbins 10<sup>th</sup>/ 659 </span></span></strong></p>",
    "correct_choice_id": 57076,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "InvestigationBased"
    ]
  },
  {
    "id": 14261,
    "choices": [
      {
        "id": 57005,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Serum ferritin is decreased</span></span></span></p>"
      },
      {
        "id": 57006,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Reduced hepcidin levels</span></span></span></p>"
      },
      {
        "id": 57007,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Transferrin saturation is decreased</span></span></span></p>"
      },
      {
        "id": 57008,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Total iron binding capacity is increased</span></span></span>\u200b\u200b\u200b\u200b\u200b</p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">A 45-year-old woman with a history of rheumatoid arthritis presents with fatigue and pallor. Her blood tests show mild anemia. Additional laboratory tests are ordered to determine the cause of her anemia. Which of the following laboratory findings is most consistent with a diagnosis of anemia of chronic disease?</span></span></span></span></span></p>",
    "unique_key": "Q6289357",
    "question_audio": null,
    "question_video": null,
    "map_id": 31895,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C. Transferrin saturation is decreased </span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Anemia of chronic disease (ACD), </strong>also known as<strong> anemia of inflammation</strong>, is a type of anemia that occurs in the setting of <strong>chronic inflammatory conditions, infections, or malignancies. </strong>It is characterized by disturbances in<strong> iron metabolism</strong>. The correct laboratory findings for the diagnosis of <strong>anemia of chronic disease </strong>are:</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Transferrin saturation </strong>is<strong> decreased </strong>in anemia of chronic disease due to<strong> limited availability of iron for erythropoiesis, </strong>even though <strong>iron stores are often adequate.</strong></span></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increased hepcidin levels </span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Transferrin saturation is decreased:</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;Serum ferritin is increased </span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Total iron-binding capacity (TIBC) is decreased </span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"margin-left:33px\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A.&nbsp; In iron deficiency anemia</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">, <strong>serum ferritin, </strong>which reflects body<strong> iron stores, is decreased. </strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Hepcidin</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> levels are typically <strong>increased in anemia of chronic disease </strong>because it is an inflammatory marker that <strong>blocks the release of iron </strong>from body stores, contributing to the anemia.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. In anemia</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> of chronic disease,<strong> TIBC </strong>is usually <strong>normal or decreased</strong>, <strong>not increased</strong>, because the <strong>body&#39;s iron is sequestered </strong>due to<strong> inflammation </strong>and is<strong> not readily available for erythropoiesis.</strong></span></span></span></p>\r\n\r\n<p style=\"margin-left:24px\"><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Educational Objective:</span></span></u></strong><u> </u></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">In <strong>anemia of chronic disease</strong>,<strong> transferrin saturation</strong> is <strong>decreased due to limited iron utilization,</strong> despite <strong>adequate or increased iron</strong> <strong>stores </strong>reflected by <strong>normal or increased serum ferritin levels.</strong></span></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u><em><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Robbins 10th/e p658</span></span></em></strong></p>",
    "correct_choice_id": 57007,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 41790,
    "choices": [
      {
        "id": 166844,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Transfusion dependency</span></span></span></p>"
      },
      {
        "id": 166845,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Splenoheptatomegaly</span></span></span></p>"
      },
      {
        "id": 166846,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ineffective erythropoiesis</span></span></span></p>"
      },
      {
        "id": 166847,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Macrocytic anaemia</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">All are seen in Thalasemia major except: </span></span></span></p>",
    "unique_key": "Q9401991",
    "question_audio": null,
    "question_video": null,
    "map_id": 31899,
    "difficulty_level": "beginner",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D. Macrocytic anaemia </span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Macrocytic anemia </strong>is typically associated with disorders of <strong>DNA synthesis, such as vitamin B12 or folate deficiency, </strong>not <strong>thalassemia major, </strong>which usually presents with <strong>microcytic (small cell) anemia due to defective hemoglobin synthesis.</strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Transfusion dependency</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> is a characteristic of<strong> thalassemia major, </strong>as patients often require regular <strong>blood transfusions </strong>to manage severe anemia due to<strong> ineffective erythropoiesis.</strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Splenohepatomegaly</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> in thalassemia major results from <strong>extramedullary hematopoiesis, </strong>where the spleen and liver try to compensate for the anemia by producing<strong> blood cells, and from iron overload due to repeated transfusions.</strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Ineffective erythropoiesis</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> refers to the bone marrow&#39;s <strong>inability to produce mature and functional red blood cells</strong>, a <strong>hallmark of thalassemia major </strong>due to mutations affecting hemoglobin production.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Thalassemia major </strong>typically presents with<strong> transfusion dependency, splenohepatomegaly, and ineffective erythropoiesis </strong>but not with <strong>macrocytic anemia</strong>, which is<strong> more consistent with deficiencies in vitamin B12 or folate.</strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong>&nbsp;</strong></span></span></p>\r\n\r\n<p><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u><em><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Robbins 10<sup>th</sup>/ 638</span></span></em></strong></p>",
    "correct_choice_id": 166847,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual"
    ]
  },
  {
    "id": 41791,
    "choices": [
      {
        "id": 166848,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Iron deficiency anemia</span></span></span></p>"
      },
      {
        "id": 166849,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Thalassemia</span></span></span></p>"
      },
      {
        "id": 166850,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sickle cell anemia</span></span></span></p>"
      },
      {
        "id": 166851,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hereditary spherocytosis</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bone infarcts are seen in: </span></span></span></p>",
    "unique_key": "Q3191808",
    "question_audio": null,
    "question_video": null,
    "map_id": 31900,
    "difficulty_level": "beginner",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C. Sickle cell anemia </span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sickled cells can cause <strong>microvascular occlusion </strong>affecting<strong> bones, brain, kidney, liver, retina and pulmonary vessels</strong>.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Sickle cell anemia </strong>is well known for <strong>vaso-occlusive crises</strong>, which can lead to <strong>bone infarcts due to the occlusion of small blood vessels by sickled cells</strong>.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Iron deficiency anemia</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> usually presents with symptoms related to a<strong> lack of hemoglobin and oxygen delivery, </strong>such as <strong>fatigue and pallor</strong>, not bone infarcts.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Thalassemia can cause bone</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> deformities <strong>due to marrow expansion </strong>but does not typically cause bone infarcts.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Hereditary spherocytosis</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> typically involves<strong> hemolysis </strong>and <strong>anemia </strong>due to defects in the<strong> red blood cell membrane</strong>, but it does not usually result in bone infarcts.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Bone infarcts </strong>are a common complication in<strong> sickle cell anemia </strong>due to <strong>vaso-occlusive events </strong>caused by the <strong>abnormal, sickled red blood cells</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><em><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Ref: Robbins 10<sup>th</sup>/ 640)</span></em></strong></span></span></p>",
    "correct_choice_id": 166850,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual"
    ]
  },
  {
    "id": 41792,
    "choices": [
      {
        "id": 166852,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Trinucleotide repeat</span></span></span></p>"
      },
      {
        "id": 166853,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Genomic imprinting</span></span></span>\u200b\u200b\u200b\u200b\u200b\u200b</p>"
      },
      {
        "id": 166854,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Single amino acid base substitution</span></span></span></p>"
      },
      {
        "id": 166855,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Antibody to red cell membrane</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 18-year-old Afro American boy presenting with a non healing ulcer of the foot, with recurrent pneumonia and chronic hemolytic anemia. The peripheral blood erythrocytes showed some peculiar appearance. Most likely cause is: </span></span></span></p>",
    "unique_key": "Q7054163",
    "question_audio": null,
    "question_video": null,
    "map_id": 31888,
    "difficulty_level": "beginner",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C. Single amino acid base substitution </span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Afro American male </strong>presenting with the mentioned features is suggestive of <strong>sickle cell anemia </strong>is due to<strong> vaso-occlusion </strong>caused by <strong>sickled cells</strong>. Sickle cell anemia can cause <strong>chronic hemolytic anemia</strong>, <strong>recurrent pneumonia </strong>and <strong>non haling painful ulcer. </strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>&ldquo;Sickle cell anemia </strong>is caused by a <strong>point mutation </strong>in the <strong>sixth codon of &beta;-globin </strong>that leads to the replacement of a <strong>glutamate residue with a valine residue</strong>&rdquo; &hellip; (Ref: Robbins)</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>&nbsp;Single amino acid base </strong>substitution, specifically a <strong>point mutation </strong>in the<strong> &beta;-globin gene (glutamic acid to valine at the sixth position), </strong>is the cause of<strong> sickle cell anemia</strong>. This mutation leads to<strong> hemoglobin polymerization under hypoxic </strong>conditions and the characteristic<strong> sickling of red blood cells.</strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Trinucleotide repeat expansions</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> cause disorders such as <strong>Huntington&#39;s disease </strong>and some forms of<strong> muscular dystrophy</strong>, <strong>not sickle cell anemia.</strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Genomic imprinting is a form of gene expression regulation</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> that does not relate to the structural changes in hemoglobin seen in sickle cell anemia.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Antibody to red cell membrane would suggest</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> an <strong>autoimmune </strong>hemolytic anemia rather than a<strong> genetically </strong>determined <strong>structural hemoglobinopathy.</strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Sickle cell anemia </strong>is caused by a <strong>single amino acid substitution </strong>(<strong>valine for glutamic acid) </strong>at the<strong> sixth </strong>position of the <strong>&beta;-globin chain </strong>of hemoglobin, which results in the<strong> sickling of red cells </strong>and related complications.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><em><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Robbins 10<sup>th</sup>/ 648</span></span></em></strong></p>",
    "correct_choice_id": 166854,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 41793,
    "choices": [
      {
        "id": 166856,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Clumps of RBCs due to IgM mediated cold autoim&shy;mune haemolytic anemia</span></span></span></p>"
      },
      {
        "id": 166857,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Clumps of RBCs due to IgG mediated warm auto&shy;immune haemolytic anemia</span></span></span></p>"
      },
      {
        "id": 166858,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">RBC lysis due to hemoglobinopathy</span></span></span></p>"
      },
      {
        "id": 166859,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Clumps of RBCs due to IgG mediated cold autoim&shy;mune haemolytic anemia</span></span></span>\u200b\u200b\u200b\u200b\u200b\u200b</p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 56-year\u2011old female presents in the month of December with chronic fatigue and cyanosis of nose with blue lips. A peripheral blood smear showed the following image. What is the most likely cause of the findings seen? </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/26/picture1_67TV6O2.jpg\" style=\"height:198px; width:300px\" /></span></span></span></p>",
    "unique_key": "Q5754262",
    "question_audio": null,
    "question_video": null,
    "map_id": 31889,
    "difficulty_level": "beginner",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A. Clumps of RBCs due to IgM mediated cold autoimmune haemolytic anemia </span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The image shows<strong> agglutinated red cells</strong>. Since the his&not;tory mentions that <strong>cyanosis </strong>is seen affecting <strong>fingers and tips of nose </strong>in the <strong>month of December</strong>, it suggests that the<strong> red cells agglutinated with cold antibody </strong>associated <strong>autoimmune haemolytic anemia</strong>.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cold autoimmune</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> hemolytic anemia (CAHA) is caused by<strong> IgM antibodies </strong>that <strong>agglutinate red blood cells at low temperatures. </strong>This typically happens in the<strong> cooler peripheral parts of the body </strong>and can lead to symptoms like <strong>cyanosis </strong>when the patient is exposed to <strong>cold environments</strong>. The condition can cause<strong> chronic fatigue due to anemia </strong>resulting from the <strong>destruction of agglutinated red blood cells</strong>.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">&nbsp;&nbsp; </span></span><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Warm autoimmune</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> hemolytic anemia (WAIHA) involves<strong> IgG antibodies </strong>that react with red blood cells<strong> at body temperature, </strong>leading to their destruction by the<strong> spleen</strong>. This would not typically be associated with cold exposure and is not consistent with the symptom of cyanosis, which is related to cold.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Hemoglobinopathies,</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> such as <strong>sickle cell disease</strong>, can cause <strong>hemolytic anemia</strong>, but the <strong>red blood cells do not clump in</strong> <strong>response to cold.</strong> Instead, hemoglobinopathies typically involve<strong> structural abnormalities of the hemoglobin molecule itself.</strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Cold agglutinin</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> disease can <strong>sometime</strong>s involve <strong>IgG antibodies</strong>, but it is<strong> more commonly associated with IgM antibodies.</strong> IgG-mediated hemolysis at cold temperatures is much less common and would not explain the typical clumping seen in CAHA.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is important to recognize the clinical and laboratory findings consistent with <strong>cold autoimmune hemolytic anemia (CAHA), </strong>where <strong>IgM antibodies bind to red blood cells at low temperatures</strong>, causing them <strong>to agglutinate</strong>. This can lead to<strong> hemolytic anemia</strong>, resulting in symptoms such as<strong> chronic fatigue and cyanosis </strong>upon cold exposure. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><em><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Robbins 10<sup>th</sup>/ 643-4</span></span></em></strong></p>",
    "correct_choice_id": 166856,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "ImageBased"
    ]
  },
  {
    "id": 41794,
    "choices": [
      {
        "id": 166860,
        "text": "<p><span style=\"font-size:12pt;\">Duffy blood group</span></p>"
      },
      {
        "id": 166861,
        "text": "<p><span style=\"font-size:12pt;\">Sickle cell anemia</span></p>"
      },
      {
        "id": 166862,
        "text": "<p><span style=\"font-size:12pt;\">Thalassemia</span></p>"
      },
      {
        "id": 166863,
        "text": "<p><span style=\"font-size:12pt;\">G6PD deficiency</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt;\">All of the following if present provide protection against malaria except:</span></p>",
    "unique_key": "Q2503253",
    "question_audio": null,
    "question_video": null,
    "map_id": 31890,
    "difficulty_level": "difficult",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A. Duffy blood group</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Conditions providing protection against malaria with the reasons</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Absence</strong> of <strong>duffy blood group:</strong> duffy antigen is required for <strong>parasite to enter the RBCs</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Sickle cell disease:</strong> P falciparum cannot multiply properly in the presence of<strong> HbS \u03b1 and \u03b2 thalassemia:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. G6 PD deficiency:</strong> G6PD is required for<strong> respiration of plasmodium</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The <strong>absence of the Duffy blood group, the trait for sickle cell disease, thalassemia traits, and G6PD deficiency </strong>are all known to confer some protection <strong>against malaria </strong>due to various mechanisms that interfere with the<strong> parasite's ability to infect or survive within red blood cells</strong>. However, the<strong> Duffy blood group's absence</strong>, while protective <strong>against Plasmodium vivax</strong>, <strong>does not provide protection against P. falciparum, the most common and virulent cause of malaria.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Summary:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_KESE5tw.png\" width=\"936\" height=\"364\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Ref</u>: Robbins 10<sup>th</sup>/ 403</strong></span></p>",
    "correct_choice_id": 166860,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "InvestigationBased"
    ]
  },
  {
    "id": 14256,
    "choices": [
      {
        "id": 56985,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Methyl violet</span></p>"
      },
      {
        "id": 56986,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Brilliant Cresyl blue</span></p>"
      },
      {
        "id": 56987,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">New methylene blue</span></p>"
      },
      {
        "id": 56988,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Indigo carmine</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt;\">Reticulocytes are BEST stained with:</span></p>",
    "unique_key": "Q4124201",
    "question_audio": null,
    "question_video": null,
    "map_id": 31886,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C. New methylene blue</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C:</strong></span></p><p>&nbsp;</p><p><span style=\"background-color:white;color:#0d0d0d;font-size:12pt;\"><strong>New methylene blue </strong>is considered the best stain for<strong> reticulocytes</strong>. It stains reticulocytes more clearly and is preferred because it has a <strong>high affinity for the ribosomal RNA, </strong>allowing for <strong>better visualization of reticulocytes </strong>in a blood smear.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p>&nbsp;</p><p><span style=\"background-color:white;color:#0d0d0d;font-size:12pt;\"><strong>Option A. Methyl violet&nbsp;</strong>is a <strong>basic dye </strong>that can be used to stain<strong> acidic components</strong> of cells like <strong>nucleic acids, </strong>but it is not the best choice for staining reticulocytes. It is commonly used in Gram staining.</span></p><p>&nbsp;</p><p><span style=\"background-color:white;color:#0d0d0d;font-size:12pt;\"><strong>Option B. Brilliant Cresyl&nbsp;</strong>blue is used to <strong>stain reticulocytes </strong>by binding to the <strong>residual ribosomal RNA</strong>. It is a vital stain, but it is <strong>not the optimal dye for reticulocyte staining </strong>as it may<strong> not be as sensitive as new methylene blue</strong>.</span></p><p>&nbsp;</p><p><span style=\"background-color:white;color:#0d0d0d;font-size:12pt;\"><strong>Option D. Indigo carmine&nbsp;</strong>is not used for<strong> staining blood cells</strong>; it is a<strong> dye </strong>more commonly used in medical procedures to <strong>highlight structures </strong>and <strong>assess the function </strong>of certain organs, such as during <strong>kidney surgery.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Reticulocytes&nbsp;</strong>are stained <strong>in living state&nbsp;</strong>in vitro so staining with dyes like brilliant cresyl blue and <strong>new methylene blue (Best stain)</strong> is referred to as <strong>supravital staining.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Ref</u></strong><i><strong>: Robbins 10<sup>th</sup> 637</strong></i></span></p>",
    "correct_choice_id": 56987,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 14296,
    "choices": [
      {
        "id": 57145,
        "text": "<p><span style=\"font-size:12pt;\">Iron deficiency anemia</span></p>"
      },
      {
        "id": 57146,
        "text": "<p><span style=\"font-size:12pt;\">Lead poisoning</span></p>"
      },
      {
        "id": 57147,
        "text": "<p><span style=\"font-size:12pt;\">Rheumatoid arthritis</span></p>"
      },
      {
        "id": 57148,
        "text": "<p><span style=\"font-size:12pt;\">Sideroblastic anemia</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt;\">Hypochromic microcytic blood picture is least commonly seen in which of the following conditions?</span></p>",
    "unique_key": "Q6604683",
    "question_audio": null,
    "question_video": null,
    "map_id": 31887,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans C. Rheumatoid arthritis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Rheumatoid arthritis </strong>is <strong>not typically </strong>associated with a <strong>hypochromic microcytic blood picture</strong>. It is more commonly associated with <strong>anemia of chronic disease</strong>, which is characterized by <strong>normocytic or mildly microcytic anemia</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">In some cases, <strong>red cells </strong>may be<strong> hypochromic. </strong>So, we would go with <strong>RA </strong>as the best answer in this question.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Rheumatoid arthritis (RA) </strong>is often associated with anemia of<strong> chronic disease (ACD)</strong>, which more commonly presents with normocytic anemia but less commonly with <strong>microcytosi</strong>s. However, the <strong>red blood cells in ACD</strong> are usually <strong>not hypochromic</strong>, making <strong>RA </strong>the least likely to present with a <strong>hypochromic microcytic blood picture.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Iron deficiency anemia</strong> classically presents with a <strong>hypochromic microcytic </strong>blood picture due to a <strong>deficiency in iron</strong>, leading to <strong>reduced hemoglobin synthesis </strong>and, consequently,<strong> smaller red blood cells with less hemoglobin</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Lead poisoning causes</strong> <strong>hypochromic microcytic anemia </strong>by interfering with several <strong>enzymatic steps </strong>in the<strong> heme synthesis pathway, </strong>leading to <strong>inadequate </strong>production of <strong>hemoglobin and microcytosis.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Sideroblastic anemia</strong> is characterized by the<strong> presence of ring sideroblasts </strong>in the bone marrow and can present with a <strong>hypochromic microcytic </strong>blood picture due to<strong> ineffective iron utilization and heme synthesis.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Rheumatoid arthritis </strong>is least likely to be associated with a <strong>hypochromic microcytic </strong>blood picture among the options provided, as it is more typically linked to<strong> normocytic or mildly microcytic anemia of chronic disease</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Summary Table:&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_L2wsIq6.png\" width=\"1193\" height=\"381\"></span></p>",
    "correct_choice_id": 57147,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "InvestigationBased"
    ]
  },
  {
    "id": 14273,
    "choices": [
      {
        "id": 57053,
        "text": "<p><span style=\"font-size:12pt;\">Iron deficiency anemia</span>\u200b\u200b\u200b\u200b\u200b</p>"
      },
      {
        "id": 57054,
        "text": "<p><span style=\"font-size:12pt;\">Thalassemia minor</span>\u200b\u200b\u200b</p>"
      },
      {
        "id": 57055,
        "text": "<p><span style=\"font-size:12pt;\">Sideroblastic anemia</span>\u200b\u200b\u200b\u200b\u200b</p>"
      },
      {
        "id": 57056,
        "text": "<p><span style=\"font-size:12pt;\">Thalassemia major</span>\u200b\u200b\u200b\u200b\u200b\u200b</p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A 13-yr-girl with fatigue and weakness was found to be having reduced hemoglobin. Her MCV 70fl, MCH 22pg and RDW was 28. What is her most likely diagnosis?</span></p>",
    "unique_key": "Q1501121",
    "question_audio": null,
    "question_video": null,
    "map_id": 31912,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A. Iron deficiency anemia</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Decreased hemoglobin </strong>with the clinical features of<strong> fatigue and weakness </strong>is diagnostic of anemia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Iron deficiency anemia </strong>is characterized by <strong>microcytic and hypochromic anemia</strong>, often with an<strong> increased RDW </strong>due to the <strong>variable size of the red blood cells </strong>as the<strong> bone marrow releases </strong>both<strong> older, larger cells and newer, smaller cells </strong>in response to <strong>iron deficiency.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Thalassemia minor</strong> often presents with <strong>microcytosis and a low MCH</strong>, but<strong> RDW </strong>is typically <strong>normal </strong>because the <strong>red blood cells are uniformly small</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Sideroblastic anemia</strong> can also present with<strong> microcytosis, </strong>but it is usually associated with <strong>ringed sideroblasts </strong>in the<strong> bone marrow </strong>and may show <strong>elevated iron indices.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Thalassemia major presents</strong> with<strong> severe microcytic anemia</strong>, usually <strong>early in life</strong>, and patients are typically symptomatic with a<strong> history of blood transfusions.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">An <strong>elevated RDW </strong>in the context of<strong> microcytic, hypochromic anemia </strong>is suggestive of <strong>iron deficiency anemia</strong>, which can be distinguished from <strong>thalassemia minor by the increased RDW.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_8G8QCWN.png\" width=\"1162\" height=\"300\"></strong></span></p>",
    "correct_choice_id": 57053,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 14279,
    "choices": [
      {
        "id": 57077,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">B12 deficiency</span></span></span></p>"
      },
      {
        "id": 57078,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Iron deficiency anemia</span></span></span></p>"
      },
      {
        "id": 57079,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Thalassemia minor</span></span></span></p>"
      },
      {
        "id": 57080,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sickle cell anemia</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient presented with fatigue and dyspnea. His peripheral blood smear demonstrated microcytic hypochromic red blood cells and pencil cells. The likely diagnosis in him is: </span></span></span></p>",
    "unique_key": "Q9061327",
    "question_audio": null,
    "question_video": null,
    "map_id": 31913,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B. Iron deficiency anemia</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Iron deficiency anemia is characterized by <strong>microcytic, hypochromic cells. Pencil cells,</strong> which are <strong>elongated red cells,</strong> can also be seen in this condition, reflecting the <strong>variability in red cell shape (poikilocytosis).</strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Vitamin B12 deficiency</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> typically causes<strong> macrocytic anemia</strong>, not microcytic, and would not present with pencil cells on the blood smear.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Thalassemia minor</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> often presents with<strong> microcytosis, but red cells are usually target cells </strong>rather than pencil cells, and other hematologic indices such as <strong>hemoglobin A2 levels </strong>can help in the diagnosis.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Sickle cell anemia</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> usually presents with <strong>normocytic anemia and sickled red cells </strong>on the blood smear, not pencil cells, and are associated with<strong> hemoglobin Son electrophoresis.</strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong> </span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Iron deficiency anemia is characterized by<strong> microcytic, hypochromic red blood cells </strong>with the presence of pencil cells on the <strong>peripheral blood smear</strong>. <strong>Iron deficiency anemia </strong>is a <strong>common</strong> cause of<strong> anemia worldwide </strong>and should be considered in patients presenting with symptoms of <strong>anemia and microcytosis.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u><em><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Robbins 10th/e p658</span></span></em></strong></p>",
    "correct_choice_id": 57078,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 14289,
    "choices": [
      {
        "id": 57117,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Total iron binding capacity</span></span></span></p>"
      },
      {
        "id": 57118,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">RBC protoporphyrin </span></span></span></p>"
      },
      {
        "id": 57119,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Transferrin saturation</span></span></span></p>"
      },
      {
        "id": 57120,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Transferrin receptor</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In a patient diagnosed with iron deficiency anemia, the values of all of the following increase <em>except</em> </span></span></span></p>",
    "unique_key": "Q5800766",
    "question_audio": null,
    "question_video": null,
    "map_id": 31914,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C. &nbsp;Transferrin saturation </span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In iron deficiency anemia, the levels of various parameters are affected. </span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Transferrin saturation: </strong>Transferrin saturation<strong> decreases in iron deficiency anemia</strong>. It is the ratio of <strong>serum iron to TIBC </strong>and reflects the <strong>percentage of transferrin </strong>that is <strong>saturated with iron</strong>. In iron deficiency, there is<strong> less iron </strong>available for<strong> binding to transferrin</strong>, leading to a <strong>decreased saturation.</strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Total iron binding capacity (TIBC):</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> TIBC<strong> increases</strong> in<strong> iron deficiency anemia</strong>. It represents the maximum amount of <strong>iron</strong> that can be<strong> bound to transferrin.</strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. RBC protoporphyrin:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> RBC protoporphyrin <strong>increases in iron deficiency anemia</strong>. It reflects <strong>decreased </strong>availability of <strong>iron for heme synthesis</strong>.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Transferrin receptor:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Transferrin receptor levels<strong> increase in iron deficiency anemia</strong>. It is a marker of <strong>increased </strong>demand for <strong>iron by erythroid precursors</strong>.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Transferrin saturation decreases</strong> in <strong>iron deficiency anemia</strong>, reflecting a <strong>reduced </strong>percentage of <strong>transferrin </strong>loaded with<strong> iron due to diminished iron stores</strong>, whereas <strong>total iron binding capacity, RBC protoporphyrin, and transferrin receptor levels increase </strong>in response to this condition.</span></span></p>",
    "correct_choice_id": 57119,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual"
    ]
  },
  {
    "id": 14300,
    "choices": [
      {
        "id": 57161,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Decreased serum iron</span></span></span></p>"
      },
      {
        "id": 57162,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increased total iron binding capacity</span></span></span></p>"
      },
      {
        "id": 57163,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Decreased serum ferritin</span></span></span></p>"
      },
      {
        "id": 57164,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increased mean corpuscular volume</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">All are laboratory finding in iron deficiency anemia except: </span></span></span></p>",
    "unique_key": "Q2994244",
    "question_audio": null,
    "question_video": null,
    "map_id": 31917,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D. Increased mean corpuscular volume </span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">I<strong>ron deficiency anemia </strong>is characterized by <strong>microcytic and hypochromic red blood cells</strong>, leading to a <strong>decreased mean corpuscular volume (MCV). </strong></span></span></span><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increased mean corpuscular volume (MCV):</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This statement is<strong> incorrect</strong>. Iron deficiency anemia is associated with a <strong>decreased MCV </strong>due to the<strong> smaller size of the red blood cells (microcytosis).</strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Decreased serum iron:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> In iron deficiency anemia, there is a <strong>decrease in serum iron levels </strong>because there is <strong>insufficient iron </strong>available for<strong> hemoglobin synthesis</strong>.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Increased total iron binding capacity (TIBC):</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> TIBC increases in iron deficiency anemia. It represents the<strong> maximum amount of iron </strong>that can be bound to<strong> transferrin</strong>.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Decreased serum ferritin:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Serum ferritin levels decrease in <strong>iron deficiency anemia</strong>. Ferritin is an indicator of<strong> iron stores, and low levels </strong>suggest<strong> depleted iron stores.</strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Increased mean corpuscular volume (MCV) </strong>is <strong>not </strong>a finding in <strong>iron deficiency anemia</strong>; rather, this condition is characterized by a <strong>decreased MCV due to microcytic, hypochromic red blood cells </strong>resulting from<strong> insufficient iron for hemoglobin synthesis.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><em><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></em></strong><strong><em><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Robbins 10<sup>th</sup>/ 652</span></em></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Robbins 10<sup>th</sup>/ 658</span></span><em><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> </span></span></em></strong></p>",
    "correct_choice_id": 57164,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 14301,
    "choices": [
      {
        "id": 57165,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mucosal cell iron stores</span></span></span></p>"
      },
      {
        "id": 57166,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Route of administration</span></span></span></p>"
      },
      {
        "id": 57167,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Preparation administered </span></span></p>"
      },
      {
        "id": 57168,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Age of the patient</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 25-year-old male is undergoing workup for fatigue and joint pain. His serum ferritin levels are markedly elevated, and a liver biopsy shows iron deposition. Which of the following most directly regulates iron uptake in the gut?</span></span></span></p>",
    "unique_key": "Q5609568",
    "question_audio": null,
    "question_video": null,
    "map_id": 31918,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A. Mucosal cell iron stores <em>&nbsp;</em></span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Mucosal cell iron stores </strong>influence the <strong>synthesis of hepcidin</strong>, a<strong> peptide hormone </strong>that regulates<strong> iron uptake </strong>by<strong> inhibiting its transport across the gut mucosa</strong>.<strong> Increased iron stores </strong>lead to <strong>increased hepcidin levels</strong>, which <strong>decreases iron absorption.</strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. The route of administration,</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> such as <strong>oral or parenteral</strong>, can influence the rate of <strong>iron absorption </strong>but does not directly regulate<strong> iron uptake at the molecular level</strong>.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. The preparation administered</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">, for example,<strong> ferrous sulfate versus ferric gluconate</strong>, can affect the<strong> efficiency of absorption but</strong>, like the route, <strong>does not regulate the iron uptake process </strong>per se.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. The age of the patient</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> can affect the <strong>demand for iron</strong>, especially during <strong>growth spurts or aging</strong>, but it is not a direct regulator of iron uptake in the gut.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Mucosal cell iron stores</strong>, through their regulation of <strong>hepcidin synthesis, </strong>play a direct role in <strong>regulating iron uptake </strong>across the<strong> gut mucosa</strong>, which is crucial for maintaining <strong>systemic iron homeostasis</strong>. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: <strong>Robbins 10<sup>th</sup>/ 658<em> </em></strong></span></span></p>",
    "correct_choice_id": 57165,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 14262,
    "choices": [
      {
        "id": 57009,
        "text": "<p><span style=\"font-size:12pt;\">Macrocytic hypochromic red cells</span></p>"
      },
      {
        "id": 57010,
        "text": "<p><span style=\"font-size:12pt;\">Target cells</span></p>"
      },
      {
        "id": 57011,
        "text": "<p><span style=\"font-size:12pt;\">Reduced poikilocytosis</span></p>"
      },
      {
        "id": 57012,
        "text": "<p><span style=\"font-size:12pt;\">Microcytic and hypochromic red cell</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt;\">A 25-year-old female presented with fatiguability and dyspnea on exertion. She was found to be having a hemoglobin of 6 g/dL. What will be most likely finding in her peripheral blood smear?</span></p>",
    "unique_key": "Q7779530",
    "question_audio": null,
    "question_video": null,
    "map_id": 31916,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. D. Microcytic and hypochromic red cells</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Microcytosis</strong> (smaller than normal red cells) and <strong>hypochromia </strong>are classic findings in <strong>iron deficiency anemia</strong>, which is consistent with the <strong>patient's symptoms and low hemoglobin.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Macrocytosis</strong> <strong>(larger than normal red cells) </strong>typically indicates a deficiency in<strong> vitamin B12 or folate</strong>, not iron. While hypochromia refers to red cells with reduced hemoglobin content, it is not typically associated with macrocytosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Target cells</strong> can be seen in various<strong> hemoglobinopathies, liver disease, and post-splenectomy, </strong>but they are not characteristic of iron deficiency anemia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Poikilocytosis</strong> refers to<strong> abnormally shaped red blood cells </strong>and is a<strong> nonspecific finding. </strong>The term \"reduced poikilocytosis\" is not typically used to describe findings in anemia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">When evaluating a patient with anemia, particularly in the setting of<strong> fatigue and dyspnea on exertion </strong>with a significantly<strong> low hemoglobin level</strong>, finding<strong> microcytic and hypochromic red cells </strong>on the peripheral blood smear strongly suggests<strong> iron deficiency anemia</strong>.</span></p>",
    "correct_choice_id": 57012,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 14259,
    "choices": [
      {
        "id": 56997,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&lt;32 </span></span></span></p>"
      },
      {
        "id": 56998,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&lt;34 </span></span></span></p>"
      },
      {
        "id": 56999,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&lt;28 </span></span></span></p>"
      },
      {
        "id": 57000,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&lt;30</span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"background-color:white\"><span style=\"color:#0d0d0d\">A 35-year-old woman presents with fatigue, pallor, and shortness of breath on exertion. Her blood tests show a low hemoglobin concentration and a mean corpuscular volume (MCV) within the low-normal range. To further evaluate her anemia, which of the following mean corpuscular hemoglobin concentration (MCHC) values would suggest a diagnosis of iron deficiency anemia?</span></span></span></span></span></p>",
    "unique_key": "Q3573531",
    "question_audio": null,
    "question_video": null,
    "map_id": 31915,
    "difficulty_level": "difficult",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B.&lt;34 </span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><em><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">At all ages the normal MCHC should be 34;</span></em></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> values <strong>below </strong>that indicate that red cells are <strong>hypochromic</strong>, which occurs in <strong>iron deficiency anaemia.</strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">When evaluating for<strong> iron deficiency anemia</strong>, an <strong>MCHC value below 34 g/dL </strong>is indicative of <strong>hypochromic red blood cells</strong>, which is a typical laboratory finding in this condition.</span></span></span></p>",
    "correct_choice_id": 56998,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 14293,
    "choices": [
      {
        "id": 57133,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cyanocobalamin deficiency</span></span></span></p>"
      },
      {
        "id": 57134,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Folate deficiency</span></span></span></p>"
      },
      {
        "id": 57135,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sideroblastic anemia</span></span></span></p>"
      },
      {
        "id": 57136,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acute blood loss</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient has been eating junk food regularly for few months and avoids fruits and vegetables. His hemoglobin is 9 g/dl and MCV is &gt;125 fl. What is the deficiency she would likely be having? </span></span></span></p>",
    "unique_key": "Q6112070",
    "question_audio": null,
    "question_video": null,
    "map_id": 31922,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B. &nbsp;Folate deficiency </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Folate deficiency </strong>can develop quickly with<strong> poor dietary habits and leads to megaloblastic anemia</strong>, which presents with a<strong> high MCV. </strong>Given the patient&#39;s diet <strong>devoid of fruits and vegetables</strong>, this is a <strong>probable cause</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Cyanocobalamin (Vitamin B12)</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>deficiency</strong> typically develops <strong>over years due to the substantial stores in the liver</strong>. While it can cause <strong>megaloblastic anemia </strong>with a<strong> high MCV,</strong> the patient&#39;s short history of symptoms makes this less likely.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Sideroblastic anemia</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> is characterized by the presence of <strong>ringed sideroblasts </strong>in the bone marrow and can be associated with certain<strong> drugs and toxins, genetic disorders</strong>, or may be<strong> idiopathic</strong>. It doesn&#39;t typically relate directly to dietary habits and usually shows a normal or increased MCV but not typically in the megaloblastic range (&gt;100 fL).</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Acute blood loss would cause anemia</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> with a<strong> low or normal MCV (microcytic or normocytic), </strong>not the high MCV (&gt;100 fL) that is typical of megaloblastic anemias. Plus, there is no history suggestive of blood loss.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Folate deficiency </strong>is the likely cause of <strong>megaloblastic anemia </strong>with a <strong>high MCV </strong>in a patient with a diet lacking in <strong>fruits and vegetables and a relatively quick onset of symptoms</strong>, as<strong> folate stores are depleted much more rapidly than vitamin B12 stores</strong>.</span></span></p>",
    "correct_choice_id": 57134,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "TreatmentBased"
    ]
  },
  {
    "id": 14299,
    "choices": [
      {
        "id": 57157,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hereditary spherocytosis</span></span></span></p>"
      },
      {
        "id": 57158,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Iron deficiency anemia</span></span></span></p>"
      },
      {
        "id": 57159,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sickle cell anemia</span></span></span></p>"
      },
      {
        "id": 57160,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Megaloblastic anemia</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 30-year-old female presents with fatigue, pallor, and a smooth tongue. She reports a vegetarian diet with minimal animal product intake. Laboratory tests show a high mean corpuscular volume (MCV) and hypersegmented neutrophils. A peripheral blood smear likely would reveal which of the following?</span></span></span></p>",
    "unique_key": "Q4694432",
    "question_audio": null,
    "question_video": null,
    "map_id": 31919,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D. Megaloblastic anemia </span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Megaloblastic anemia: Two principal findings:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pathology:<strong> Defective DNA synthesis </strong>and <strong>diminished erythropoiesis </strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Morphology - <strong>Anisocytosis </strong>(various size + shape), <strong>Macrocytosis </strong>(MCV &gt; 100 fl), <strong>MCHC is normal and, Macropolymorphonuclear (hyper segmented) neu&not;trophils</strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Megaloblastic anemia is characterized by the presence of<strong> large red blood cells or macropolycytes, </strong>which are due to <strong>defective DNA synthesis</strong>. <strong>Hypersegmented neutrophils </strong>are also a <strong>classic feature</strong>.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Hereditary spherocytosis</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> is characterized by the <strong>presence of spherocytes</strong>, which are <strong>small, dense red blood cells without the central pallor, not macropolycytes</strong>.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Iron deficiency anemia</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> typically shows <strong>microcytic, hypochromic red blood cells </strong>due to <strong>decreased hemoglobin </strong>content, not macropolycytes.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Sickle cell anemia</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> is identified by the presence of<strong> sickle-shaped cells due to abnormal hemoglobin</strong>, which does not include macropolycytes.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Macropolycytes </strong>in a peripheral blood smear are a feature of <strong>megaloblastic anemia</strong>, which is often<strong> due to vitamin B12 or folate deficiency </strong>and is characterized by <strong>macrocytosis and hypersegmented neutrophils. </strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u><em><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Robbins 10<sup>th</sup>/ 652 </span></span></em></strong></p>",
    "correct_choice_id": 57160,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 14315,
    "choices": [
      {
        "id": 57221,
        "text": "<p><span style=\"font-size:12pt;\">Sideroblastic anemia</span></p>"
      },
      {
        "id": 57222,
        "text": "<p><span style=\"font-size:12pt;\">Iron deficiency anemia</span></p>"
      },
      {
        "id": 57223,
        "text": "<p><span style=\"font-size:12pt;\">Thalassemia</span></p>"
      },
      {
        "id": 57224,
        "text": "<p><span style=\"font-size:12pt;\">Folic acid deficiency</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt;\">A 26-year\u2011old female presents with pallor with a hemoglobin of 9.5 g/dL, PCV 30 mm Hg and RBC count of 2 million per cubic millimeters. What is the likely diagnosis?&nbsp;<i>&nbsp;</i></span></p>",
    "unique_key": "Q4049737",
    "question_audio": null,
    "question_video": null,
    "map_id": 31920,
    "difficulty_level": "difficult",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. D. Folic acid deficiency</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D:</strong></span></p><p><br><span style=\"font-size:12pt;\">Looking at the parameters being mentioned in the ques\u00adtion, we analyse and understand the&nbsp;type of anemia the patient is having:</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/10/whatsapp-image-2024-09-10-at-114902-am.jpeg\" alt=\"\" width=\"500\" height=\"416\"></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Hence, the patient is having <strong>macrocytic anemia</strong>. The answer is <strong>folic acid deficiency anemia</strong>. All other options lead to <strong>microcytic anemia</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Folic acid deficiency</strong>, as well as<strong> vitamin B12 deficiency, </strong>are common causes of <strong>macrocytic anemia</strong>, which is characterized by an <strong>MCV greater than 100 fL (107)</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Sideroblastic anemia</strong> usually results in a<strong> microcytic anemia </strong>due to <strong>ineffective iron utilization</strong>, making it an unlikely cause of macrocytic anemia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Iron deficiency anemia</strong> typically presents with<strong> microcytic, hypochromic anemia </strong>due to the <strong>reduced </strong>hemoglobin content within <strong>RBC</strong>s, not macrocytic anemia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Thalassemia is another</strong> cause of <strong>microcytic anemia</strong>, associated with<strong> genetic mutations </strong>leading to <strong>abnormal hemoglobin production</strong>. It does not cause macrocytic anemia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Upon finding an <strong>MCV of 150 fL</strong>, which indicates<strong> macrocytic anemia, folic acid deficiency </strong>becomes the most likely diagnosis among the options provided because it, along with<strong> vitamin B12 deficiency, can cause macrocytosis</strong>.</span></p>",
    "correct_choice_id": 57224,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual"
    ]
  },
  {
    "id": 14263,
    "choices": [
      {
        "id": 57013,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increased reticulocyte count</span></span></span></p>"
      },
      {
        "id": 57014,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Raised Bilirubin</span></span></span></p>"
      },
      {
        "id": 57015,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mild splenomegaly</span></span></span></p>"
      },
      {
        "id": 57016,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Nucleated RBC</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">A 52-year-old male presents with fatigue, light-headedness, and a beefy-red tongue. Laboratory tests show macrocytosis and hypersegmented neutrophils. Which of the following laboratory findings is inconsistent with untreated megaloblastic anemia?</span></span></span></span></span></p>",
    "unique_key": "Q4204689",
    "question_audio": null,
    "question_video": null,
    "map_id": 31923,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A. Increased reticulocyte count </span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">An <strong>increased reticulocyte count </strong>is not a feature of <strong>untreated megaloblastic anemia</strong>. In megaloblastic anemia, the <strong>reticulocyte count is typically low </strong>because of <strong>ineffective erythropoiesis</strong>. However, the count <strong>increases once treatment with vitamin B12</strong> and <strong>folate</strong> is initiated, reflecting a response to treatment.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Raised bilirubin</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> levels can be seen in <strong>megaloblastic anemia</strong> due to<strong> increased destruction of defective erythroid precursor</strong> <strong>cells in the bone marrow, </strong>which release <strong>bilirubin</strong> into the blood.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Mild splenomegaly</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> may be observed in <strong>megaloblastic anemia </strong>as the spleen works to <strong>filter the abnormal cells </strong>from the <strong>bloodstream.</strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. The presence</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> of <strong>nucleated RBCs </strong>in the peripheral blood smear is a sign of<strong> severe anemia</strong>, including<strong> megaloblastic anemia</strong>, where<strong> immature and abnormal erythroid precursor cells </strong>are released into the bloodstream.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">in <strong>untreated megaloblastic anemia</strong>, the<strong> reticulocyte count is low due to impaired DNA synthesis</strong> and <strong>ineffective erythropoiesis.</strong> An <strong>increased reticulocyte count</strong> after initiating treatment with<strong> vitamin B12 and folate supplementation</strong> indicates a positive response to therapy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">:<em> Robbins 10<sup>th</sup>/ 645, Wintrobe&rsquo;s 12th/1151-3 </em></span></span><em><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> </span></span></em></strong></p>",
    "correct_choice_id": 57013,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "InvestigationBased"
    ]
  },
  {
    "id": 14264,
    "choices": [
      {
        "id": 57017,
        "text": "<p><span style=\"font-size:12pt;\">Ankylostoma duodenale</span></p>"
      },
      {
        "id": 57018,
        "text": "<p><span style=\"font-size:12pt;\">Diphyllobothrium latum</span></p>"
      },
      {
        "id": 57019,
        "text": "<p><span style=\"font-size:12pt;\">Giardia lamblia</span></p>"
      },
      {
        "id": 57020,
        "text": "<p><span style=\"font-size:12pt;\">Taenia solium</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt;\">A 40-year-old male presents with fatigue, pallor, and glossitis. Laboratory findings show macrocytic anemia. He reports frequently consuming raw fish. Which organism is most likely responsible for his anemia?</span></p>",
    "unique_key": "Q5736752",
    "question_audio": null,
    "question_video": null,
    "map_id": 31924,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B.&nbsp;Diphyllobothrium latum</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Diphyllobothrium latum: </strong>D. latum, or <strong>fish tapeworm</strong>, can cause <strong>megaloblastic anemia</strong> by competing with the<strong> host for vitamin B12</strong>, leading to a<strong> deficiency despite adequate intake</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Ankylostoma duodenale: </strong>Ankylostoma duodenale, or<strong> hookworm, causes iron deficiency anemia </strong>by <strong>chronic blood loss in the intestines </strong>where the worms attach to the<strong> mucosa and feed on blood</strong>, leading to<strong> microcytic hypochromic anemia.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Giardia lamblia:</strong> Giardiasis, caused by Giardia lamblia, typically leads to<strong> malabsorption and diarrhea </strong>but <strong>does not directly</strong> <strong>cause anemia</strong>. It is not known to cause megaloblastic anemia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D:&nbsp;Taenia solium: </strong>Taenia solium, or <strong>pork tapeworm</strong>, usually causes <strong>intestinal disturbances or systemic issues </strong>when in its <strong>larval form </strong>but does not cause megaloblastic anemia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The correct answer is <strong>Option B: Diphyllobothrium latum or fish tapeworm causes megaloblastic anemia due to vitamin B12 deficiency</strong>,</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_zQPyjwq.png\" width=\"1179\" height=\"344\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Ref</u>: Robbins 10<sup>th</sup>/ 651</strong></span></p>",
    "correct_choice_id": 57018,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 14265,
    "choices": [
      {
        "id": 57021,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Microcytic hypochromic anemia</span></span></span></p>"
      },
      {
        "id": 57022,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sickled red cells</span></span></span></p>"
      },
      {
        "id": 57023,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Anemia occurs after 3-4 years of poor absorption</span></span></span></p>"
      },
      {
        "id": 57024,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Development of polycythemia</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">A 52-year-old male with a history of strict vegetarianism presents with weakness and paresthesias. A CBC shows macrocytosis, and his serum vitamin B12 level is low. Which of the following is most consistent with the pathophysiology of his condition?</span></span></span> </span></span></p>",
    "unique_key": "Q6120876",
    "question_audio": null,
    "question_video": null,
    "map_id": 31925,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C. Anemia occurs after 3-4 years of poor absorption </span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">Option C:</span></span></strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">Because the<strong> liver stores several years</strong>&#39; worth of<strong> vitamin B12</strong>, it can take years of <strong>inadequate dietary intake </strong>before clinical symptoms of <strong>vitamin B12 deficiency anemia</strong> develop.</span></span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">Explanation:</span></span></u></strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">Option A.</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\"> <strong>Microcytic hypochromic anemia </strong>is typically associated with<strong> iron deficiency, thalassemia, </strong>or other disorders of <strong>hemoglobin synthesis, </strong>not with <strong>vitamin B12 deficiency</strong>.</span></span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">Option B.</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\"> <strong>Sickled red cells </strong>are characteristic of<strong> sickle cell anemia</strong>, a <strong>genetic disorder </strong>caused by a<strong> mutation in the hemoglobin gene</strong>, not related to vitamin B12 absorption.</span></span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">Option D.</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\"><strong> Polycythemia </strong>refers to an <strong>increased concentration of hemoglobin in the blood</strong>, typically not related to vitamin B12 deficiency. Instead,<strong> vitamin B12 deficiency </strong>would lead to a <strong>decrease in red cell production </strong>due to <strong>maturation failure</strong>.</span></span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">Educational Objective:</span></span></u></strong> </span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">When considering a diagnosis of<strong> megaloblastic anemia due to vitamin B12 deficiency, </strong>significant <strong>hepatic stores of vitamin B12 </strong>can <strong>delay the onset of anemia for several years </strong>in patients with<strong> poor dietary intake</strong>. </span></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: <em>Robbins 10<sup>th</sup>/ 651-2</em></span></span></strong></p>",
    "correct_choice_id": 57023,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 14266,
    "choices": [
      {
        "id": 57025,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cyanocobalamin deficiency</span></span></span></p>"
      },
      {
        "id": 57026,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Folic acid deficiency</span></span></span></p>"
      },
      {
        "id": 57027,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Thiamine deficiency</span></span></span></p>"
      },
      {
        "id": 57028,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Riboflavin deficiency</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 32-year-old female presents with fatigue, weakness, and shortness of breath. Laboratory investigations reveal macrocytic anemia, and the FIGLU test is conducted to assess the etiology. FIGLU test is done for: </span></span></span></p>",
    "unique_key": "Q5704196",
    "question_audio": null,
    "question_video": null,
    "map_id": 31926,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B. Folic acid deficiency </span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">Option B:</span></span></strong> </span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">Folate deficiency can also cause<strong> macrocytic anemia</strong>. An <strong>elevated urinary FIGLU (formiminoglutamic acid) </strong>test indicates an<strong> inability to metabolize FIGLU </strong>due to<strong> insufficient folate</strong>, which is needed for its<strong> conversion to glutamic acid</strong></span></span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">Explanation:</span></span></u></strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">Option A. Vitamin B12</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\"> deficiency can lead to <strong>macrocytic anemia </strong>and is usually confirmed by<strong> low serum levels of B12 or elevated serum methylmalonic acid and homocysteine levels</strong>, not typically with a FIGLU test.</span></span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">Option C. Deficiency</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\"> of<strong> thiamine </strong>leads to conditions like<strong> beriberi or Wernicke-Korsakoff syndrome</strong>, not typically associated with macrocytic anemia or a positive FIGLU test.</span></span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">Option D. Riboflavin</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\"> deficiency is associated with symptoms such as <strong>angular stomatitis and glossitis, </strong>but not usually with macrocytic anemia, and it does not cause elevated FIGLU levels.</span></span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">Educational Objective:</span></span></u></strong> </span></span></span></p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">In patients with <strong>unexplained macrocytic anemia,</strong> a <strong>positive FIGLU test </strong>in the urine indicates a<strong> deficiency in folate</strong>. FIGLU is a </span></span></span><strong><em><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">biomarker </span></span></em></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>for </strong><em><strong>intracellular levels of folate</strong>. </em></span></span></p>",
    "correct_choice_id": 57026,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 14267,
    "choices": [
      {
        "id": 57029,
        "text": "<p><span style=\"font-size:12pt;\">Hemolytic</span>\u200b\u200b\u200b\u200b\u200b</p>"
      },
      {
        "id": 57030,
        "text": "<p><span style=\"font-size:12pt;\">Iron deficiency</span></p>"
      },
      {
        "id": 57031,
        "text": "<p><span style=\"font-size:12pt;\">Megaloblastic</span>\u200b\u200b\u200b\u200b\u200b\u200b</p>"
      },
      {
        "id": 57032,
        "text": "<p><span style=\"font-size:12pt;\">Aplastic</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt;\">Hypersegmented neutrophils are present in which of the following anemia?</span></p>",
    "unique_key": "Q6144852",
    "question_audio": null,
    "question_video": null,
    "map_id": 31927,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C. Megaloblastic</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Hypersegmented neutrophils </strong>are a characteristic finding in<strong> megaloblastic anemias</strong>. Megaloblastic anemias are a group of disorders characterized by<strong> impaired DNA synthesis</strong>, leading to the production of <strong>large, immature red blood cells (megaloblasts) </strong>and <strong>hypersegmentation of neutrophils </strong>in the peripheral blood.</span></p><p>&nbsp;</p><p><span style=\"background-color:white;font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p>&nbsp;</p><p><span style=\"background-color:white;font-size:12pt;\"><strong>Option A. Hemolytic</strong> <strong>anemias</strong> are characterized by the premature destruction of red blood cells, but they do not typically cause <strong>hypersegmentation of neutrophils</strong>.</span></p><p>&nbsp;</p><p><span style=\"background-color:white;font-size:12pt;\"><strong>Option B. Iron deficiency anemia</strong> is characterized by <strong>microcytic and hypochromic red blood cells</strong>, and it does not usually result in hypersegmentation of neutrophils.</span></p><p>&nbsp;</p><p><span style=\"background-color:white;font-size:12pt;\"><strong>Option D. Aplastic anemia</strong> is characterized by a <strong>reduction in the number of all blood cell types (red blood cells, white blood cells, and platelets) </strong>due to <strong>bone marrow failure</strong>. It does not cause hypersegmentation of neutrophils.</span></p><p>&nbsp;</p><p><span style=\"background-color:white;font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p>&nbsp;</p><p><span style=\"background-color:white;font-size:12pt;\"><strong>Hypersegmented neutrophils </strong>are indicative of<strong> megaloblastic anemia</strong>, a condition arising from <strong>impaired DNA synthesis </strong>which leads to abnormally<strong> large red blood cells </strong>and <strong>distinctive changes in neutrophils</strong>. This finding is not typical of hemolytic, iron deficiency, or aplastic anemias.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">What are hypersegmented neutrophils?</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Normal neutrophils have: 3\u20134 nuclear lobes.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Hypersegmented neutrophils: Diagnosed when:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">\u22655% of neutrophils have \u22655 lobes or</span></li><li><span style=\"font-size:12.0pt;\">at least 1 neutrophil has \u22656 lobes</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Why do they occur in megaloblastic anemia?</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Megaloblastic anemia is caused by impaired DNA synthesis (usually due to B12 deficiency or folate deficiency) leading to nuclear-cytoplasmic asynchrony (DNA synthesis is slowed, but RNA and protein synthesis continue at normal speed)</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">Cytoplasm matures (normal Hb and granules)</span></li><li><span style=\"font-size:12.0pt;\">Nucleus is immature \u2192 cells get stuck in the cell cycle \u2192 develop extra nuclear lobes.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">So, hypersegmented neutrophils reflect the same nuclear maturation defect that causes macrocytic RBCs and megaloblasts in bone marrow.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Typical peripheral smear in megaloblastic anemia:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_xaAvka5.png\" width=\"1090\" height=\"296\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Ref</u>: Robbins 10<sup>th</sup>/ 652</strong></span></p>",
    "correct_choice_id": 57031,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "InvestigationBased"
    ]
  },
  {
    "id": 14295,
    "choices": [
      {
        "id": 57141,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Plasma homocysteine levels</span></span></span></p>"
      },
      {
        "id": 57142,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Peripheral smear showing megaloblasts</span></span></span></p>"
      },
      {
        "id": 57143,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">High value of mean cell volume</span></span></span></p>"
      },
      {
        "id": 57144,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Serum methylmalonic acid levels</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following test best differentiates cobalamin and folate deficiency?</span></span></span></p>",
    "unique_key": "Q3159348",
    "question_audio": null,
    "question_video": null,
    "map_id": 31921,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D. Serum methylmalonic acid levels</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Serum methylmalonic acid levels </strong>are<strong> increased </strong>specifically in <strong>cobalamin deficiency </strong>because<strong> cobalamin is a cofactor </strong>for the conversion of <strong>methylmalonic acid to succinyl CoA</strong>. In <strong>folate deficiency, methylmalonic acid levels remain normal.</strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Plasma homocysteine levels</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> are <strong>elevated </strong>in both <strong>cobalamin (vitamin B12) and folate deficiencies,</strong> as both vitamins are involved in the <strong>metabolism of homocysteine</strong>. Therefore, it does not differentiate between the two.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Peripheral smear</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> showing <strong>megaloblasts</strong> is a feature common to both<strong> cobalamin and folate deficiencies</strong>, as both lead to <strong>impaired DNA synthesis and resultant megaloblastic anemia.</strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. A high mean cell volume</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> (MCV) is indicative of <strong>macrocytic anemia</strong>, which can result from <strong>either cobalamin or folate deficiency</strong>. This finding is <strong>not specific </strong>to either condition.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Serum methylmalonic acid </strong>levels is one of<strong> diagnostic test </strong>that differentiates between <strong>cobalamin and folate deficiencies, </strong>since it is <strong>increased in cobalamin deficiency </strong>but remains <strong>normal in folate deficiency.</strong></span></span></p>",
    "correct_choice_id": 57144,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 14288,
    "choices": [
      {
        "id": 57113,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Red cell enzyme defect</span></span></span>\u200b\u200b\u200b\u200b\u200b</p>"
      },
      {
        "id": 57114,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hypersplenism</span></span></span></p>"
      },
      {
        "id": 57115,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mechanical heart valves</span></span></span>\u200b\u200b\u200b\u200b\u200b</p>"
      },
      {
        "id": 57116,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Thyroid dysfunction</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In a patient with raised LDH, elevated bilirubin and hemoglobinuria. Peripheral smear shows schistocytes. What would the likely diagnosis? </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/25/picture38.jpg\" style=\"height:194px; width:300px\" /></span></span></span></p>",
    "unique_key": "Q2796313",
    "question_audio": null,
    "question_video": null,
    "map_id": 31953,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C. Mechanical heart valves </span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span><br />\r\n<span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Mechanical heart valves </strong>are associated with the <strong>shearing of red blood cells</strong>, leading to the release of <strong>free hemoglobin </strong>and the characteristic <strong>schistocytes </strong>seen in the peripheral smear. This condition is known as<strong> prosthetic valve hemolysis.</strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Schistocytes are fragmented red cells </strong>which are associ&shy;ated with<strong> angiopathic hemolytic anemias</strong>. The presence of additional findings like <strong>raised LDH, elevated bilirubin, hemoglobinuria </strong>also point to a <strong>hemolytic problem</strong>. So, the answer is <strong>mechanical heart valves</strong>.</span></span></span></p>\r\n\r\n<p><strong>Explanation:</strong></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Red cell enzyme</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> defects typically <strong>do not </strong>cause <strong>microangiopathic hemolytic anemia with schistocytes.</strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Hypersplenism is associated</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> with the <strong>sequestration and destruction of blood cells </strong>in the spleen but is not typically associated with the specific findings mentioned in the question.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Thyroid dysfunction</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> is<strong> not known </strong>to cause <strong>microangiopathic hemolytic anemia with schistocytes.</strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong> </span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The correct diagnosis in a patient with<strong> elevated LDH, hyperbilirubinemia, hemoglobinuria, and schistocytes on the peripheral blood smear </strong>is<strong> mechanical heart valve</strong>-related <strong>hemolysis. </strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><em><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Robbins 10th/e p650</span></em></strong></span></span></p>",
    "correct_choice_id": 57115,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "ImageBased",
      "InvestigationBased"
    ]
  },
  {
    "id": 14302,
    "choices": [
      {
        "id": 57169,
        "text": "<p><span style=\"font-size:16px;\">Hepcidin</span></p>"
      },
      {
        "id": 57170,
        "text": "<p><span style=\"font-size:16px;\">DMT1</span></p>"
      },
      {
        "id": 57171,
        "text": "<p><span style=\"font-size:16px;\">Ferroportin</span></p>"
      },
      {
        "id": 57172,
        "text": "<p><span style=\"font-size:16px;\">Ferritin</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:16px;\">A 45-year-old male with a history of hereditary hemochromatosis is being evaluated for his condition. Which of the following is considered the most important but nonspecific regulator of iron metabolism?</span></p>",
    "unique_key": "Q9204622",
    "question_audio": null,
    "question_video": null,
    "map_id": 31955,
    "difficulty_level": "difficult",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. A. Hepcidin</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option A:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Hepcidin is considered the most important but nonspecific regulator of iron metabolism. It's synthesized in the liver and plays a central role in systemic iron homeostasis.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong><u>Explanation:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option B. DMT1</strong> (Divalent metal transporter 1) is a specific transporter that moves ferrous iron across the apical membrane of enterocytes. While important for iron uptake, it has a more focused role.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option C. Ferroportin</strong> is the protein responsible for exporting iron from cells into the plasma. It has a specific function and is regulated by hepcidin.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option D. Ferritin</strong> is the primary intracellular iron storage protein and is a marker of iron stores but does not regulate iron metabolism directly.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong><u>Educational Objective:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Hepcidin is the most important but nonspecific regulator of iron metabolism since it not only controls iron homeostasis but also has broader effects including antimicrobial activity and is influenced by various physiological and pathological conditions.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Ref: Robbins 10th/ 652</strong></span></p>",
    "correct_choice_id": 57169,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 14304,
    "choices": [
      {
        "id": 57177,
        "text": "<p><span style=\"font-size:12pt;\">Anti IgM</span></p>"
      },
      {
        "id": 57178,
        "text": "<p><span style=\"font-size:12pt;\">Anti IgG</span></p>"
      },
      {
        "id": 57179,
        "text": "<p><span style=\"font-size:12pt;\">IgM</span></p>"
      },
      {
        "id": 57180,
        "text": "<p><span style=\"font-size:12pt;\">Donath-Landsteiner antibody</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt;\">A 52-year-old man presents with acrocyanosis and hemolysis after exposure to cold temperatures. His direct Coombs' test is positive with cold sub type of antibodies. Which of the following antibodies is most likely responsible for his condition?</span></p>",
    "unique_key": "Q6461646",
    "question_audio": null,
    "question_video": null,
    "map_id": 31943,
    "difficulty_level": "difficult",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. C) IgM</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option C:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\">Clinical presentation given in the stem of the question is suggestive of Cold Agglutinin disease.</span></li><li><span style=\"font-size:16px;\">Cold hemagglutinin is associated with IgM antibodies. These are not to be confused with anti-IgM antibodies given as other option in the question.&nbsp;</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong><u>Explanation:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option A.&nbsp; Anti-IgM would imply</strong> an <strong>antibody against IgM&nbsp;</strong>itself, which is <strong>not&nbsp;</strong>the cause of <strong>cold hemagglutinin disease</strong>. Cold agglutinins are typically IgM antibodies that can agglutinate and lyse red blood cells at cold temperatures.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option B.&nbsp; Anti-IgG suggests</strong> an <strong>antibody against IgG</strong>, which is <strong>not&nbsp;</strong>typically involved in <strong>cold hemagglutinin disease</strong>. IgG antibodies can, however, cause<strong> warm autoimmune hemolytic anemia</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option D. Donath-Landsteiner antibody:</strong> The Donath-Landsteiner antibody is seen in paroxysmal cold hemoglobinuria..</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong><u>Educational Objective:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Cold agglutinin disease is characterised by IgM antibodies whereas PCH is characterised by Donath-Landsteiner (IgG antibodies against P-antigen on RBC surface)&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong><u>Ref</u>: Robbins 10<sup>th</sup>/ 649-50</strong></span></p>",
    "correct_choice_id": 57179,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual"
    ]
  },
  {
    "id": 14298,
    "choices": [
      {
        "id": 57153,
        "text": "<p><span style=\"font-size:12pt;\">Congenital spherocytosis</span></p>"
      },
      {
        "id": 57154,
        "text": "<p><span style=\"font-size:12pt;\">Autoimmune acquired hemolytic anemia</span></p>"
      },
      {
        "id": 57155,
        "text": "<p><span style=\"font-size:12pt;\">Thalassemia</span></p>"
      },
      {
        "id": 57156,
        "text": "<p><span style=\"font-size:12pt;\">All of the above</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt;\">Microspherocytes in peripheral blood smear are seen in:</span></p>",
    "unique_key": "Q9252667",
    "question_audio": null,
    "question_video": null,
    "map_id": 31954,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B. Autoimmune acquired hemolytic anemia</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">Spherocytes (small, round, dense red cells without central pallor) can be seen in:</span></li><li><span style=\"font-size:12.0pt;\">Hereditary (congenital) spherocytosis: classic finding, usually uniform in size \u2192 these are called spherocytes, not microspherocytes.</span></li><li><span style=\"font-size:12.0pt;\">Autoimmune hemolytic anemia (AIHA): due to partial phagocytosis of the RBC membrane by macrophages \u2192 results in smaller spherocytes called microspherocytes (they are smaller than normal RBCs and appear hyperchromic).</span></li><li><span style=\"font-size:12.0pt;\">Thalassemia: usually shows target cells, basophilic stippling, microcytosis \u2014 spherocytes/microspherocytes are not a typical feature.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A:&nbsp;Congenital spherocytosis:</strong> The spherocytes are usually of normal RBC size (though still spherical).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C: Thalassemia:</strong> Does not show spherocytes. Thalassemia typically presents with target cells and microcytes on blood smear. It involves a defect in hemoglobin production.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D.</strong> While spherocytes can be seen in congenital spherocytosis and autoimmune hemolytic anemia, they are not a feature of thalassemia. Hence, the presence of spherocytes is not common to all the conditions listed.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Educational Objective</u></strong><u>:</u></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">When you see microspherocytes specifically (very small, dense RBCs without central pallor), it strongly points towards AIHA, especially when combined with a positive direct Coombs test.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In hereditary spherocytosis, you see spherocytes (usually normal-sized or mildly smaller), increased MCHC, and family history.</span></p>",
    "correct_choice_id": 57154,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 14314,
    "choices": [
      {
        "id": 57217,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Drug induced AIHA</span></span></span></p>"
      },
      {
        "id": 57218,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Aplastic anemia</span></span></span></p>"
      },
      {
        "id": 57219,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hemolytic anemia due to transfusion</span></span></span></p>"
      },
      {
        "id": 57220,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hemolytic disease of newborn</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient presents with signs of anemia and a history of taking a medication known to cause hemolysis. Blood tests reveal anemia, and a direct antiglobulin test (DAT) is performed.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following conditions is least likely to be associated with a positive direct Coombs test?</span></span></span></p>",
    "unique_key": "Q4246662",
    "question_audio": null,
    "question_video": null,
    "map_id": 31951,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B. Aplastic anemia </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Direct Coombs test </strong>is<strong> positive </strong>in conditions associated with presence of <strong>antibodies on the surface of the cells</strong>. It is therefore <strong>negative in a patient of aplastic anemia</strong>. Some of the important conditions with positive Coombs test include: </span></span></span></p>\r\n\r\n<p><strong><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Autoimmune haemolytic anaemia </span></span></span></strong></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Haemolytic disease of new born or<strong> Rh incompatibility </strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Haemolytic anaemia </strong>due to <strong>mismatched blood transfusion </strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Aplastic anemia </strong>involves <strong>the failure of the bone marrow to produce adequate numbers of RBCs </strong>and is<strong> not </strong>typically associated with <strong>antibodies on the surface of RBCs</strong>, hence a <strong>direct Coombs test </strong>would usually be<strong> negative</strong>.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Drug-induced AIHA</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> can lead to the production of<strong> antibodies against red blood cells (RBCs) </strong>or induce the <strong>RBCs to adsorb plasma proteins, </strong>in either case leading to a positive Coombs test.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Hemolytic anemia</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> due to a<strong> transfusion reaction </strong>can occur if the transfused blood is <strong>not compatible</strong> with the <strong>patient&#39;s blood type</strong>, leading to <strong>antibody-mediated destruction of RBCs </strong>and a <strong>positive Coombs test</strong>.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Hemolytic disease</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> of the newborn, such as <strong>Rh or ABO incompatibility, </strong>involves<strong> maternal antibodies </strong>targeting <strong>fetal RBCs</strong>, which would yield a positive Coombs test.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A<strong> positive direct Coombs test </strong>indicates the<strong> presence of antibodies </strong>bound to<strong> RBCs</strong>, which is seen in conditions like<strong> drug-induced AIHA, hemolytic transfusion reactions, and hemolytic disease of the newborn, </strong>but <strong>not in aplastic anemia.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><em><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></em></strong><strong><em><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Robbins 10<sup>th</sup>/ 655 </span></em></strong></span></span></p>",
    "correct_choice_id": 57218,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 14316,
    "choices": [
      {
        "id": 57225,
        "text": "<p><span style=\"font-size:12pt;\">G6PD deficiency</span></p>"
      },
      {
        "id": 57226,
        "text": "<p><span style=\"font-size:12pt;\">Hereditary spherocytosis</span></p>"
      },
      {
        "id": 57227,
        "text": "<p><span style=\"font-size:12pt;\">Hypersplenism</span></p>"
      },
      {
        "id": 57228,
        "text": "<p><span style=\"font-size:12pt;\">Pyruvate kinase deficiency</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt;\">A patient presents with anemia and jaundice. The patient has an enlarged spleen. Which of the following is not an intrinsic cause of hemolytic anemia?</span></p>",
    "unique_key": "Q7030870",
    "question_audio": null,
    "question_video": null,
    "map_id": 31952,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C. Hypersplenism</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Hypersplenism </strong>is an<strong> extracorpuscular </strong>cause of<strong> hemo\u00aclytic anemia</strong>. All other options are<strong> intracorpuscular/ intrinsic </strong>causes of <strong>hemolytic anemia.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Hypersplenism </strong>is an<strong> extrinsic cause of hemolytic anemia</strong>. It can lead to<strong> increased destruction of red blood cells </strong>due to an <strong>overactive spleen</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. G6PD deficiency</strong> is an <strong>intrinsic </strong>cause of<strong> hemolytic anemia </strong>due to a defect in the<strong> red blood cell enzyme G6PD, </strong>which is necessary to <strong>protect the cell </strong>from <strong>oxidative damage.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Hereditary</strong> <strong>spherocytosis </strong>is an<strong> intrinsic cause of hemolytic anemia </strong>characterized by a defect in the <strong>red blood cell membrane proteins </strong>that provide <strong>structural support</strong>, resulting in <strong>spherical red blood cells </strong>that are <strong>prone to destruction</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Pyruvate kinase</strong> <strong>deficiency </strong>is an intrinsic cause of<strong> hemolytic anemia </strong>due to a defect in the<strong> enzyme pyruvate kinase</strong>, which is involved in the<strong> glycolytic pathway of red blood cells</strong>, leading&nbsp;to a <strong>lack of ATP </strong>and <strong>subsequent cell death</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Hypersplenism </strong>is an<strong> extracorpuscular </strong>cause of <strong>hemolytic anemia </strong>and <strong>not an intrinsic defect of the red blood cell itself</strong>, which distinguishes it from conditions such as<strong> G6PD deficiency, hereditary spherocytosis, and pyruvate kinase deficiency </strong>that are<strong> intrinsic to the red cells.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Types of hemolytic anemia:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">Intrinsic (intracorpuscular) defects \u2192 the problem is inside the RBC:</span></li><li><span style=\"font-size:12.0pt;\">Membrane defects: hereditary spherocytosis, elliptocytosis</span></li><li><span style=\"font-size:12.0pt;\">Enzyme defects: G6PD deficiency, pyruvate kinase deficiency</span></li><li><span style=\"font-size:12.0pt;\">Hemoglobinopathies: sickle cell, thalassemia</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Extrinsic (extracorpuscular) defects \u2192 the RBC itself is normal; the problem is in the environment:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">Autoimmune hemolysis</span></li><li><span style=\"font-size:12.0pt;\">Mechanical trauma (prosthetic valves)</span></li><li><span style=\"font-size:12.0pt;\">Hypersplenism</span></li><li><span style=\"font-size:12.0pt;\">Infections, toxins&nbsp;</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Ref:</u> Robbins 9/e 631</strong></span></p>",
    "correct_choice_id": 57227,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 14305,
    "choices": [
      {
        "id": 57181,
        "text": "<p><span style=\"font-size:12pt;\">Ankyrin</span></p>"
      },
      {
        "id": 57182,
        "text": "<p><span style=\"font-size:12.0pt;\">Palladin</span></p>"
      },
      {
        "id": 57183,
        "text": "<p><span style=\"font-size:12pt;\">Glycophorin C</span></p>"
      },
      {
        "id": 57184,
        "text": "<p><span style=\"font-size:12pt;\">Anion transport protein</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A 16-year-old male presents with jaundice and anemia. A blood smear shows numerous spherocytes, and a family history reveals a similar condition in his mother. Which of the following proteins, if defective, is most likely to be the cause of his hereditary spherocytosis?</span></p>",
    "unique_key": "Q5304023",
    "question_audio": null,
    "question_video": null,
    "map_id": 31944,
    "difficulty_level": "difficult",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A. Ankyrin</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Option A: Ankyrin is a key protein in the RBC membrane that links the integral membrane proteins to the underlying spectrin-actin cytoskeleton. Mutations in ankyrin are the most common cause of hereditary spherocytosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Option:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B</strong>: Palladin is not commonly associated with the RBC membrane or hereditary spherocytosis. This protein is involved in cytoskeletal organization and cell morphology, mainly in non-erythroid cells.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C</strong>: Glycophorin C is another membrane protein of the RBC; however, deficiencies in glycophorin C are more commonly associated with hereditary elliptocytosis, not hereditary spherocytosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D</strong>: The anion transport protein, also known as band 3, is an integral membrane protein of the RBC. Defects in band 3 are a well-established cause of hereditary spherocytosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Ankyrin is the most commonly mutated protein in hereditary spherocytosis. It plays a crucial role in linking the RBC membrane proteins to the spectrin-actin cytoskeleton, maintaining the biconcave shape of RBCs. Defects in ankyrin result in loss of membrane stability, leading to the formation of spherocytes and increased RBC destruction.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">&nbsp;The most common defective proteins:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_THBVUV9.png\" width=\"820\" height=\"296\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">(Ref: Robbins 10th/ 635)</span></p>",
    "correct_choice_id": 57181,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 14307,
    "choices": [
      {
        "id": 57189,
        "text": "<p><span style=\"font-size:12pt;\">Biliverdin</span></p>"
      },
      {
        "id": 57190,
        "text": "<p><span style=\"font-size:12pt;\">Conjugated and unconjugated bilirubin</span></p>"
      },
      {
        "id": 57191,
        "text": "<p><span style=\"font-size:12pt;\">Unconjugated bilirubin</span></p>"
      },
      {
        "id": 57192,
        "text": "<p><span style=\"font-size:12pt;\">Conjugated bilirubin</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt;\">An Rh -ve woman became pregnant with Rh +ve fetus. Within few days after birth, the infant developed jaundice, ascites, hepatomegaly and edema. The likely substance(s) deposited in skin and sclera in jaundice is/are given below. Which is the best possible answer?</span></p>",
    "unique_key": "Q3531871",
    "question_audio": null,
    "question_video": null,
    "map_id": 31946,
    "difficulty_level": "difficult",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B. Conjugated and unconjugated bilirubin</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">In conditions like <strong>erythroblastosis fetalis</strong>, both <strong>conjugated and unconjugated bilirubin </strong>can accumulate due to <strong>excessive hemolysis </strong>and <strong>the liver's limited ability </strong>to<strong> conjugate </strong>and <strong>excrete </strong>all the resulting<strong> bilirubin. </strong>These<strong> can deposit in the skin and sclera</strong>, causing <strong>jaundice.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Biliverdin is a green tetrapyrrolic bile pigment</strong>, and it is an <strong>intermediate product </strong>in the breakdown of<strong> heme</strong>. It is subsequently<strong> reduced to bilirubin </strong>in the liver.<strong> Biliverdin </strong>itself<strong> does not </strong>contribute to the<strong> yellow discoloration </strong>seen in jaundice.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Unconjugated bilirubin</strong> is the form that is i<strong>nitially produced </strong>during the<strong> breakdown of hemoglobin</strong>. While it does <strong>accumulate </strong>in conditions of<strong> increased hemolysis</strong>, it is<strong> not water-soluble </strong>and requires<strong> conjugation by the liver to become water-soluble</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Conjugated bilirubin</strong> is <strong>water-soluble </strong>and can be <strong>excreted into the bile and urine. High levels of conjugated bilirubin </strong>can indicate <strong>liver dysfunction or biliary obstruction</strong>, but on its own does not typically cause the systemic findings seen in erythroblastosis fetalis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Both<strong> conjugated and unconjugated bilirubin </strong>can deposit in the <strong>skin and sclera </strong>in newborns with <strong>erythroblastosis fetalis, </strong>contributing to the<strong> yellow discoloration </strong>observed in <strong>jaundice.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Summary Table:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_aGMzgQR.png\" width=\"993\" height=\"232\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Ref</u>: Robbins 10<sup>th</sup>/ 857</strong></span></p>",
    "correct_choice_id": 57190,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 14313,
    "choices": [
      {
        "id": 57213,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Yellowing of eyes and sclera</span></span></span></p>"
      },
      {
        "id": 57214,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increased LDH</span></span></span></p>"
      },
      {
        "id": 57215,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Decrease in haptoglobin</span></span></span></p>"
      },
      {
        "id": 57216,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Low reticulocyte count</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient presents with fatigue, pallor, and dark urine. Laboratory tests reveal anemia with increased bilirubin levels. Which of the following laboratory findings is inconsistent with a diagnosis of hemolytic anemia?</span></span></span></p>",
    "unique_key": "Q3189646",
    "question_audio": null,
    "question_video": null,
    "map_id": 31950,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D. Low reticulocyte count</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Haemolytic anaemia </strong>is characterised by the <strong>increased reticulocyte count, splenomegaly (especially extravascular hemolysis) </strong>and <strong>increased concentration of bilirubin and urobilinogen</strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;A<strong> low reticulocyte count </strong>would be unusual in <strong>hemolytic anemia </strong>because the<strong> bone marrow </strong>typically responds to anemia by <strong>increasing production of reticulocytes</strong>, the<strong> immature red blood cells</strong>.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Yellowing of eyes</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong> and sclera </strong>is due to<strong> hyperbilirubinemia</strong>, which is commonly seen in<strong> hemolytic anemia </strong>as a result of <strong>increased breakdown of red blood cells</strong>.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Increased lactate</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>dehydrogenase </strong>(LDH) is often observed in <strong>hemolytic anemia </strong>because this <strong>intracellular enzyme </strong>is released into the blood when <strong>red cells are destroyed</strong>.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. A decrease in haptoglobin</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> is expected in hemolytic anemia. <strong>Haptoglobin binds free hemoglobin </strong>released from <strong>lysed red blood cells</strong>, and its<strong> levels drop </strong>as it is<strong> consumed </strong>in this process.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Hemolytic anemia </strong>is typically characterized by an<strong> increased reticulocyte count </strong>as the <strong>bone marrow compensates </strong>for the loss of<strong> red blood cells</strong>. A<strong> low reticulocyte count </strong>suggests an <strong>inadequate bone marrow response</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><em><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref:</span></u></em></strong><strong><em><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Robbins 10<sup>th</sup>/ 634 </span></em></strong></span></span></p>",
    "correct_choice_id": 57216,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 14308,
    "choices": [
      {
        "id": 57193,
        "text": "<p><span style=\"font-size:12pt;\">Warm agglutinin</span></p>"
      },
      {
        "id": 57194,
        "text": "<p><span style=\"font-size:12pt;\">Cold hemolysin</span></p>"
      },
      {
        "id": 57195,
        "text": "<p><span style=\"font-size:12pt;\">Defect in PIGA gene</span></p>"
      },
      {
        "id": 57196,
        "text": "<p><span style=\"font-size:12pt;\">Antiplatelet antibody</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt;\">A young child presents with the sudden onset of hemoglobinuria following a viral infection. He was noted to have red urine after playing outside in the cold weather. Which of the following is the etiological factor responsible for this patient\u2019s condition?</span></p>",
    "unique_key": "Q9687904",
    "question_audio": null,
    "question_video": null,
    "map_id": 31947,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B. Cold hemolysin</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Paroxysomal cold hemoglobinuria</strong> is characterized by the presence of <strong>Donath-Landsteiner</strong> <strong>antibody.</strong> It has <strong>anti-P specificity</strong> and bind to red cells only at <strong>low temperature (optimally at 4\u00b0C). </strong>These antibodies are called as cold-hemolysin antibodies.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Warm agglutinins are antibodies</strong>, typically <strong>IgG</strong>, that react with <strong>red blood cell antigens at body temperature </strong>and are often involved in warm <strong>autoimmune hemolytic anemia.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Defect in PIGA gene</strong> is seen in paroxysmal Nocturnal hemoglobinuria and not PCH</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Antiplatelet antibody</strong> is seen with Immune thrombocytopenia</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Cold hemolysin have</span><span style=\"color:black;font-size:12pt;\">&nbsp;</span><span style=\"font-size:12pt;\">anti-P specificity, and&nbsp;is responsible for hemoglobinuria in patients with paroxysmal cold hemoglobinuria</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Ref</u>: Robbins 10<sup>th</sup>/ 660</strong></span></p>",
    "correct_choice_id": 57194,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 14306,
    "choices": [
      {
        "id": 57185,
        "text": "<p><span style=\"font-size:12pt;\">Antiphospholipid antibody syndrome</span></p>"
      },
      {
        "id": 57186,
        "text": "<p><span style=\"font-size:12pt;\">Thrombotic thrombocytopenic purpura</span></p>"
      },
      {
        "id": 57187,
        "text": "<p><span style=\"font-size:12pt;\">Microscopic polyangiitis</span></p>"
      },
      {
        "id": 57188,
        "text": "<p><span style=\"font-size:12pt;\">Metallic cardiac valves</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt;\">A 60-year-old woman with a prosthetic heart valve presents with anemia and schistocytes on peripheral smear. Which of the following conditions is least likely to be associated with microangiopathic hemolytic anemia?</span></p>",
    "unique_key": "Q3409785",
    "question_audio": null,
    "question_video": null,
    "map_id": 31945,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. D. Metallic cardiac valves</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Microangiopathic hemolytic anemia </strong>is associated with <strong>fragmentation of the red cells </strong>in the <strong>microcirculation</strong>. It is associated with <strong>anti-phospholopid antibody syndrome.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Metallic cardiac valves</strong>, particularly when<strong> malfunctioning</strong>, can cause<strong> hemolysis </strong>due to the <strong>physical destruction of red blood cells </strong>as they pass through the<strong> prosthetic valve</strong>, a process known as<strong> macroangiopathic hemolysis </strong>rather than<strong> microangiopathic.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Antiphospholipid antibody</strong> syndrome is characterized by the presence of<strong> autoantibodies </strong>that increase the risk of <strong>thrombosis</strong>, which can lead to <strong>MAHA </strong>due to <strong>mechanical damage </strong>to<strong> red cells </strong>as they pass through the narrowed,<strong> thrombosed vessels</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Thrombotic thrombocytopenic</strong> purpura (TTP) is a well-known cause of<strong> MAHA </strong>and is due to the formation of<strong> microthrombi </strong>that <strong>shear red blood cells </strong>as they<strong> traverse the microcirculation.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Microscopic polyangiitis</strong> is a type of <strong>small vessel vasculitis </strong>and can be associated with<strong> MAHA </strong>due to the damage to<strong> red cells </strong>caused by the<strong> inflammation of blood vessels.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Metallic cardiac valves are associated with macroangiopathic hemolytic anemia due to physical destruction of red blood cells rather than microangiopathic hemolytic anemia, which is characterized by red cell fragmentation in the microcirculation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Conditions commonly associated with MAHA:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-09-05%20171517.png\" width=\"1184\" height=\"544\"></span></p>",
    "correct_choice_id": 57188,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 14311,
    "choices": [
      {
        "id": 57205,
        "text": "<p><span dir=\"ltr\" lang=\"PT\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">IgG </span></span></p>"
      },
      {
        "id": 57206,
        "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">IgM</span></span></p>"
      },
      {
        "id": 57207,
        "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">IgA</span></span></p>"
      },
      {
        "id": 57208,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">IgD</span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient presents with acrocyanosis and hemolytic anemia after exposure to cold weather. Laboratory tests reveal agglutination of red blood cells at temperatures between 4 to 6&deg;C. Which type of immunoglobulin is most likely responsible for this agglutination?</span></span></span></p>",
    "unique_key": "Q3798098",
    "question_audio": null,
    "question_video": null,
    "map_id": 31948,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B. IgM </span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Cold agglutinins </strong>are<strong> monoclonal IgM antibodies </strong>that react at<strong> 4 to 6&deg;C</strong>. They are called <strong>agglutinins </strong>because the <strong>IgM directed against the &lsquo;I&rsquo; antigen </strong>present on the RBCs can <strong>agglutinate red cells </strong>due to its large size <strong>(pentamer).</strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>IgM antibodies </strong>are known as <strong>cold agglutinins </strong>and are the <strong>primary antibodies </strong>involved in <strong>cold agglutinin disease</strong>. They have a <strong>pentameric structure </strong>that allows them to <strong>effectively bridge and agglutinate red blood cells</strong>.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. IgG antibodies</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> are generally involved in<strong> warm autoimmune hemolytic anemias </strong>and do not typically cause agglutination at low temperatures.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. IgA antibodies</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> are mainly<strong> secretory antibodies </strong>and do not usually cause agglutination of red blood cells in cold environments.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. IgD antibodies</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> are found in <strong>very low concentrations in serum </strong>and are not associated with cold agglutination of red blood cells.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>IgM antibodies</strong>, known as <strong>cold agglutinins</strong>, can cause <strong>agglutination of red blood cells </strong>at <strong>low temperatures</strong>, as seen in <strong>cold agglutinin disease</strong>. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><em><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></em></strong><strong><em><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Robbins 10<sup>th</sup>/ 648 </span></em></strong></span></span></p>",
    "correct_choice_id": 57206,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 14312,
    "choices": [
      {
        "id": 57209,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hemolytic uremic syndrome</span></span></span></p>"
      },
      {
        "id": 57210,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Polysplenia</span></span></span></p>"
      },
      {
        "id": 57211,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Spherocytosis</span></span></span></p>"
      },
      {
        "id": 57212,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acanthocytosis</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A child presents with acute renal failure, thrombocytopenia, and a microangiopathic hemolytic anemia after a diarrheal illness. A peripheral blood smear shows fragmented red cells, including helmet cells. Which condition is most consistent with these findings?</span></span></span></p>",
    "unique_key": "Q9708488",
    "question_audio": null,
    "question_video": null,
    "map_id": 31949,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A. Hemolytic uremic syndrome </span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Hemolytic uremic syndrome (HUS) </strong>often follows a<strong> diarrheal illness </strong>caused by certain strains of<strong> E. coli. </strong>It is characterized by the <strong>triad of acute renal failure, thrombocytopenia, and microangiopathic hemolytic anemia with schistocytes, </strong>including<strong> helmet cells </strong>on peripheral smear.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Polysplenia</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> is a condition where <strong>multiple small spleens </strong>are present and is typically associated with <strong>congenital abnormalities</strong>; it does not characteristically present with schistocytes or helmet cells.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Spherocytosis</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> is a disorder causing <strong>spherically shaped red blood cells </strong>due to a defect in the<strong> RBC membrane, </strong>not typically associated with schistocytes or helmet cells.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Acanthocytosis</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> refers to <strong>spur cells with spiculated membranes</strong>, which are seen in<strong> liver disease and abetalipoproteinemia, </strong>among others, and does not present with helmet cells.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Helmet cells </strong>on a blood smear are characteristic of <strong>microangiopathic hemolytic anemias</strong>, such as those seen in<strong> hemolytic uremic syndrome (HUS), </strong>which can present with<strong> renal failure and thrombocytopenia </strong>following<strong> gastroenteritis</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u><em><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Robbins 10<sup>th</sup>/ 662 </span></span></em></strong></p>",
    "correct_choice_id": 57209,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "InvestigationBased"
    ]
  },
  {
    "id": 14258,
    "choices": [
      {
        "id": 56993,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Iron deficiency anemia</span></p>"
      },
      {
        "id": 56994,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Megaloblastic anemia</span></p>"
      },
      {
        "id": 56995,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Anemia of chronic disease</span>\u200b\u200b\u200b</p>"
      },
      {
        "id": 56996,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Hereditary spherocytosis</span></p>"
      }
    ],
    "text": "<p><span style=\"background-color:white;color:#0d0d0d;font-size:12pt;\">A 16-year-old male presents with jaundice and anemia. His blood smear shows spherical red blood cells, and laboratory tests reveal an increase in mean corpuscular hemoglobin concentration (MCHC). Which of the following is the most likely cause of his anemia?</span></p>",
    "unique_key": "Q1106309",
    "question_audio": null,
    "question_video": null,
    "map_id": 31901,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. D. &nbsp;Hereditary spherocytosis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Hereditary spherocytosis is a<strong> genetic disorder </strong>characterized by a defect in the<strong> red blood cell membrane</strong>, leading to a <strong>spherical or spheroid shape</strong>. Due to the <strong>loss of membrane surface area</strong>, the concentration of hemoglobin within the <strong>smaller, more compacted cells </strong>is increased, resulting in an <strong>elevated MCHC</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Elevated MCHC is a characteristic feature of spherocytes.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Iron deficiency anemia:&nbsp;</strong>It is characterized by a <strong>decrease in the amount of hemoglobin </strong>in red blood cells, leading to a <strong>decreased MCHC</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Megaloblastic anemia:&nbsp;</strong>It can be associated with <strong>vitamin B12 or folate deficiency </strong>and ha<strong>s macrocytosis</strong>. This condition is associated with a<strong> normal or decreased MCHC.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Anemia of chronic disease:&nbsp;</strong>The anomie is often <strong>normocytic and normochromic</strong>, with a <strong>normal MCH</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Hereditary spherocytosis </strong>often presents with an<strong> elevated MCHC </strong>due to the <strong>spherical shape of red blood cells</strong>, which concentrates the <strong>haemoglobin content</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Ref</u>: Robbins 10<sup>th</sup>/ 639</strong></span></p>",
    "correct_choice_id": 56996,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "InvestigationBased"
    ]
  },
  {
    "id": 14271,
    "choices": [
      {
        "id": 57045,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Decrease in reduced glutathione</span></span></span></p>"
      },
      {
        "id": 57046,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Decrease in NADPH</span></span></span></p>"
      },
      {
        "id": 57047,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increased in lipid peroxidation</span></span></span></p>"
      },
      {
        "id": 57048,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Decreased RBC membrane damage</span></span></span>\u200b\u200b\u200b</p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 30-year-old African American male presents to the emergency room with jaundice and dark urine after taking a sulfa drug for a urinary tract infection. He has a past medical history of a similar episode after eating fava beans. His labs reveal hemolytic anemia. Which of the following is NOT a consequence of the enzyme deficiency this patient most likely has?</span></span></span></p>",
    "unique_key": "Q6449129",
    "question_audio": null,
    "question_video": null,
    "map_id": 31904,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D. Decreased RBC membrane damage </span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>G6PD deficiency </strong>is associated with <strong>decrease in reduced glutathione and decreased NADPH. </strong>It is associated with<strong> <em>increased lipid peroxidation </em></strong>and <strong><em>more RBC membrane damage.</em></strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Decreased red blood cell membrane damage </strong>is<strong> not </strong>associated with <strong>G6PD deficiency.</strong> In fact, the <strong>lack of NADPH </strong>leads to increased <strong>oxidative stress </strong>and thus <strong>increased membrane damage</strong>, causing <strong>hemolysis</strong>.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. In G6PD deficiency</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">, there is a <strong>decrease in reduced glutathione </strong>due to <strong>insufficient NADPH</strong>, leading to <strong>decreased ability to neutralize oxidative stress </strong>in red blood cells.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. G6PD deficiency</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> results in a<strong> decrease in NADPH production</strong>, a critical factor in maintaining the <strong>reduced state of glutathione.</strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Without enough</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong> reduced glutathione</strong>, red blood cells are <strong>more susceptible to oxidative stress</strong>, leading to increased<strong> lipid peroxidation and membrane damage</strong>.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong> </span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Decreased red blood cell membrane </strong>damage is<strong> not </strong>associated with <strong>G6PD deficiency.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u><em><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Robbins 10th/e p640 </span></span></em></strong></p>",
    "correct_choice_id": 57048,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 14310,
    "choices": [
      {
        "id": 57201,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Controlling reduction stress on RBC</span></span></span></p>"
      },
      {
        "id": 57202,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Controlling oxidative stress on RBC</span></span></span></p>"
      },
      {
        "id": 57203,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Maintaining flexibility of cell membrane</span></span></span></p>"
      },
      {
        "id": 57204,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Component of electron transport chain</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient presents with an acute hemolytic episode after taking an antimalarial drug. His urine is dark brown, almost black. Laboratory findings are suggestive of intravascular hemolysis. A deficiency in which of the following enzymes is most likely responsible for this patient&rsquo;s condition?&nbsp;&nbsp;&nbsp;&nbsp;</span></span></span></p>",
    "unique_key": "Q2976255",
    "question_audio": null,
    "question_video": null,
    "map_id": 31903,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B. Controlling oxidative stress on RBC</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><em>&nbsp;</em></strong></span></span><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>G6PD</strong> helps in<strong> neutralizing </strong>the effect of <strong>oxidative stress on the RBC</strong>. Oxidative stress is induced by drugs like<strong> primaquine </strong>and hence in patients of<strong> G6PD </strong>there is <strong>accelerated hemolysis (intravascular during the hemolytic episode) </strong>resulting in<strong> hemoglobinuria and passage of shockingly black urine </strong>by the patient.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Glucose-6-phosphate dehydrogenase (G6PD) </strong>helps in controlling<strong> oxidative stress on RBCs </strong>by producing <strong>NADPH,</strong> which in turn maintains the reduced state of<strong> glutathione</strong>. Glutathione is vital for<strong> detoxifying harmful oxidative agents</strong>. <strong>Deficiency of G6PD </strong>can lead to<strong> hemolytic episodes </strong>when exposed to<strong> oxidative drugs or foods</strong>.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Controlling reduction stress</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> on <strong>RBC </strong>refers to the balance of <strong>redox states </strong>within the cell. While redox balance is crucial, there is no specific enzyme known as the &lsquo;reduction stress controller&rsquo; in RBCs.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Maintaining flexibility</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> of <strong>cell membrane </strong>is related to the <strong>cytoskeletal proteins of the RBC</strong>, such as <strong>spectrin</strong>, and does not involve G6PD.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Components of the electron</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> transport chain are involved in<strong> energy production in the mitochondria</strong>, which<strong> RBCs lack</strong>; hence, it does not relate to the<strong> integrity of RBCs</strong>.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The role of <strong>G6PD </strong>is in maintaining the <strong>redox balance </strong>to protect<strong> RBCs from oxidative stress</strong>, where its deficiency can lead to <strong>hemolytic anemia upon exposure to certain oxidative drugs or foods</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><em><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></em></strong><strong><em><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Robbins 10<sup>th</sup>/640 </span></em></strong></span></span></p>",
    "correct_choice_id": 57202,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 14260,
    "choices": [
      {
        "id": 57001,
        "text": "<p><span style=\"font-size:12pt;\">Autoimmune hemolytic anemia</span></p>"
      },
      {
        "id": 57002,
        "text": "<p><span style=\"font-size:12pt;\">Hereditary spherocytosis</span></p>"
      },
      {
        "id": 57003,
        "text": "<p><span style=\"font-size:12pt;\">Microangiopathic haemolytic anemia</span></p>"
      },
      {
        "id": 57004,
        "text": "<p><span style=\"font-size:12pt;\">Thermal injury causing anemia</span>\u200b\u200b\u200b\u200b</p>"
      }
    ],
    "text": "<p><span style=\"background-color:white;color:#0d0d0d;font-size:12pt;\">A 10-year-old male presents with jaundice and anemia. His peripheral blood smear shows numerous small, dense, and spherically shaped red blood cells. He reports a family history of similar symptoms. A defect in which of the following is the most likely cause of his anemia?</span></p>",
    "unique_key": "Q1821186",
    "question_audio": null,
    "question_video": null,
    "map_id": 31902,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B. Hereditary spherocytosis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B:</strong></span></p><p>&nbsp;</p><p><span style=\"background-color:white;font-size:12pt;\">Hereditary spherocytosis is characterized by a <strong>genetic defect </strong>in the red blood <strong>cell membrane proteins</strong>, leading to <strong>spherically shaped cells </strong>that are<strong> less deformable </strong>and <strong>more prone to destruction in the spleen.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p>&nbsp;</p><p><span style=\"background-color:white;font-size:12pt;\"><strong>Option A.</strong>&nbsp; <strong>Autoimmune hemolytic anemia</strong> is caused by <strong>antibodies </strong>targeting and <strong>destroying red blood cells</strong>, not by an intrinsic defect in the red blood cell membrane.</span></p><p>&nbsp;</p><p><span style=\"background-color:white;font-size:12pt;\"><strong>Option C. Leading to red blood cell fragmentation Microangiopathic hemolytic anemia</strong> is caused by red blood cells being damaged as they pass through <strong>narrowed or damaged small blood vessels</strong>, not by an intrinsic membrane defect.</span></p><p>&nbsp;</p><p><span style=\"background-color:white;font-size:12pt;\"><strong>Option D. Thermal injury causes anemia</strong> due to<strong> direct heat damage to the red blood cells </strong>or indirect effects following <strong>burn injury</strong>, not due to<strong> intrinsic membrane defects</strong>.</span></p><p>&nbsp;</p><p><span style=\"background-color:white;font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">Hereditary spherocytosis (HS):</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12.0pt;\">Autosomal dominant disorder (so usually has a positive family history)</span></li><li><span style=\"font-size:12.0pt;\">Caused by defects in RBC membrane proteins:</span></li><li><span style=\"font-size:12.0pt;\">Most commonly: spectrin, ankyrin, band 3, or protein 4.2</span></li></ul></li><li><span style=\"font-size:12.0pt;\">Leads to loss of membrane surface area \u2192 RBCs become spherocytes:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12.0pt;\">Small, round, dense cells without central pallor</span></li><li><span style=\"font-size:12.0pt;\">Spherocytes are less deformable \u2192 get trapped and destroyed in spleen \u2192 extravascular hemolysis</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Ref</u>: Robbins 10<sup>th</sup>/ 632</strong></span></p>",
    "correct_choice_id": 57002,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 14272,
    "choices": [
      {
        "id": 57049,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Thalassemia major</span></span></span></p>"
      },
      {
        "id": 57050,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Thalassemia minor</span></span></span></p>"
      },
      {
        "id": 57051,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Iron deficiency anemia</span></span></span>\u200b</p>"
      },
      {
        "id": 57052,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Anemia of chronic disease</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 20-year-old female presents with the following laboratory values: hemoglobin 9gm%, MCV is 55%, RBC is 4.5 million/mm3. There is no history of blood transfusion. What is the most likely diagnosis out of the following?</span></span></span></p>",
    "unique_key": "Q8775889",
    "question_audio": null,
    "question_video": null,
    "map_id": 31928,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><em><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B. Thalassemia minor </span></em></strong></span></span></p>\r\n\r\n<p>&nbsp;&nbsp;<span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Thalassemia major </strong>patient presents with <strong>severe anemia and cannot survive without blood transfusion, </strong>so this option can be easily ruled out. For other options, <strong>Mentzer index </strong>is useful for <strong>differentiating between thalassemia minor and iron deficiency anemia. </strong></span></span></span></p>\r\n\r\n<p>&nbsp;&nbsp;<span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Thalassemia minor </strong>often presents with <strong>mild to moderate anemia </strong>and a <strong>low MCV. </strong>The <strong>Mentzer index</strong>, calculated as <strong>MCV </strong>divided by the <strong>RBC count</strong>, is less than <strong>13 in thalassemia minor.</strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Patients with thalassemia</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>major </strong>typically present with <strong>severe anemia</strong> requiring regular<strong> blood transfusions. </strong>The degree of anemia in the <strong>vignette</strong> is not consistent with thalassemia major.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Iron deficiency anemia</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> typically presents with<strong> microcytic and hypochromic anemia</strong>. The<strong> Mentzer index </strong>is generally <strong>greater than 13</strong>, which is not the case here.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Anemia of chronic disease</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> usually presents with <strong>normocytic or sometimes microcytic anemia</strong>, but it is often characterized by a<strong> normal or increased storage iron level</strong>, which can be evaluated by <strong>serum ferritin.</strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong> </span></span></p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">When presented with<strong> mild to moderate microcytic anemia </strong>and an <strong>MCV/RBC count </strong>that yields a <strong>Mentzer index of less than 13, thalassemia minor </strong>is a likely diagnosis. </span></span></p>",
    "correct_choice_id": 57050,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 14275,
    "choices": [
      {
        "id": 57061,
        "text": "<p><span style=\"font-size:12pt;\">Iron deficiency anemia</span></p>"
      },
      {
        "id": 57062,
        "text": "<p><span style=\"font-size:12pt;\">Thalassemia major</span></p>"
      },
      {
        "id": 57063,
        "text": "<p><span style=\"font-size:12pt;\">Thalassemia minor</span></p>"
      },
      {
        "id": 57064,
        "text": "<p><span style=\"font-size:12pt;\">Megaloblastic anemia</span>\u200b\u200b\u200b\u200b\u200b\u200b</p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt;\">A 30 years old female undergoes blood investigations which reveal RBC count 4.5 million, MCV 55fl and TLC 8000/mm3. There is no history of blood transfusion. What is the likely diagnosis?</span></p>",
    "unique_key": "Q3517952",
    "question_audio": null,
    "question_video": null,
    "map_id": 31929,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C. Thalassemia minor</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Thalassemia minor (beta-thalassemia trait) </strong>typically presents with <strong>mild to moderate microcytic, hypochromic anemia </strong>and a <strong>normal or slightly elevated RBC count</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Iron deficiency anemia</strong> (IDA) is characterized by<strong> microcytic, hypochromic red cells</strong>, often with a<strong> high RDW and low serum ferritin levels</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Thalassemia major presents</strong> with <strong>severe microcytic anemia </strong>usually requiring <strong>blood transfusions for survival</strong>, often diagnosed in childhood.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Megaloblastic anemia Megaloblastic</strong> anemia is characterized by <strong>macrocytosis </strong>with an <strong>MCV </strong>typically greater than <strong>100 fL due to impaired DNA synthesis</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">In a patient with <strong>microcytic anemia </strong>and <strong>an MCV of 55 fL, a normal TLC, </strong>and <strong>no history of transfusion, thalassemia minor </strong>is likely, particularly when using indices such as the<strong> Mentzer index (MCV/RBC count), </strong>which is <strong>less than 13 </strong>in thalassemia minor.</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_zwWMveA.png\" width=\"867\" height=\"238\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Ref:</u> Robbins 10<sup>th</sup> 644</strong></span></p>",
    "correct_choice_id": 57063,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 14268,
    "choices": [
      {
        "id": 57033,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Beta thalassemia trait</span></span></span></p>"
      },
      {
        "id": 57034,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sickle cell anemia</span></span></span></p>"
      },
      {
        "id": 57035,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hereditory spherocytosis</span></span></span></p>"
      },
      {
        "id": 57036,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">G6 PD deficiency</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">A 24-year-old woman presents with mild anemia noted on routine screening. She reports a family history of anemia but has no significant personal medical history. She denies any symptoms of anemia. A hemoglobin electrophoresis is performed, showing an increased HbA2 level. Which of the following is the most likely diagnosis?</span></span></span></span></span></p>",
    "unique_key": "Q9765507",
    "question_audio": null,
    "question_video": null,
    "map_id": 31936,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A. Beta thalassemia trait </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">Beta thalassemia trait is characterized by a mutation in the beta-globin gene, leading to reduced (&beta;+) or absent (&beta;0) production of &beta;-globin chains. Compensatory increase in HbA2 (&alpha;2&delta;2) is a hallmark of this condition.</span></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">Hemoglobin electrophoresis usually reveals an increase in HbA2 (&alpha;2&delta;2) to 4% to 8% of the total hemoglobin (nor&not;mal, 2.5% &plusmn; 0.3%), which is a reflection of an elevated ra&not;tio of &delta;-chain to &beta;-chain synthesis. HbF levels are generally normal or occasionally slightly increased</span></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">Explanation:</span></span></u></strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">Option B. Sickle cell anemia</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\"> is characterized by a mutation in the beta-globin gene that leads to the production of hemoglobin S. Hemoglobin electrophoresis in sickle cell anemia typically shows a predominance of HbS and possibly elevated HbF but not HbA2.</span></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">Option C. Hereditary spherocytosis</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\"> is a disorder of the red blood cell membrane leading to spherical erythrocytes and hemolytic anemia. It does not involve abnormalities in hemoglobin synthesis or elevated HbA2 levels.</span></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">Option D. G6PD deficiency</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\"> is an X-linked enzymatic defect leading to hemolytic anemia under conditions of oxidative stress. It is not associated with an increase in HbA2 on electrophoresis.</span></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">Educational Objective:</span></span></u></strong><u> </u></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">When a hemoglobin electrophoresis reveals increased HbA2 levels, it is indicative of beta thalassemia trait, reflecting an imbalance in globin chain production. </span></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">:<em> Robbins 10<sup>th</sup>/ 641 </em></span></span><em><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> </span></span></em></strong></p>",
    "correct_choice_id": 57033,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual"
    ]
  },
  {
    "id": 41782,
    "choices": [
      {
        "id": 166812,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Alpha thalassemia</span></span></span></p>"
      },
      {
        "id": 166813,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Beta thalassemia</span></span></span></p>"
      },
      {
        "id": 166814,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sickle cell anemia</span></span></span></p>"
      },
      {
        "id": 166815,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">G6PD deficiency</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 6-years-old child belonging to Punjabi family with past history of blood transfusions presented with hemoglobin 3.5 g/dl, MCV &ndash; 30 fl, MCHC &ndash; 20. Peripheral smear findings of microcytic hypochromic anemia with target cell and reduced osmotic fragility. What is the he probable diagnosis of patient? </span></span></span></p>",
    "unique_key": "Q3311716",
    "question_audio": null,
    "question_video": null,
    "map_id": 31931,
    "difficulty_level": "beginner",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B. Beta thalassemia </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Friends, let&rsquo;s get the answer of this question in a methodical manner. The clues in the question:</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Reduced values of MCV and MCHC:<strong> microcytic hypochromic anemia </strong>(G6PD deficiency is ruled out)</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Age of presentation and ethnicity:<strong> 6-year-old and Punjabi ethnicity </strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">History of <strong>repeated blood transfusion: </strong>in favour of <strong>thalassemia </strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Osmotic fragility is reduced: </strong>in favour of thalassemia again though it may be seen in sickle cell also </span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Also, the hemoglobin is the question is more suggestive of <strong>severe anemia</strong> with<strong> positive</strong> <strong>history of multiple blood transfusions</strong> both being important pointers towards <strong>thalassemia major</strong>. Other ethnic groups having high prevalence of thalassemia are<strong> Punajbis, Sindhis, Gujaratis, Parsis, Begalis and Lohanas.</strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The above-mentioned points point to thalassemia. Since<strong> beta thalassemia is more prevalent, </strong>it is&nbsp;</span></span></span><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">a better option than alpha thalassemia. </span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Alpha thalassemia</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> typically presents with <strong>microcytic anemia </strong>and can be<strong> severe </strong>depending on the<strong> number of gene deletions </strong>but is less common in the Punjabi population.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Sickle cell anemia</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> usually presents with<strong> normocytic anemia </strong>and not typically microcytic anemia. It can have target cells but is most commonly associated with the<strong> African population.</strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. G6PD deficiency</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> can lead to<strong> hemolytic anemia,</strong> often episodic and related to <strong>oxidative stress,</strong> but it typically<strong> does not cause a microcytic hypochromic anemia or a reduced&nbsp;</strong></span></span></span><strong><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">MCV and MCHC.</span></span></span></strong></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The&nbsp; presentation of s<strong>evere microcytic hypochromic anemia with target cells</strong>, a history of<strong> multiple blood transfusions,</strong> and <strong>reduced</strong> <strong>osmotic fragility</strong> in a child from an <strong>ethnicity with a high prevalence of thalassemia </strong>strongly suggests <strong>beta thalassemia major</strong> as the most likely diagnosis.</span></span></p>",
    "correct_choice_id": 166813,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 41783,
    "choices": [
      {
        "id": 166816,
        "text": "<p><span style=\"font-size:12pt;\">\u03b2- thalassemia</span></p>"
      },
      {
        "id": 166817,
        "text": "<p><span style=\"font-size:12pt;\">Hereditary spherocytosis</span></p>"
      },
      {
        "id": 166818,
        "text": "<p><span style=\"font-size:12pt;\">Autoimmune haemolytic anaemia</span></p>"
      },
      {
        "id": 166819,
        "text": "<p><span style=\"font-size:12pt;\">Megaloblastic anaemia</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt;\">NESTROF test is a screening test for which of the following conditions?</span></p>",
    "unique_key": "Q9047769",
    "question_audio": null,
    "question_video": null,
    "map_id": 31932,
    "difficulty_level": "beginner",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A.&nbsp;\u03b2- thalassemia</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>\u03b2-thalassemia</strong> - <strong>NESTROFT is</strong> used to<strong> screen for beta-thalassemia </strong>because red blood cells in this condition exhibit reduced<strong> fragility.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_gpLLE9O.png\" width=\"968\" height=\"289\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>NESTROFT </strong>is a screening test for<strong> beta-thalassemia, </strong>which is based on the<strong> decreased osmotic fragility </strong>of red blood cells in this condition.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The NESTROFT test (Naked Eye Single Tube Red cell Osmotic Fragility Test) is a simple, cheap screening test used especially in countries like India to screen for \u03b2-thalassemia trait (carrier state).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">How it works:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">Based on the principle that RBCs in thalassemia are microcytic and hypochromic \u2192 they have a reduced osmotic fragility (more resistant to lysis in hypotonic saline).</span></li><li><span style=\"font-size:12.0pt;\">In the test:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12.0pt;\">A single hypotonic saline solution (usually around 0.36% NaCl) is used.</span></li><li><span style=\"font-size:12.0pt;\">After incubation, if the solution remains turbid \u2192 positive test (RBCs did not lyse \u2192 likely \u03b2-thalassemia trait).</span></li><li><span style=\"font-size:12.0pt;\">If the solution becomes clear \u2192 negative test (RBCs lysed \u2192 normal).</span></li></ul></li></ul>",
    "correct_choice_id": 166816,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "InvestigationBased"
    ]
  },
  {
    "id": 41785,
    "choices": [
      {
        "id": 166824,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Deletion of alpha genes</span></span></span></p>"
      },
      {
        "id": 166825,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Deletion of beta genes</span></span></span></p>"
      },
      {
        "id": 166826,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Excess of alpha genes</span></span></span></p>"
      },
      {
        "id": 166827,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Single amino acid substitution in alpha chain</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is the cause of alpha thalassemia?</span></span></span></p>",
    "unique_key": "Q5794467",
    "question_audio": null,
    "question_video": null,
    "map_id": 31933,
    "difficulty_level": "beginner",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A. Deletion of alpha genes </span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Deletion of alpha genes </strong>is the primary cause of<strong> alpha thalassemia. </strong>The number of deleted genes can affect the<strong> severity of the disease</strong>; the<strong> loss of two genes </strong>causes mild disease, while the <strong>loss of all four genes leads to hydrops fetalis</strong>.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Deletion of beta</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> genes leads to<strong> beta thalassemia. </strong>This condition results from <strong>mutations in the beta-globin gene </strong>on <strong>chromosome 11</strong>, not the alpha-globin gene on chromosome 16.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Excess of alpha</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> genes <strong>does not cause alpha thalassemia. </strong>Typically, an<strong> imbalance between alpha and beta chains </strong>due to a relative lack of<strong> alpha genes </strong>is what causes <strong>thalassemias.</strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Single amino</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> acid substitution in the<strong> alpha chain </strong>is commonly associated with hemoglobin variants like <strong>Hemoglobin C or S, </strong>but <strong>not with thalassemia</strong>, which is a<strong> quantitative problem with globin chain production.</strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Alpha thalassemia </strong>is most commonly caused by the <strong>deletion of alpha genes on chromosome 16</strong>, which leads to a<strong> quantitative reduction </strong>in the production of <strong>alpha-globin chains.</strong></span></span></span></p>",
    "correct_choice_id": 166824,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual"
    ]
  },
  {
    "id": 41786,
    "choices": [
      {
        "id": 166828,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Deletion of 4 alpha chains</span></span></span></p>"
      },
      {
        "id": 166829,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Deletion of 3 alpha chains</span></span></span></p>"
      },
      {
        "id": 166830,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Deletion of 2 alpha chains</span></span></span></p>"
      },
      {
        "id": 166831,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Deletion of 1 alpha chain</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">HbH is formed due to which of the following? </span></span></span></p>",
    "unique_key": "Q8500792",
    "question_audio": null,
    "question_video": null,
    "map_id": 31934,
    "difficulty_level": "intermediate",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B. Deletion of 3 alpha chains </span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Deletion of 3 alpha chains </strong>leads to the formation of<strong> HbH disease</strong>. HbH is composed of<strong> four beta-globin chains </strong>and is formed in response to the lack of sufficient<strong> alpha chains</strong>.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Deletion</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>of all 4 alpha chains </strong>typically results in<strong> hydrops fetalis </strong>and is usually<strong> incompatible with life</strong>; hence it does not lead to the formation of HbH.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Deletion</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>of 1</strong> <strong>alpha chain </strong>usually causes no significant clinical symptoms and is known as <strong>silent carrier state</strong>; it does not lead to HbH formation.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Option C: Deletion of 2</strong> <strong>alpha chains </strong>often causes a milder form of<strong> alpha thalassemia, </strong>known as<strong> alpha thalassemia trait or alpha thalassemia minor</strong>, not typically associated with the formation of HbH.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>HbH disease </strong>is caused by the <strong>deletion of three alpha-globin genes</strong>, which leads to an <strong>excess of beta-globin chains </strong>that form the <strong>abnormal hemoglobin H (beta4).</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><em><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></em></strong><strong><em><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Robbins 10<sup>th</sup>/ 645 </span></em></strong></span></span></p>",
    "correct_choice_id": 166829,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual"
    ]
  },
  {
    "id": 41787,
    "choices": [
      {
        "id": 166832,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Stability</span></span></span></p>"
      },
      {
        "id": 166833,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Function</span></span></span></p>"
      },
      {
        "id": 166834,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Affinity</span></span></span></p>"
      },
      {
        "id": 166835,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Solubility</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">What is affected in sickled hemoglobin; HbS? </span></span></span></p>",
    "unique_key": "Q5216378",
    "question_audio": null,
    "question_video": null,
    "map_id": 31935,
    "difficulty_level": "intermediate",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D. Solubility </span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Solubility </strong>is the property most affected by the <strong>mutation causing HbS</strong>. Under<strong> deoxygenated </strong>conditions,<strong> HbS polymerizes, </strong>leading to the formation of<strong> insoluble fibers </strong>that deform the <strong>red blood cells into a sickle shape</strong>.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Stability</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> refers to the <strong>hemoglobin molecule&#39;s resistance to denaturation and degradation</strong>. While HbS can be less stable under deoxygenating conditions, this is not the primary issue.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;Option B. Function pertains</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> to the <strong>ability </strong>of hemoglobin to<strong> carry oxygen</strong>. HbS can still <strong>carry oxygen</strong>, but the sickling process can hinder its release to tissues.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Affinity refers</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> to the<strong> hemoglobin&#39;s ability </strong>to<strong> bind oxygen</strong>. <strong>HbS </strong>has a <strong>slightly different oxygen</strong> affinity compared to normal hemoglobin, but again, this is not the main problem.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Sickle cell hemoglobin (HbS) </strong>is primarily characterized by <strong>reduced solubility </strong>under<strong> deoxygenated </strong>conditions, leading to <strong>polymerization and sickling </strong>of red blood cells. This results in<strong> vaso-occlusive crises and chronic hemolytic anemia.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><em><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Robbins 10<sup>th</sup>/ 638</span></span></em></strong></p>",
    "correct_choice_id": 166835,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual"
    ]
  },
  {
    "id": 41788,
    "choices": [
      {
        "id": 166836,
        "text": "<p><span style=\"font-size:12.0pt;\">Autosplenectomy</span></p>"
      },
      {
        "id": 166837,
        "text": "<p><span style=\"font-size:12.0pt;\">Bone marrow expansion in the calvarium</span></p>"
      },
      {
        "id": 166838,
        "text": "<p><span style=\"font-size:12.0pt;\">Effective erythropoeisis</span></p>"
      },
      {
        "id": 166839,
        "text": "<p><span style=\"font-size:12.0pt;\">Predisposition to *Hemophilus influenzae *infections</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Which of the following manifestations is common to sickle cell anemia and thalassemia major?</span></p>",
    "unique_key": "Q4381514",
    "question_audio": null,
    "question_video": null,
    "map_id": 31930,
    "difficulty_level": "difficult",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B. Bone marrow expansion in the calvarium</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Bone marrow expansion in the calvarium is a response to the increased erythropoietic demand in both sickle cell anemia and thalassemia major. This compensatory mechanism for chronic anemia causes a characteristic radiographic appearance.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation</strong>:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A</strong>. Autosplenectomy is the process of spleen shrinkage and fibrosis due to chronic damage, commonly seen in sickle cell anemia as a result of repeated vaso-occlusive episodes but is not a typical feature of thalassemia major.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C</strong>. Effective erythropoiesis refers to the production of functional red blood cells that successfully mature and enter circulation. This is not characteristic of either condition, as both sickle cell anemia and thalassemia major are marked by ineffective erythropoiesis resulting in inadequate functional red cell production.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D</strong>. Predisposition to Hemophilus influenzae infections is more commonly associated with asplenic or hyposplenic individuals, but it is not directly related to the bone marrow changes seen on skull x-rays.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Both sickle cell anemia and thalassemia major can lead to bone marrow expansion in the calvarium as a compensatory response to increased erythropoietic demand due to chronic hemolytic anemia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref</strong>: Robbins 10th/ 640</span></p>",
    "correct_choice_id": 166837,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual"
    ]
  },
  {
    "id": 41789,
    "choices": [
      {
        "id": 166840,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sickle cell trait</span></span></span></p>"
      },
      {
        "id": 166841,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Haemoglobin SC disease</span></span></span></p>"
      },
      {
        "id": 166842,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sickle thalassaemia</span></span></span></p>"
      },
      {
        "id": 166843,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sickle &ndash;Hb E disease</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">One of the common variants of sickle cell anemia frequently marked by lesser degree of haemolytic anemia and greater propensity for the development of retinopathy and aseptic necrosis of bones is: </span></span></span></p>",
    "unique_key": "Q1291495",
    "question_audio": null,
    "question_video": null,
    "map_id": 31937,
    "difficulty_level": "difficult",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C. Sickle thalassaemia </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sickle thalassaemia is one of the common variants of sickle cell anemia frequently marked by <strong>lesser degree of haemolytic anemia</strong> and <strong>greater propensity</strong> for the development of <strong>retinopathy and aseptic necrosis of bones</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sickle thalassemia is a coinheritance of a sickle cell gene and a thalassemia gene. It can present with a variable clinical picture, often with a lesser degree of hemolytic anemia but can have complications such as retinopathy and aseptic necrosis of bones.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Sickle cell trait</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">, the heterozygous form of sickle cell disease, usually causes no symptoms or a very mild clinical course and does not typically lead to complications like retinopathy or aseptic necrosis of bones.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Hemoglobin</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> SC disease is a compound heterozygous condition with one sickle cell gene and one gene for hemoglobin C. It can present with a clinical picture similar to sickle cell disease but usually with a milder course.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Sickle-Hb E disease</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> involves coinheritance of the sickle cell gene and hemoglobin E gene. It usually presents with milder symptoms compared to sickle cell anemia but can have clinical variability.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sickle thalassemia often presents with less severe hemolytic anemia compared to sickle cell anemia but has a greater propensity for complications such as retinopathy and aseptic necrosis of bones.</span></span></p>",
    "correct_choice_id": 166842,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual"
    ]
  },
  {
    "id": 14303,
    "choices": [
      {
        "id": 57173,
        "text": "<p><span style=\"font-size:12pt;\">Spectrin</span></p>"
      },
      {
        "id": 57174,
        "text": "<p><span style=\"font-size:12pt;\">Defect in complement activating proteins</span></p>"
      },
      {
        "id": 57175,
        "text": "<p><span style=\"font-size:12pt;\">Defective GPI anchor</span></p>"
      },
      {
        "id": 57176,
        "text": "<p><span style=\"font-size:12.0pt;\">Mannose-binding residue effect</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt;\">A 30-year-old male presents with dark urine in the morning and has been found to have hemolytic anemia on laboratory evaluation. A diagnostic test reveals increased sensitivity of his red blood cells to lysis in acidified serum. Which of the following underlying defects is most consistent with these findings?</span></p>",
    "unique_key": "Q6543400",
    "question_audio": null,
    "question_video": null,
    "map_id": 31940,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. C. Defective GPI anchor</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option C:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Ham\u2019s acidified </strong>serum test is used for the diagnosis of <strong>paroxysmal nocturnal hemoglobinuria (PNH). </strong>In this condition, <strong>defective GPI anchor </strong>prevents the attachment of <strong>CD55, CD59 and C8 binding protein</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">A <strong>defective GPI (glycosylphosphatidylinositol) </strong>anchor leads to<strong> paroxysmal nocturnal hemoglobinuria (PNH) </strong>by failing to secure protective proteins such as<strong> CD55 and CD59 to the cell membrane</strong>, leaving<strong> red blood cells </strong>susceptible to<strong> complement-mediated lysis</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong><u>Explanation:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option A. Spectrin is a cytoskeletal protein</strong> that helps maintain the<strong> red blood cell's shape</strong>. Defects in spectrin can cause <strong>hereditary spherocytosis </strong>but are not associated with increased red cell lysis in acidified serum.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option B.</strong> <strong>Defect in complement activating proteins:</strong> PNH is due to complement regulatory (inhibitory) proteins not because of complement activating proteins.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option D. The Mannose-binding lectin</strong> pathway is involved in <strong>innate immunity </strong>and can lead to<strong> opsonization and phagocytosis </strong>of pathogens, but defects here do not lead to the clinical picture described.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong><u>Educational Objective:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">A<strong> defective GPI anchor </strong>is implicated in<strong> paroxysmal nocturnal hemoglobinuria (PNH), </strong>a condition that can be diagnosed with the <strong>Ham test</strong>, indicating <strong>increased red blood cell lysis </strong>in acidified serum due to<strong> increased complement sensitivity.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong><u>Ref</u>: Robbins 10<sup>th</sup>/ 645</strong></span></p>",
    "correct_choice_id": 57175,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 14269,
    "choices": [
      {
        "id": 57037,
        "text": "<p><span style=\"font-size:12pt;\">Thrombosis</span></p>"
      },
      {
        "id": 57038,
        "text": "<p><span style=\"font-size:12pt;\">Leukemia</span></p>"
      },
      {
        "id": 57039,
        "text": "<p><span style=\"font-size:12pt;\">Aplastic anemia</span>\u200b\u200b\u200b\u200b\u200b</p>"
      },
      {
        "id": 57040,
        "text": "<p><span style=\"font-size:12pt;\">Hemolysis</span>\u200b\u200b\u200b\u200b\u200b</p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt;\">Which of the following is NOT a clinical presentation feature of paroxysmal nocturnal hemoglobinuria?</span></p>",
    "unique_key": "Q3645182",
    "question_audio": null,
    "question_video": null,
    "map_id": 31939,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B. Leukemia</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The<strong> triad of pancytopenia</strong>,<strong> thrombosis and hemolytic anemia is characteristic of PNH.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Aplastic anemia </strong>can be a presenting feature <strong>(as per Wintrobes, Hematology). </strong>We need to remem\u00acber that <strong>PNH</strong> may progress to <strong>leukemia </strong>(leukaemia CAN be a complication and NOT a feature).</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">While patients with <strong>PNH </strong>may have an<strong> increased risk of developing leukemia, </strong>it is not a defining feature of <strong>PNH </strong>but rather a potential late complication.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Thrombosis,</strong> particularly in unusual sites such as the <strong>hepatic or cerebral veins</strong>, is a well-recognized complication <strong>of paroxysmal nocturnal hemoglobinuria (PNH)</strong> due to the<strong> increased propensity for red blood cells </strong>to activate the <strong>complement system and the coagulation cascade</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Aplastic anemia</strong> can be a presenting feature of<strong> PNH due to the associated bone marrow failure </strong>that can occur with the disease process.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Intravascular hemolysis</strong> is a<strong> hallmark of PNH</strong>, caused by the <strong>increased sensitivity of red blood cells to complement due to a deficiency in GPI-anchored proteins </strong>that normally protect the <strong>cell membrane from complement activation</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>PNH </strong>is characterized by<strong> hemolytic anemia, pancytopenia, and thrombosis</strong>, but<strong> leukemia is not a feature of PNH </strong>but may be a <strong>secondary complication </strong>of the disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Ref</u>: Robbins 10th/e p648</strong></span></p>",
    "correct_choice_id": 57038,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual"
    ]
  },
  {
    "id": 14309,
    "choices": [
      {
        "id": 57197,
        "text": "<p><span style=\"font-size:12pt;\">LDH levels are raised</span></p>"
      },
      {
        "id": 57198,
        "text": "<p><span style=\"font-size:12pt;\">Increased hemosiderin in urine</span></p>"
      },
      {
        "id": 57199,
        "text": "<p><span style=\"font-size:12pt;\">Decreased leukocyte alkaline phosphatase</span></p>"
      },
      {
        "id": 57200,
        "text": "<p><span style=\"font-size:12pt;\">Increased platelets</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt;\">A 40-year-old patient presents with fatigue, episodes of dark urine, especially in the morning, and a recent history of thrombosis. Lab tests show hemolytic anemia and cytopenias. Which of the following findings is least likely to be associated with the likely diagnosis of paroxysmal nocturnal hemoglobinuria (PNH)?</span></p>",
    "unique_key": "Q6817225",
    "question_audio": null,
    "question_video": null,
    "map_id": 31938,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. D. Increased platelets</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Paroxysmal nocturnal hemoglobinuria (PNH) </strong>is a rare acquired disorder characterized by <strong>hemolysis, thrombosis, and bone marrow failure</strong>. Let's go through each option:</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Increased platelets:</strong> <strong>False</strong>.<strong> PNH </strong>is associated with a <strong>decreased platelet count</strong>, not an increased one. <strong>Thrombocytopenia </strong>is a common feature due to <strong>increased platelet consumption and intravascular thrombosis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. LDH levels are raised:</strong> <strong>True </strong>as<strong> LDH (lactate dehydrogenase) </strong>levels are often <strong>elevated in PNH </strong>due to<strong> intravascular hemolysis</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Increased hemosiderin in urine:</strong> <strong>True</strong>; Hemolysis in<strong> PNH </strong>can result in the release of<strong> free hemoglobin</strong>, which is filtered by the <strong>kidneys</strong>, leading to<strong> hemosiderinuria.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Decreased leukocyte alkaline phosphatase:</strong> <strong>True; PNH cells </strong>are deficient in <strong>GPI-linked proteins, </strong>including <strong>alkaline phosphatase</strong>. Therefore,<strong> leukocyte alkaline phosphatase </strong>is <strong>decreased in PNH</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Thrombocytopenia</strong>, not thrombocytosis, is a <strong>common feature of PNH </strong>due to<strong> increased platelet consumption and intravascular thrombosis</strong>, leading to a <strong>decreased platelet count</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">This is classic for paroxysmal nocturnal hemoglobinuria (PNH):</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">Acquired clonal stem cell disorder \u2192 deficiency of GPI-anchored proteins (CD55, CD59)</span></li><li><span style=\"font-size:12.0pt;\">Complement-mediated intravascular hemolysis</span></li><li><span style=\"font-size:12.0pt;\">Thrombosis is a major cause of morbidity/mortality (often in unusual sites like hepatic veins)</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Ref</u>: Robbins 10<sup>th</sup>/ 645</strong></span></p>",
    "correct_choice_id": 57200,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 15341,
    "choices": [
      {
        "id": 61324,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Splenomegaly is conspicuous </span></span></span></p>"
      },
      {
        "id": 61325,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Results from an expansion of neoplastic T-lympho&shy;cytes </span></span></span></p>"
      },
      {
        "id": 61326,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cells are positive for Tartarate Resistant Acid phos&shy;phatase </span></span></span></p>"
      },
      {
        "id": 61327,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">The cells express CD25 consistently </span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">All of the following statements about hairy cell leukemia are true except:</span></span></span></p>",
    "unique_key": "Q4466720",
    "question_audio": null,
    "question_video": null,
    "map_id": 32035,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B. Results from an expansion of neoplastic T-lymphocytes<em> </em></span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Hairy cell leukemia (HCL) </strong>is a<strong> rare </strong>type of <strong>chronic lymphoproliferative disorder </strong>characterized by the proliferation of <strong>neoplastic B-lymphocytes, </strong>not T-lymphocytes. Therefore, statement (b) is false.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Splenomegaly </strong>is a characteristic feature of hairy cell leukemia.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong> Cells are positive </strong>for <strong>Tartrate-Resistant Acid Phosphatase (TRAP</strong>) which is a helpful diagnostic marker for HCL.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Hairy cells </strong>consistently express<strong> CD25 </strong>(also known as the interleukin-2 receptor alpha chain).</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Hairy cell leukemia </strong>results from an expansion of<strong> neoplastic B-lymphocytes, </strong>not T-lymphocytes.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><em><strong><em><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Ref: Robbins 10<sup>th</sup> 604)</span></span></em></strong></em></span></span></p>",
    "correct_choice_id": 61325,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "Factual"
    ]
  },
  {
    "id": 14291,
    "choices": [
      {
        "id": 57125,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Myelodysplasia</span></span></p>"
      },
      {
        "id": 57126,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Aplastic anemia</span></span></span>\u200b\u200b\u200b\u200b\u200b\u200b</p>"
      },
      {
        "id": 57127,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">ITP</span></span></p>"
      },
      {
        "id": 57128,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">PNH</span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 12-year-old with history of recurrent infection and bleeding gums. On investigations the patient had pancytopenia and the peripheral smear showed macrocytes. The bone marrow biopsy showed no megakaryocytes and filled with fat globules. What is your diagnosis? </span></span></span></p>",
    "unique_key": "Q3370656",
    "question_audio": null,
    "question_video": null,
    "map_id": 31956,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B. &nbsp;Aplastic anemia </span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The given clinical presentation of a<strong> 12-year-old </strong>with <strong>recurrent infections, bleeding gums, pancytopenia, macrocytes on peripheral</strong> <strong>smear, absence of megakaryocytes in bone marrow,</strong> and the<strong> presence of fat globules </strong>in the bone marrow biopsy is suggestive of <strong>aplastic anemia.&nbsp;</strong></span></span></span><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Aplastic anemia </strong>is characterized by a <strong>deficiency of all blood cell types (pancytopenia) </strong>due to <strong>bone marrow failure</strong>. The <strong>absence of megakaryocytes </strong>in the bone marrow biopsy indicates a<strong> lack of platelet precursors, </strong>which can lead to <strong>bleeding manifestations</strong>. The presence of<strong> fat globules </strong>suggests replacement of<strong> hematopoietic cells by adipose tissue </strong>in the bone marrow.</span></span></span></p>\r\n\r\n<p><u><strong>EXPLANATION:</strong></u></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Option A. Myelodysplastic syndromes :</strong>may also present with <strong>cytopenias and dysplastic </strong>changes in the bone marrow, but the <strong>absence of megakaryocytes </strong>and the<strong> presence of fat globules are not typical features.</strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Option C. ITP:&nbsp;</strong>is characterized by<strong> isolated thrombocytopenia </strong>without affecting other cell lines. It does not typically present with pancytopenia or the absence of megakaryocytes in the bone marrow.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Option D. PNH:&nbsp;&nbsp;</strong>is characterized by <strong>hemolysis, </strong>often presenting with <strong>hemoglobinuria. </strong>However, it is <strong>not typically </strong>associated with <strong>pancytopenia and fat globules in the bone </strong>marrow.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The clinical presentation of<strong> recurrent infections, bleeding gums, pancytopenia, macrocytes on peripheral smear, absence of megakaryocytes in bone marrow</strong>, and <strong>presence of fat globules </strong>in bone marrow biopsy is indicative of<strong> aplastic anemia</strong>. This diagnosis is supported by the<strong> bone marrow biopsy </strong>findings showing a <strong>lack of megakaryocytes, indicative of platelet precursor deficiency, </strong>and <strong>fat globules </strong>suggesting the replacement of <strong>hematopoietic cells by adipose tissue</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Robbins 10th/458</span></span></strong></p>",
    "correct_choice_id": 57126,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 15293,
    "choices": [
      {
        "id": 61132,
        "text": "<p><span style=\"font-size:12pt;\">Burkitt\u2019s lymphoma</span></p>"
      },
      {
        "id": 61133,
        "text": "<p><span style=\"font-size:12pt;\">Acute erythroblastic leukemia</span></p>"
      },
      {
        "id": 61134,
        "text": "<p><span style=\"font-size:12pt;\">Acute megakaryocytic leukemia</span></p>"
      },
      {
        "id": 61135,
        "text": "<p><span style=\"font-size:12pt;\">Acute undifferentiated leukemia</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt;\">Myelofibrosis leading to a dry tap on bone marrow aspiration is seen with which of the following conditions?</span></p>",
    "unique_key": "Q3189302",
    "question_audio": null,
    "question_video": null,
    "map_id": 31957,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C. Acute megakaryocytic leukemia</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Acute megakaryocytic leukemia </strong>is a<strong> subtype of AML </strong>characterized by the proliferation of<strong> megakaryocytic precursors</strong>. This condition <i><strong>can lead to fibrosis in the bone marrow</strong></i>. As a consequence, a <strong>dry tap on bone marrow aspiration </strong>may occur due to the<strong> increased fibrous tissue</strong>. Therefore, this option is associated with<strong> myelofibrosis and a dry tap</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A:</strong> <strong>Burkitt\u2019s lymphoma </strong>is a type of <strong>non-Hodgkin lymphoma</strong> that primarily involves<strong> B cells.</strong> It typically presents with <strong>rapidly</strong> <strong>growing tumors</strong>, often in the <strong>jaw or abdomen</strong>. Bone marrow involvement in Burkitt's lymphoma is uncommon. While <strong>bone marrow</strong> examination may reveal<strong> lymphoma cells</strong>, it is <strong>not </strong>typically associated with <strong>myelofibrosis, and a dry tap </strong>is not a characteristic finding.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B:</strong> <strong>Acute erythroblastic leukemia (erythroleukemia) </strong>is a rare<strong> subtype of acute myeloid leukemia (AML) </strong>characterized by the <strong>proliferation of immature erythroid precursors</strong>. This condition can<strong> infiltrate the bone marrow</strong>, leading to a<strong> hypercellular marrow </strong>with an excess o<strong>f erythroid precursors</strong>. Myelofibrosis and dry tap are not typical features of acute erythroblastic leukemia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D: Acute undifferentiated leukemia </strong>refers to a<strong> subtype of acute leukemia </strong>in which the <strong>blasts (immature cells) </strong>in the bone marrow<strong> lack specific features </strong>that would allow classification into<strong> myeloid or lymphoid lineages. </strong>While<strong> acute leukemias </strong>can sometimes be associated with <strong>bone marrow fibrosis</strong>, the <strong>dry tap is not </strong>typically a defining feature of this <strong>subtype.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Acute megakaryocytic leukemia</strong>, a <strong>subtype of acute myeloid leukemia</strong> characterized by the <strong>proliferation of megakaryocytic</strong> <strong>precursors</strong>, is associated with the <strong>development of myelofibrosis</strong> within the bone marrow, which can lead to a '<strong>dry tap' </strong>during<strong> bone</strong> <strong>marrow aspiration due to increased fibrous tissue.</strong></span></p>",
    "correct_choice_id": 61134,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual"
    ]
  },
  {
    "id": 15300,
    "choices": [
      {
        "id": 61160,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Genotyping/karyotyping</span></span></span></p>"
      },
      {
        "id": 61161,
        "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Immunophenotyping </span></span></p>"
      },
      {
        "id": 61162,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bone marrow </span></span></span></p>"
      },
      {
        "id": 61163,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Peripheral smear study </span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Adult patient presents with generalized lymphadenop&shy;athy and blood film shows 70% immature looking lym&shy;phocytes. What should be the next best investigation?</span></span></span></p>",
    "unique_key": "Q4148394",
    "question_audio": null,
    "question_video": null,
    "map_id": 32004,
    "difficulty_level": "difficult",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B. Immunophenotyping </span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Immunophenotyping </strong>is the process of analyzing the types of <strong>surface markers expressed on cells</strong>, which is crucial for diagnosing <strong>different types of leukemia and lymphomas</strong>. This would be the most appropriate<strong> next step for identifying the specific type of leukemia</strong>, as it allows for the classification of the lymphocytes<strong> based on their surface markers.</strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Genotyping/Karyotyping </strong>is used to detect <strong>chromosomal abnormalities and gene mutations, </strong>which can provide information on <strong>prognosis and guide treatment</strong>, but it is<strong> not typically the first step following a blood film analysis </strong>showing<strong> immature lymphocytes</strong>.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong> Bone Marrow Aspiration/Biopsy </strong>is used to examine the<strong> morphology of marrow cells and architecture</strong>, which can confirm a diagnosis <strong>suggested by immunophenotyping</strong>, but it&#39;s usually <strong>not the first follow-up test </strong>when a<strong> specific leukemia subtype </strong>is suspected from a <strong>blood smear</strong>.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong> Peripheral Smear Study </strong>is an <strong>initial investigation </strong>that has already been <strong>performed, showing immature lymphocytes</strong>. This prompts further <strong>investigation </strong>with more specific tests like<strong> immunophenotyping, rather than repeating the same analysis</strong>.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The presence of<strong> immature lymphocytes </strong>in a patient with <strong>generalized lymphadenopathy </strong>strongly suggests a need for <strong>immunophenotyping </strong>to identify the specific type of <strong>leukemia</strong>. It may be <strong>chronic lymphocytic leukemia </strong>which can be picked up by certain<strong> surface markers </strong>like <strong>CD19, CD20, CD23, and CD5.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><em><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Ref: Robbins 10<sup>th</sup>/ 597) </span></em></strong></span></span></p>",
    "correct_choice_id": 61161,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 15315,
    "choices": [
      {
        "id": 61220,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">ALL </span></span></span></p>"
      },
      {
        "id": 61221,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">AML </span></span></span></p>"
      },
      {
        "id": 61222,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mixed phenotypic leukaemia </span></span></span></p>"
      },
      {
        "id": 61223,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Undifferentiated leukaemia </span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 6-year-old child presents with pallor that required two blood transfusions previously. He has now developed fever and petechial haemorrhages. His hemoglobin is 9 g/dL, platelet count is 20,000/mm<strong><sup>3</sup> </strong>and TLC is 60,000/mm<strong><sup>3</sup></strong>. Flow cytometry reveals the cells to be CD10+ve, MPO+ ve, CD 19 + ve, CD 33 &ndash; ve, CD 117 + ve, and CD3 &ndash; ve. Which of the following is the most likely diagnosis?</span></span></span></p>",
    "unique_key": "Q8154056",
    "question_audio": null,
    "question_video": null,
    "map_id": 32008,
    "difficulty_level": "difficult",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C. Mixed phenotypic leukaemia</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong><strong> </strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mixed Phenotypic Leukemia (MPL):</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> MPL, also known as <strong>mixed lineage or biphenotypic leukemia, </strong>is characterized by the presence of both <strong>lymphoid and myeloid </strong>markers on <strong>leukemic cells</strong>. This type of leukemia is rare and can be<strong> challenging to treat</strong>. The diagnosis is made by identifying <strong>specific combinations </strong>of markers from<strong> different lineages on the same cells, </strong>as demonstrated by the<strong> flow cytometry </strong>results provided in the<strong> vignette (CD10, CD19, MPO, CD117 positive and CD33, CD3 negative).</strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acute Lymphoblastic Leukemia (ALL):&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">ALL is a malignancy characterized by the<strong> overproduction of immature lymphoid cells</strong>, known as <strong>lymphoblasts, </strong>in the bone marrow. It is the most common type of cancer in<strong> children </strong>and is characterized by the presence of<strong> B or T lymphoid markers</strong>, but not typically myeloid markers. The flow cytometry results in the<strong> vignette showing CD10 and CD19 positivity </strong>suggest a<strong> lymphoid origin</strong>, which would be consistent with <strong>ALL. </strong>However, the presence of <strong>MPO</strong>, which is a <strong>myeloid marker, makes pure ALL less likely</strong>.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acute Myeloid Leukemia (AML):&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">AML is a malignancy of <strong>myeloid lineage cells </strong>and is associated with the presence of myeloid markers such as<strong> CD13, CD33, </strong>and <strong>myeloperoxidase (MPO).</strong> It usually presents with signs of <strong>bone marrow failure like anemia, infection, and bleeding due to dysfunctional hematopoiesis</strong>. <strong>CD117 </strong>can also be present in<strong> AML</strong>. In the given case, the presence of<strong> MPO and CD117 supports myeloid involvement, </strong>but the additional presence of<strong> B-cell markers (CD10, CD19) would be atypical for AML</strong>.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Undifferentiated Leukemia:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Undifferentiated leukemia </strong>is a term used when l<strong>eukemic cells </strong>do not express <strong>lineage-specific markers </strong>that allow classification as either<strong> myeloid or lymphoid</strong>. These cells may express <strong>non-lineage specific markers like CD34, HLA-DR, and TdT, </strong>but <strong>lack </strong>definitive markers for<strong> B-cell, T-cell, or myeloid cell lines. </strong>In the vignette, the presence of lineage-specific markers does not support the diagnosis of undifferentiated leukemia.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective: </span></u></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>B </strong>lymphoid markers: <strong>CD10, CD19 and CD79 </strong></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>T </strong>lineage markers:<strong> CD2, CD3 and CD7 </strong></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Myeloid markers</strong>;<strong> CD13, CD33, CD117 and myeloperoxidase (MPO). </strong></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Non lineage </strong>specific markers of hematopoietic progenitor cells:<strong> CD34, HLA-DR and TdT </strong></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/24/picture6.jpg\" style=\"height:242px; width:700px\" /></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><em><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Ref: Wintrobes 12<sup>th</sup> /1814-8, Dacie and Lewis hematol&shy;ogy 10<sup>th</sup> /344-6)</span></em></strong></span></span></p>",
    "correct_choice_id": 61222,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual"
    ]
  },
  {
    "id": 15317,
    "choices": [
      {
        "id": 61228,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">M3</span></span></span></p>"
      },
      {
        "id": 61229,
        "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">M4</span></span></p>"
      },
      {
        "id": 61230,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">M5</span></span></p>"
      },
      {
        "id": 61231,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">M6</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Non-specific esterase is positive in all the categories of AML except:</span></span></span></p>",
    "unique_key": "Q8276309",
    "question_audio": null,
    "question_video": null,
    "map_id": 32009,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) M6 </span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: </span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(M6 - Acute Erythroid Leukemia):</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> M6, also known as <strong>acute erythroid leukemia or erythroleukemia, </strong>is a rare form of AML characterized by a proliferation of <strong>erythroid precursors. </strong>It <strong>does not </strong>typically show<strong> NSE positivity </strong>because this enzyme marker is <strong>not </strong>associated with the <strong>erythroid lineage.</strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: (M3 - Acute Promyelocytic Leukemia, APL):</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> M3 or APL is characterized by a<strong> specific chromosomal translocation t(15;17), </strong>which leads to the production of the <strong>PML-RARA fusion protein. </strong>The morphological hallmark of<strong> APL </strong>is the presence of <strong>promyelocytes with heavy granulation and Auer rods</strong>. Nonspecific esterase staining may be positive in a minority of APL cases, but this is not the main diagnostic marker. <strong>APL </strong>is particularly associated with a risk of <strong>disseminated intravascular coagulation</strong> (DIC) and is treated uniquely with <strong>all-trans retinoic acid (ATRA) and arsenic trioxide</strong>, which target the<strong> PML-RARA fusion protein.</strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: (M4 - Acute Myelomonocytic Leukemia):</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> M4 or acute myelomonocytic leukemia is characterized by the proliferation of <strong>both myeloid and monocyte cells</strong>.<strong> Nonspecific esterase </strong>staining is<strong> positive</strong> because of the <strong>monocytic component,</strong> distinguishing it from other forms of<strong> AML</strong>. These cells often show<strong> dual esterase </strong>staining when stained with <strong>both specific and nonspecific esterase, </strong>reflecting their <strong>mixed lineage.</strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: (M5 - Acute Monocytic Leukemia):</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> M5 or acute monocytic leukemia is characterized by an <strong>excess of monocytes </strong>in the <strong>bone marrow and blood</strong>. <strong>Nonspecific esterase </strong>staining is <strong>strongly positive </strong>in these cells, which reflects the presence of the <strong>monocytic component</strong>. M5 can be further<strong> subdivided into M5a and M5b</strong>, based on the<strong> maturity of the monocytes.</strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Non-specific esterase (NSE) </strong>staining is characteristic of<strong> M4 and M5 subtypes of AML </strong>due to their <strong>monocytic components </strong>and is not a feature of the <strong>M6 class</strong>, which is marked by a <strong>proliferation of erythroid precursors.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><em><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Ref: Robbins 10<sup>th</sup>/618) </span></span></em></strong><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><em><span style=\"font-size:12.0pt\"><span style=\"color:black\"> </span></span></em></strong></span></span></p>",
    "correct_choice_id": 61231,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual"
    ]
  },
  {
    "id": 15318,
    "choices": [
      {
        "id": 61232,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Blasts of acute myeloid leukemia are typically Su&shy;dan black negative </span></span></span></p>"
      },
      {
        "id": 61233,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Blasts of acute lymphoblastic leukemia are typically myeloperoxidase positive </span></span></span></p>"
      },
      {
        "id": 61234,
        "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Low leucocyte alkaline phosphatase score is charac&shy;teristically seen in blastic phase of chronic myeloid leukemia </span></span></p>"
      },
      {
        "id": 61235,
        "text": "<p><span style=\"font-size:11.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tartarate resistant acid phosphatase positivity is typically seen in hairy cell leukemia</span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following statements pertaining to leukemia is correct?</span></span></span></p>",
    "unique_key": "Q2631088",
    "question_audio": null,
    "question_video": null,
    "map_id": 32010,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D. Tartarate resistant acid phosphatase positivity is typically seen in hairy cell leukemia </span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong> </span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Tartarate resistant acid phosphatase (TRAP) </strong>positivity is a hallmark feature of<strong> hairy cell leukemia (HCL). </strong>This staining helps to distinguish<strong> HCL from other lymphoproliferative disorders </strong>and is positive in the<strong> majority of HCL cases</strong>.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Blasts </strong>in<strong> acute myeloid leukemia (AML) </strong>are often<strong> Sudan black positive</strong>. This histochemical stain is used to detect the presence of <strong>myeloid granules in blasts</strong>, which are typically <strong>abundant in AML cells</strong>.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong> Blasts of acute lymphoblastic leukemia (ALL) </strong>are generally <strong>myeloperoxidase (MPO) negative</strong>. MPO is an enzyme found predominantly in<strong> myeloid cells </strong>and is used as a marker to<strong> distinguish AML (where blasts are typically MPO positive) from ALL</strong>.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> A <strong>low leukocyte alkaline phosphatase (LAP) </strong>score is seen in the chronic phase of<strong> chronic myeloid leukemia (CML), </strong>reflecting the abundance of <strong>immature leukocytes. </strong>However, the <strong>LAP score </strong>often<strong> increases </strong>when <strong>CML progresses to the blast crisis phase</strong>, due to the presence of a <strong>higher </strong>proportion of <strong>mature leukocytes.</strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Tartarate resistant acid phosphatase (TRAP) positivity </strong>is typically seen in <strong>hairy cell leukemia (HCL), </strong>which is useful for its <strong>diagnosis and differentiation</strong> from other <strong>hematologic disorders.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><em><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Ref: Robbins 10<sup>th</sup>/ 604) </span></span></em></strong></p>",
    "correct_choice_id": 61235,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual"
    ]
  },
  {
    "id": 15319,
    "choices": [
      {
        "id": 61236,
        "text": "<p><span style=\"font-size:12pt;\">TLC 4000-10000</span></p>"
      },
      {
        "id": 61237,
        "text": "<p><span style=\"font-size:12pt;\">Age between 1-10 years</span></p>"
      },
      {
        "id": 61238,
        "text": "<p><span style=\"font-size:12pt;\">Presence of testicular involvement at presentation</span></p>"
      },
      {
        "id": 61239,
        "text": "<p><span style=\"font-size:12pt;\">Presence of blasts in peripheral smear</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt;\">Which of the following is having poor prognosis in ALL?&nbsp;</span></p>",
    "unique_key": "Q6229189",
    "question_audio": null,
    "question_video": null,
    "map_id": 32011,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C. Presence of testicular involvement at presenta\u00adtion</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>(Presence of testicular involvement at presentation):</strong> Testicular involvement at presentation is considered an <strong>adverse prognostic factor in ALL</strong>. It suggests<strong> extramedullary disease</strong>, which can be associated with a<strong> higher risk of relapse </strong>and may require <strong>more intensive treatment, </strong>including <strong>radiotherapy.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A: (TLC 4000-10000):</strong> Total leukocyte count (TLC) at presentation is an important<strong> prognostic factor in ALL</strong>. <strong>Normal or moderately elevated TLCs </strong>are generally associated with a<strong> better prognosis</strong>. A <strong>very high TLC</strong>, particularly above <strong>100,000, </strong>is typically considered a <strong>poor prognostic indicator in ALL</strong>, particularly in<strong> T-cell ALL</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B: (Age between 1-10 years):</strong> age less than 1 year or more than 10 years has&nbsp;poor&nbsp;prognosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D: (Presence of blasts in peripheral smear):</strong> The presence of <strong>blasts </strong>in the peripheral blood smear is characteristic of ALL but on its own is<strong> not necessarily a poor prognostic indicator</strong>. The percentage and the<strong> total number of blasts </strong>can provide <strong>more specific prognostic information</strong>, with a <strong>higher burden </strong>sometimes indicating<strong> more aggressive disease.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The <strong>presence of testicular </strong>involvement at presentation in <strong>Acute Lymphoblastic Leukemia (ALL) </strong>is associated with a<strong> poorer prognosis </strong>due to the risk of<strong> extramedullary relapse </strong>and the need for <strong>more aggressive treatment</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Poor Prognostic Factors in ALL:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">Age &lt; 1 or &gt; 10 years</span></li><li><span style=\"font-size:12.0pt;\">TLC &gt; 50,000/\u00b5L</span></li><li><span style=\"font-size:12.0pt;\">CNS or testicular involvement</span></li><li><span style=\"font-size:12.0pt;\">Philadelphia chromosome (BCR-ABL)</span></li><li><span style=\"font-size:12.0pt;\">Poor response to induction therapy</span></li><li><span style=\"font-size:12.0pt;\">Hypodiploidy</span></li></ul>",
    "correct_choice_id": 61238,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual"
    ]
  },
  {
    "id": 15328,
    "choices": [
      {
        "id": 61272,
        "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">M1</span></span></p>"
      },
      {
        "id": 61273,
        "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">M3</span></span></p>"
      },
      {
        "id": 61274,
        "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">M2</span></span></p>"
      },
      {
        "id": 61275,
        "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">M4</span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">AML with gum infiltration and hepatosplenomegaly is most likely associated with which of the following subtypes of AML?</span></span></span></p>",
    "unique_key": "Q2333307",
    "question_audio": null,
    "question_video": null,
    "map_id": 32002,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) M4<em> </em></span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(M4 - Acute Myelomonocytic Leukemia):</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong> M4 </strong>subtype includes features of <strong>both myeloblastic and monocytic lineage. </strong>The monocytic component has a predilection for <strong>tissue infiltration, </strong>such as <strong>gum hypertrophy and skin involvement (leukemia cutis), </strong>making this <strong>subtype more</strong> likely to present with<strong> gum infiltration and hepatosplenomegaly.</strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: (M1 - Acute Myeloblastic Leukemia without maturation):</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> M1 subtype is characterized by a <strong>proliferation of myeloblasts without </strong>significant<strong> differentiation</strong>. While<strong> organomegaly can occur</strong>, M1 is<strong> not </strong>typically associated with <strong>gum infiltration.</strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: (M3 - Acute Promyelocytic Leukemia):</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong> M3 subtype </strong>is unique due to its association with the<strong> t(15;17) translocation </strong>and the <strong>PML-RARA fusion gene</strong>. It can present with <strong>disseminated intravascular coagulation (DIC),</strong> but <strong>gum infiltration</strong> is<strong> less </strong>characteristic of <strong>M3</strong>.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: (M2 - Acute Myeloblastic Leukemia with maturation):</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>M2 </strong>subtype shows some <strong>degree of myeloid maturation</strong>. It can occasionally involve<strong> extramedullary sites</strong>, but<strong> gum infiltration and hepatosplenomegaly </strong>are <strong>more typical of AML with monocytic differentiation</strong>, such as <strong>M4 and M5</strong>.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Acute Myelomonocytic Leukemia (M4) </strong>is commonly associated with extramedullary manifestations such as <strong>gum infiltration and hepatosplenomegaly </strong>due to the<strong> infiltrative nature of the monocytic component </strong>of the leukemia. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><em><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Ref: Robbins 10<sup>th</sup>/ 618) </span></span></em></strong></p>",
    "correct_choice_id": 61275,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual"
    ]
  },
  {
    "id": 15331,
    "choices": [
      {
        "id": 61284,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acid phosphatase</span></span></span></p>"
      },
      {
        "id": 61285,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Non-specific esterase </span></span></span></p>"
      },
      {
        "id": 61286,
        "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Myeloperoxidase </span></span></p>"
      },
      {
        "id": 61287,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Toluidine blue </span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 42-year-old man was referred with a 2 week history of fever weakness and bleeding gum. Peripheral smear showed pancytopenia. The bone marrow examination revealed 26% blasts frequency exhibiting Auer rods and mature myeloid cells. An occasional neutrophil with pseudo Pelger-Huet anomaly was also detected. Which of the following cytochemical stains is most likely to be positive? </span></span></span></p>",
    "unique_key": "Q3445553",
    "question_audio": null,
    "question_video": null,
    "map_id": 32003,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C. Myeloperoxidase<em> </em></span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Patient </strong>here gives a <strong>short history (acute onset) </strong>of development of <strong>pancytopenia (fever; weakness and gum bleeding suggest leucopenia; anemia and thrombocytopenia respectively).</strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Myeloperoxidase):</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Myeloperoxidase (MPO) is an enzyme found in <strong>myeloid cells</strong>, particularly <strong>myeloblasts, </strong>and its presence is a <strong>hallmark of AML</strong>. AML blasts, especially those with <strong>Auer rods</strong>, which are<strong> highly </strong>suggestive of<strong> AML</strong>, will usually be <strong>MPO positive.</strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: (Acid Phosphatase):</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Acid phosphatase staining is primarily used to identify cells of the <strong>T-lymphoid lineage </strong>and is a key diagnostic marker in <strong>T-cell acute lymphoblastic leukemia (ALL). </strong>It would<strong> not </strong>typically be <strong>positive in myeloid cells or AML</strong>.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: (Non-Specific Esterase):</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Non-specific esterase staining is characteristic of <strong>monocytes and their malignant counterparts in acute monocytic leukemia (AML M5 subtype). </strong>It&#39;s not a specific marker for myeloblasts, which are the predominant cells in most AML subtypes.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: (Toluidine Blue):</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Toluidine blue staining is used to highlight <strong>mast cells </strong>and is not typically used in the diagnosis of<strong> AML or other types of leukemia</strong>.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In a patient with <strong>acute onset of pancytopenia and 26% blasts </strong>exhibiting<strong> Auer rods in the bone marrow</strong>, <strong>myeloperoxidase (MPO) </strong>staining is most likely to be<strong> positive</strong>, supporting a diagnosis of<strong> Acute Myeloid Leukemia (AML).</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"><strong><em><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Ref: Robbins 10<sup>th</sup>/ 621) </span></span></em></strong> </span></span></span></span></p>",
    "correct_choice_id": 61286,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual"
    ]
  },
  {
    "id": 15333,
    "choices": [
      {
        "id": 61292,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">t (15;17) </span></span></span></span></p>"
      },
      {
        "id": 61293,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">t (9;22) </span></span></span></span></p>"
      },
      {
        "id": 61294,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">t (17;21) </span></span></span></span></p>"
      },
      {
        "id": 61295,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">t (8: 21) </span></span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chromosomal translocation characteristic in acute promyelocytic leukemia is: </span></span></span></p>",
    "unique_key": "Q4794327",
    "question_audio": null,
    "question_video": null,
    "map_id": 32005,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A. t (15: 17) </span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">t (15;17):</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> is a <strong>chromosomal translocation </strong>that is characteristic of<strong> Acute Promyelocytic Leukemia (APL). </strong>It involves the fusion of the <strong>PML (promyelocytic leukemia) </strong>gene on<strong> chromosome 15 with the RARA (retinoic acid receptor alpha) </strong>gene on<strong> chromosome 17. </strong>The resulting <strong>PML-RARA fusion gene </strong>is<strong> oncogenic</strong>, leading to the development of<strong> APL</strong>.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: t (9;22):</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This translocation is characteristic of<strong> Chronic Myelogenous Leukemia (CML) </strong>and is known as the<strong> Philadelphia chromosome. </strong>It involves the fusion of the <strong>BCR (breakpoint cluster region) </strong>gene on <strong>chromosome 22 with the ABL1 (Abelson murine</strong> <strong>leukemia viral oncogene homolog 1) </strong>gene on <strong>chromosome 9, </strong>resulting in the <strong>BCR-ABL1 fusion gene</strong>. This fusion gene produces a constitutively active<strong> tyrosine kinase</strong>, contributing to the pathogenesis of<strong> CML.</strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: t (17;21):</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This translocation is <strong>not a well-known </strong>chromosomal abnormality in<strong> leukemia. </strong>It doesn&#39;t correspond to a recognized leukemia subtype.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: t (8;21):</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This translocation is characteristic of <strong>Acute Myeloid Leukemia (AML) </strong>with maturation<strong> (AML-M2 subtype). </strong>It involves the fusion of the <strong>AML1 (also known as RUNX1) gene on chromosome 21 with the ETO (Eight-Twenty-One) gene on chromosome 8</strong>, resulting in the <strong>AML1-ETO fusion gene</strong>. This translocation is associated with a subtype of AML and is used in its classification.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></u></strong> </span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The<strong> chromosomal translocation </strong>characteristic of <strong>Acute Promyelocytic Leukemia is t(15;17), </strong>resulting in the <strong>PML-RARA fusion gene</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><em><span style=\"font-size:11.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"><strong><em><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Ref: Robbins 10<sup>th</sup>/ 613) </span></span></em></strong> </span></span></span></em></strong></p>",
    "correct_choice_id": 61292,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual"
    ]
  },
  {
    "id": 15335,
    "choices": [
      {
        "id": 61300,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Elevated total leukocyte count </span></span></span></p>"
      },
      {
        "id": 61301,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Leucocyte alkaline phosphatase </span></span></span></p>"
      },
      {
        "id": 61302,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Erythrocyte sedimentation rate </span></span></span></p>"
      },
      {
        "id": 61303,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Presence of immature cells</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">The difference between leukemia and leukemoid reaction is done by:</span></span></span></p>",
    "unique_key": "Q8514067",
    "question_audio": null,
    "question_video": null,
    "map_id": 32006,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B. Leucocyte alkaline phosphatase </span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Leukocyte alkaline phosphatase (LAP) </strong>is a marker that can help d<strong>istinguish between chronic myeloid leukemia (CML) and a leukemoid reaction</strong>. In CML,<strong> LAP is typically low, </strong>while in a <strong>leukemoid reaction, it is normal or elevated. </strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A.</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;<strong>Elevated total leukocyte count:</strong>&nbsp;<strong>Both leukemia and leukemoid reaction </strong>can result in an <strong>elevated total leukocyte count. </strong>However, the specific characteristics of the white blood cells, along with other parameters, help differentiate between the two.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C.</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>&nbsp;Erythrocyte sedimentation rate (ESR):&nbsp;</strong>is a<strong> non-specific marker of inflammation </strong>and is not commonly used to differentiate between leukemia and leukemoid reaction. </span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D.</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;<strong>Presence of immature cells: </strong>The <em>presence</em> of<strong> immature or blast cells </strong>is <strong><em>not helpful</em> </strong>for differentiating between <strong>leukemia from a leukemoid reaction. </strong>The <strong><em>percentage of immature cells</em></strong> is a crucial factor in distinguishing leukemia from a leukemoid reaction.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Leukocyte alkaline phosphatase (LAP) </strong>score helps differentiate between <strong>chronic myeloid leukemia (CML), where it is typically low</strong>, and a<strong> leukemoid reaction, where it is normal or elevated.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><em><span style=\"font-size:11.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"><strong><em><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Ref: Robbins 10<sup>th</sup>/ 584)</span></span></em></strong></span></span></span></em></strong></p>",
    "correct_choice_id": 61301,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual"
    ]
  },
  {
    "id": 15338,
    "choices": [
      {
        "id": 61312,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acute lymphoblastic leukemia </span></span></span></p>"
      },
      {
        "id": 61313,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acute myelogenous leukemia </span></span></span></p>"
      },
      {
        "id": 61314,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chronic lymphocytic leukemia </span></span></span></p>"
      },
      {
        "id": 61315,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chronic myelogenous leukemia </span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">The presence of the Philadelphia chromosome is associated with a worse prognosis in patients with which of the following diseases?</span></span></span></p>",
    "unique_key": "Q9651393",
    "question_audio": null,
    "question_video": null,
    "map_id": 32007,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A. Acute lymphoblastic leukemia </span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Acute Lymphoblastic Leukemia, ALL):</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> In ALL, the presence of the <strong>Philadelphia chromosome</strong>, which involves the <strong>translocation t(9;22) resulting in the BCR-ABL1 fusion gene</strong>, is associated with a<strong> more aggressive disease </strong>course and a <strong>poorer prognosis. </strong>This is because the<strong> BCR-ABL1 fusion protein has increased tyrosine kinase activity</strong>, which drives the <strong>leukemogenesis. </strong>Patients with <strong>Philadelphia chromosome-positive ALL </strong>often require<strong> more </strong>intensive treatment, such as <strong>tyrosine kinase inhibitors (TKIs) </strong>in addition to<strong> chemotherapy</strong>, and may be considered for <strong>stem cell transplantation.</strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: (Acute Myelogenous Leukemia, AML):</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> The <strong>Philadelphia chromosome</strong> is <strong>not </strong>commonly associated with <strong>AML</strong>. AML has other chromosomal abnormalities that are<strong> more predictive of prognosis</strong>, such as the presence of mutations in genes like<strong> FLT3, NPM1, or alterations like t(15;17) in acute promyelocytic leukemia (APL).</strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: (Chronic Lymphocytic Leukemia, CLL):</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> CLL is typically <strong>not</strong> associated with the<strong> Philadelphia chromosome.</strong> CLL has its own prognostic markers, such as<strong> deletions in chromosome 13q, 11q, and trisomy 12</strong>, or the mutation status of <strong>IGHV (immunoglobulin heavy chain variable region genes).</strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: (Chronic Myelogenous Leukemia, CML):</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> The<strong> Philadelphia chromosome </strong>is the <strong>hallmark of CML</strong> and is present in the vast majority of cases. The<strong> presence of this chromosome </strong>is part of the diagnostic criteria for <strong>CML </strong>and is <strong>not </strong>considered a<strong> worse prognostic factor </strong>within this disease context. The treatment for CML includes<strong> TKIs</strong>, which target the<strong> BCR-ABL1 protein </strong>resulting from the<strong> Philadelphia chromosome translocation.</strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">The presence of the<strong> Philadelphia chromosome</strong>, a <strong>translocation from the long arm of chromosome 22 to chromosome 9 [t(9;22)], </strong>is associated with a<strong> favorable prognosis </strong>in <strong>chronic myelogenous leukemia but</strong> it associated with an <strong>unfavorable outcome in Acute lymphoblastic leukemia</strong>. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><em><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Ref: Robbins 10<sup>th</sup>/ 601) </span></span></em></strong></p>",
    "correct_choice_id": 61312,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual"
    ]
  },
  {
    "id": 14274,
    "choices": [
      {
        "id": 57057,
        "text": "<p><span style=\"font-size:12pt;\">Iron deficiency anemia</span></p>"
      },
      {
        "id": 57058,
        "text": "<p><span style=\"font-size:12pt;\">Myelodysplastic syndrome</span>\u200b\u200b\u200b\u200b\u200b</p>"
      },
      {
        "id": 57059,
        "text": "<p><span style=\"font-size:12pt;\">Thalassemia</span></p>"
      },
      {
        "id": 57060,
        "text": "<p><span style=\"font-size:12pt;\">Anemia of chronic disease</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt;\">A 68-year-old male with a history of progressive fatigue and a recent diagnosis of alcoholism presents for evaluation. His complete blood count shows a macrocytic anemia and the bone marrow biopsy reveals the presence of ringed sideroblasts. Which of the following is the most likely diagnosis?</span></p>",
    "unique_key": "Q4454496",
    "question_audio": null,
    "question_video": null,
    "map_id": 31942,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B. Myelodysplastic syndrome</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Myelodysplastic syndrome (MDS)</strong> is associated with ineffective<strong> hematopoiesis </strong>and the presence of <strong>ringed sideroblasts</strong> can be a feature when there is a <strong>disturbance in iron </strong>incorporation into the <strong>hemoglobin molecule.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Iron deficiency anemia</strong> is characterized by<strong> microcytic, hypochromic red cells </strong>without the presence of ringed sideroblasts in the bone marrow.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Thalassemia syndromes</strong> are <strong>hereditary hemoglobinopathies </strong>leading to<strong> ineffective erythropoiesis and anemia</strong>, but they do not typically present with ringed sideroblasts.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Anemia of chronic disease</strong> can cause a<strong> microcytic anemia</strong>, but it is usually <strong>normocytic </strong>and does not present with ringed sideroblasts.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Myelodysplastic syndrome (MDS) </strong>is associated with <strong>ineffective hematopoiesis </strong>and the presence of <strong>ringed sideroblasts</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Most common causes of ringed sideroblasts:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_cs4IlUx.png\" width=\"1099\" height=\"290\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Ref</u>: Robbins 10<sup>th</sup>/620</strong></span></p>",
    "correct_choice_id": 57058,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 15336,
    "choices": [
      {
        "id": 61304,
        "text": "<p><span style=\"font-size:12pt;\">Platelet precursors in the bone marrow are normal or elevated</span></p>"
      },
      {
        "id": 61305,
        "text": "<p><span style=\"font-size:12pt;\">Leucocyte precursors in the marrow are normal or elevated</span></p>"
      },
      {
        "id": 61306,
        "text": "<p><span style=\"font-size:12pt;\">Always has hypocellular bone marrow</span></p>"
      },
      {
        "id": 61307,
        "text": "<p><span style=\"font-size:12pt;\">Refractory anemia</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt;\">In myelodysplastic syndrome, the following statement is incorrect:</span></p>",
    "unique_key": "Q9806708",
    "question_audio": null,
    "question_video": null,
    "map_id": 31941,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C.&nbsp;Always has hypocellular bone marrow</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Always has hypocellular bone marrow:</strong> This statement is<strong> incorrect.</strong> MDS is often associated with a<strong> hypercellular or normocellular bone marrow </strong>and rarely hypocellular bone marrow.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A:</strong> <strong>Platelet precursors </strong>in the bone marrow are often <strong>normal or elevated in myelodysplastic syndrome (MDS). </strong>This condition is characterized by <strong>ineffective hematopoiesis</strong>, and it commonly leads to <strong>cytopenias in the peripheral blood</strong>.&nbsp; <strong>Thrombocytopenia </strong>is a common feature in<strong> MDS</strong>, and it contributes to the <strong>increased risk of bleeding </strong>in affected individuals.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B:</strong>&nbsp;<strong>Leucocyte precursors in the bone marrow are normal or elevated:</strong> This statement is correct</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D:</strong>&nbsp;<strong>Refractory anemia:</strong> This statement is correct. <strong>Refractory anemia </strong>is a common <strong>subtype of MDS</strong>, characterized by <strong>ineffective erythropoiesis </strong>leading to <strong>anemia </strong>that <strong>does not </strong>respond well to <strong>conventional treatment.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Bone marrow in MDS is hypercellular (most commonly) or normocellular (sometimes) or rarely hypocellular</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>(Ref: Robbins 10<sup>th</sup>/ 620-1)</strong></span></p>",
    "correct_choice_id": 61306,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual"
    ]
  },
  {
    "id": 15302,
    "choices": [
      {
        "id": 61168,
        "text": "<p><span style=\"font-size:12pt;\">Diffuse large B cell Lymphoma</span></p>"
      },
      {
        "id": 61169,
        "text": "<p><span style=\"font-size:12.0pt;\">B cell lymphoma</span></p>"
      },
      {
        "id": 61170,
        "text": "<p><span style=\"font-size:12.0pt;\">&nbsp;Hairy cell leukemia</span></p>"
      },
      {
        "id": 61171,
        "text": "<p><span style=\"font-size:12.0pt;\">T cell Lymphoblastic ALL</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt;\">A young boy came with dyspnea and was found to have a mediastinal mass. Which of the following is known to produce mediastinal lymphadenopathy?</span></p>",
    "unique_key": "Q3682536",
    "question_audio": null,
    "question_video": null,
    "map_id": 32012,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. D) T cell Lymphoblastic ALL</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>T-ALL </strong>is a type of<strong> acute lymphoblastic leukemia (ALL) </strong>characterized by the <strong>proliferation of immature T-cell lymphoblasts </strong>in the <strong>bone marrow, blood, </strong>and sometimes in <strong>extramedullary sites </strong>such as the <strong>mediastinum</strong>. T-cell lymphoblastic acute lymphoblastic leukemia (T-ALL) is known to produce <strong>mediastinal lymphadenopathy </strong>leading to<strong> compression of nearby structures </strong>and causing symptoms such as<strong> dyspnea.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A.</strong>&nbsp;<strong>Diffuse large B-cell lymphoma (DLBCL) </strong>is a type of<strong> B-cell lymphoma </strong>that typically presents with <strong>nodal or extranodal masses</strong>, but it is<strong> not specifically</strong> associated with <strong>mediastinal lymphadenopathy.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B</strong>.&nbsp;<strong>B-cell rich T-cell lymphoma</strong> is<strong> not a well-recognized entity</strong>. The common types of lymphomas are generally classified as either <strong>B-cell or T-cell lymphomas</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C.&nbsp;Hairy cell leukemia:</strong> Causes involvement of bone marrow and spleen (red pulp)</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>T-cell Lymphoblastic ALL&nbsp; </strong>is associated with <strong>mediastinal lymphadenopathy</strong>, typically presenting with symptoms such as<strong> dyspnea due to compression of thoracic structures.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>(Ref: Robbins 10<sup>th</sup>/ 595)</strong></span></p>",
    "correct_choice_id": 61171,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "InvestigationBased"
    ]
  },
  {
    "id": 15353,
    "choices": [
      {
        "id": 61372,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lymphocyte predominant </span></span></span></p>"
      },
      {
        "id": 61373,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Nodular sclerosis</span></span></span></p>"
      },
      {
        "id": 61374,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mixed cellularity </span></span></span></p>"
      },
      {
        "id": 61375,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lymphocyte depleted </span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 32-year-old male presents with painless enlargement of a cervical lymph node. Excisional biopsy reveals a subtype of Hodgkin&rsquo;s disease, which is histogenetically distinct from all the other subtypes. Which of the following is the likely diagnosis? </span></span></span></p>",
    "unique_key": "Q1146916",
    "question_audio": null,
    "question_video": null,
    "map_id": 32024,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A. Lymphocyte predominant </span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lymphocyte Predominant</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This subtype is characterized by a <strong>nodular pattern </strong>with a predominance of<strong> lymphocytes </strong>and the presence of<strong> popcorn cells (Lacunar cells). </strong>Popcorn cells are<strong> large, atypical mononuclear or multinucleated cells</strong>. This subtype is generally associated with an<strong> excellent prognosis</strong>.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Nodular Sclerosis</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Nodular sclerosis is the <strong>most common </strong>subtype of <strong>Hodgkin&#39;s lymphoma in the world. </strong>It is characterized by the presence of <strong>collagen bands </strong>dividing the <strong>lymph node architecture into nodules</strong>.<strong> Reed-Sternberg cells</strong>, the hallmark cells of <strong>Hodgkin&#39;s lymphoma, </strong>are found in lacunar spaces. This subtype often affects<strong> young adults </strong>and typically presents with <strong>mediastinal involvement</strong>. It has a favorable prognosis.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Mixed Cellularity:</strong> This subtype is characterized by a<strong> mixed inflammatory infiltrate</strong>, including <strong>eosinophils, plasma cells, and histiocytes</strong>, along with<strong> Reed-Sternberg cells</strong>. It is often associated with an<strong> advanced stage of the disease </strong>and has a less favorable prognosis compared to nodular sclerosis.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Lymphocyte Depleted</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This<strong> subtype </strong>is characterized by a<strong> scarcity of lymphocytes </strong>and <strong>an abundance of Reed-Sternberg cells</strong>. It is associated<strong> with </strong>an <strong>advanced stage of the disease </strong>and is often seen in <strong>immunocompromised individuals</strong>. Lymphocyte-depleted Hodgkin&#39;s lymphoma has a <strong>less favorable prognosis</strong>.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Lymphocyte predominant Hodgkin&rsquo;s disease </strong>is<strong> histogenetically distinct </strong>from other <strong>subtypes, </strong>characterized by a <strong>nodular pattern </strong>with a <strong>predominance of lymphocytes </strong>and the presence of <strong>popcorn cells</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><em><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Ref: Robbins 10<sup>th</sup> 613)</span></span></em></strong></p>",
    "correct_choice_id": 61372,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 15344,
    "choices": [
      {
        "id": 61336,
        "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Burkitt&rsquo;s lymphoma </span></span></p>"
      },
      {
        "id": 61337,
        "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Follicular lymphoma </span></span></p>"
      },
      {
        "id": 61338,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Diffuse large B-cell lymphoma </span></span></span></p>"
      },
      {
        "id": 61339,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Small lymphocytic lymphoma </span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Over-expression of BCL-2 proteins occurs in: </span></span></span></p>",
    "unique_key": "Q1433249",
    "question_audio": null,
    "question_video": null,
    "map_id": 32017,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B. Follicular lymphoma </span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Over-expression of BCL-2 proteins </strong>is commonly associated with<strong> follicular lymphoma. Follicular lymphoma </strong>is characterized by the <strong>t(14;18) chromosomal translocation</strong>, which results in the<strong> over-expression </strong>of the<strong> anti-apoptotic BCL-2 protein. </strong>This translocation leads to the <strong>prolonged survival of B-cells </strong>and contributes to the <strong>pathogenesis of follicular lymphoma</strong>.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A:</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Burkitt&#39;s lymphoma</strong> is associated with a <strong>translocation </strong>involving the <strong>MYC gene.</strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C:</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Diffuse large B-cell lymphoma (DLBCL)</strong> is a<strong> heterogeneous group of lymphomas </strong>and may have various<strong> genetic alterations, </strong>but it is not primarily associated<strong> with BCL-2 over-expression</strong>.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Small lymphocytic lymphoma (SLL)</strong> is <strong>closely </strong>related to <strong>chronic lymphocytic leukemia (CLL) </strong>and is <strong>not </strong>typically associated with <strong>BCL-2 over-expression </strong>as a defining characteristic.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Over-expression of BCL-2 proteins </strong>is commonly associated with <strong>follicular lymphoma </strong>due to the<strong> t (14;18) chromosomal translocation.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><em><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Ref: Robbins 10<sup>th</sup> 600) </span></span></em></strong><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><strong><em><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"> </span></span></em></strong></span></span></p>",
    "correct_choice_id": 61337,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 15345,
    "choices": [
      {
        "id": 61340,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Burkitt&rsquo;s lymphoma </span></span></span></p>"
      },
      {
        "id": 61341,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mantle cell lymphoma</span></span></span></p>"
      },
      {
        "id": 61342,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Extra nodal marginal zone B-cell lymphoma</span></span></span></p>"
      },
      {
        "id": 61343,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chronic myeloid leukemia </span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">&lsquo;Starry sky&rsquo; appearance is seen in: </span></span></span></p>",
    "unique_key": "Q2050090",
    "question_audio": null,
    "question_video": null,
    "map_id": 32018,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A. Burkitt&rsquo;s lymphoma </span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The<strong> &quot;starry sky&quot; </strong>appearance in histopathology is a result of<strong> macrophages phagocytosing apoptotic debris</strong>, creating a background of <strong>numerous small clear spaces (resembling stars) </strong>around the more densely packed<strong> tumor cells</strong>. This pattern is particularly associated with<strong> Burkitt&#39;s lymphoma</strong>, which is often characterized by a <strong>high proliferation rate </strong>of<strong> rapidly dividing cells</strong>.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong> Mantle cell lymphoma </strong>does <strong>not</strong> typically exhibit the &quot;<strong>starry sky&quot;</strong> appearance.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Extra nodal marginal zone B-cell lymphoma is not </strong>typically associated with the <strong>&quot;starry sky</strong>&quot; appearance.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong> Chronic myeloid leukemia </strong>is a <strong>myeloproliferative disorder </strong>involving the <strong>myeloid lineage</strong>, and it<strong> does not </strong>show the<strong> &quot;starry sky&quot; </strong>appearance.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>&quot;starry sky</strong>&quot; appearance is characteristically seen in<strong> Burkitt&#39;s lymphoma</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><em><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Ref: Robbins 10<sup>th</sup> 598)</span></span></em></strong><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><strong><em><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"> </span></span></em></strong></span></span></p>",
    "correct_choice_id": 61340,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual"
    ]
  },
  {
    "id": 15346,
    "choices": [
      {
        "id": 61344,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Burkitt&rsquo;s lymphoma </span></span></span></p>"
      },
      {
        "id": 61345,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mycosis fungoides </span></span></span></p>"
      },
      {
        "id": 61346,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mantle cell lymphoma</span></span></span></p>"
      },
      {
        "id": 61347,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Follicular cell lymphoma </span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">All are B cell lymphomas except:</span></span></span></p>",
    "unique_key": "Q5018277",
    "question_audio": null,
    "question_video": null,
    "map_id": 32019,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B. Mycosis fungoides </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Mycosis fungoides </strong>is <strong>not a B-cell lymphoma</strong>; it is a type of<strong> cutaneous T-cell lymphoma. </strong>It primarily involves the <strong>skin and represents a neoplastic proliferation of mature T-helper cells</strong>.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\">&nbsp;</span></span><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Burkitt&#39;s lymphoma </strong>is indeed a<strong> B-cell lymphoma. </strong>It is an aggressive form of<strong> non-Hodgkin lymphoma </strong>that is associated with the <strong>Epstein-Barr virus (EBV) </strong>and characterized by the <strong>translocation </strong>involving the <strong>MYC gene</strong>.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Mantle cell lymphoma </strong>is a<strong> B-cell lymphoma </strong>characterized by the<strong> proliferation of malignant B-cells </strong>with characteristic involvement of the <strong>mantle zone in lymphoid follicles</strong>.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong> Follicular lymphoma </strong>is a<strong> B-cell lymphoma</strong>. It is a <strong>slow-growing, indolent lymphoma </strong>characterized by the proliferation of <strong>abnormal B-cells </strong>within the lymph nodes.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Mycosis fungoides </strong>is a type of<strong> cutaneous T-cell lymphoma </strong>and not a B-cell lymphoma.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><em><span style=\"font-size:12.0pt\"><span style=\"color:black\"><strong><em><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Ref: Robbins 10<sup>th</sup> 606)</span></span></em></strong></span></span></em></strong></span></span></p>",
    "correct_choice_id": 61345,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 15347,
    "choices": [
      {
        "id": 61348,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Follicular Lymphoma </span></span></span></p>"
      },
      {
        "id": 61349,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Burkitt Lymphoma </span></span></span></p>"
      },
      {
        "id": 61350,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Small lymphocytic lymphoma </span></span></span></p>"
      },
      {
        "id": 61351,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lymphoplasmacytic lymphoma</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which one of the following Non-Hodgkin Lymphomas is aggressive?</span></span></span></p>",
    "unique_key": "Q9274575",
    "question_audio": null,
    "question_video": null,
    "map_id": 32020,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B. Burkitt Lymphoma</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Burkitt Lymphoma </strong>is considered an aggressive<strong> Non-Hodgkin Lymphoma. </strong>It is characterized by a high proliferation rate of<strong> rapidly dividing cells </strong>and is often associated with the <strong>translocation involving the MYC gene</strong>. Burkitt Lymphoma can occur in<strong> three main</strong> forms:<strong> endemic, sporadic, and immunodeficiency-associated subtypes. </strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong> Follicular Lymphoma </strong>is an<strong> indolent (slow-growing) Non-Hodgkin Lymphoma</strong>. It has a <strong>more chronic course </strong>and tends to be<strong> less aggressive </strong>compared to Burkitt Lymphoma.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Small lymphocytic lymphoma </strong>is a<strong> low-grade, indolent lymphoma </strong>that is related to <strong>chronic lymphocytic leukemia (CLL). </strong>It is characterized by the<strong> proliferation of small mature B-cells.</strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong> Lymphoplasmacytic lymphoma </strong>is typically an<strong> indolent lymphoma </strong>characterized by the <strong>infiltration of the bone marrow </strong>and other tissues by<strong> small lymphocytes, plasma cells, and lymphoplasmacytic cells.</strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Burkitt Lymphoma </strong>is an <strong>aggressive Non-Hodgkin Lymphoma </strong>characterized by a <strong>high proliferation rate </strong>and<strong> MYC gene translocation</strong>. <em>&ldquo;<strong>Burkitt lymphoma </strong>is believed to be the <strong>fastest growing hu&shy;man tumor</strong>&rdquo;</em>&hellip;direct line</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\"><strong><em><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Ref: Robbin 10<sup>th</sup> 598)</span></span></em></strong></span></span></span></span></p>",
    "correct_choice_id": 61349,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "InvestigationBased"
    ]
  },
  {
    "id": 15348,
    "choices": [
      {
        "id": 61352,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fungal infections of skin </span></span></span></p>"
      },
      {
        "id": 61353,
        "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Leukemia </span></span></p>"
      },
      {
        "id": 61354,
        "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Exfoliative erythroderma </span></span></p>"
      },
      {
        "id": 61355,
        "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cutaneous lymphoma </span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 50-year-old male presents with persistent skin lesions, including pruritic, erythematous patches and plaques and is diagnosed with mycosis fungoides. Which of the following is true about this condition? </span></span></span></p>",
    "unique_key": "Q3315439",
    "question_audio": null,
    "question_video": null,
    "map_id": 32021,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D. Cutaneous lymphoma </span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Cutaneous lymphoma):</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Mycosis fungoides </strong>is a <strong>primary cutaneous T-cell lymphoma, </strong>meaning it is a <strong>lymphoma </strong>of the skin. It is characterized histologically by the<strong> presence of malignant T cells </strong>with <strong>cerebriform nuclei</strong>, which can form aggregates in the dermis and may<strong> invade </strong>the <strong>epidermis </strong>to form<strong> Pautrier microabscesses.</strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: (Fungal infections of skin):</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> The term &quot;<strong>mycosis fungoides</strong>&quot; might<strong> misleadingly suggest a fungal infection, </strong>but the condition is<strong> not caused by fungi</strong>. It is actually a type of <strong>non-Hodgkin lymphoma </strong>and has<strong> no infectious etiology</strong>.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: (Leukemia):</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Leukemia generally refers to c<strong>ancers of the blood or bone marrow </strong>characterized by an<strong> abnormal proliferation of blood cells</strong>.<strong> Mycosis fungoides </strong>can sometimes <strong>progress </strong>to a<strong> leukemic phase </strong>known as <strong>S&eacute;zary syndrome</strong>, but it primarily manifests with <strong>skin involvement </strong>and is not initially leukemia.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: (Exfoliative erythroderma):</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> While patients with <strong>advanced mycosis fungoides </strong>may develop <strong>exfoliative erythroderma</strong>, which is <strong>widespread inflammation </strong>and <strong>scaling of the skin, </strong>this is <strong>not the primary </strong>or sole <strong>manifestation of the disease</strong>.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Mycosis fungoides </strong>is a<strong> cutaneous T-cell lymphoma </strong>that may present with <strong>pruritic, erythematous patches and plaques</strong>, and is characterized histologically by<strong> Sezary Lutzner cells </strong>with a <strong>cerebriform contour</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><span style=\"color:black\"><span style=\"font-family:Arial,sans-serif\"><span style=\"color:black\"><span style=\"font-size:8.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong><em><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Ref: Robbins 10<sup>th</sup> 605) </span></span></em></strong></span></span></span></span></span></span></span></p>",
    "correct_choice_id": 61355,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual"
    ]
  },
  {
    "id": 15339,
    "choices": [
      {
        "id": 61316,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">t (8:14) </span></span></span></p>"
      },
      {
        "id": 61317,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">t (9:22) </span></span></span></p>"
      },
      {
        "id": 61318,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">t (11:14) </span></span></span></p>"
      },
      {
        "id": 61319,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">t (8:21) </span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Burkitt&rsquo;s lymphoma is associated most commonly with of the following translocations?</span></span></span></p>",
    "unique_key": "Q5327676",
    "question_audio": null,
    "question_video": null,
    "map_id": 32014,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A. t (8:14) </span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Burkitt&#39;s lymphoma </strong>is most commonly associated with the<strong> translocation t(8:14). </strong>This translocation involves the<strong> c-MYC gene </strong>on <strong>chromosome 8 and the immunoglobulin heavy chain (IgH) gene on chromosome 14</strong>. The result of this translocation is the dysregulation and constitutive activation of the <strong>c-MYC oncogene</strong>, leading to <strong>uncontrolled cell proliferation </strong>characteristic of<strong> Burkitt&#39;s lymphoma.</strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: t (9:22)</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: is associated with <strong>Chronic Myelogenous Leukemia (CML) </strong>and<strong> Acute Lymphoblastic Leukemia (ALL) </strong>but not Burkitt&#39;s lymphoma.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: t (11;14)</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: is associated with <strong>Mantle Cell Lymphoma </strong>but not Burkitt&#39;s lymphoma.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>t (8:21)</strong>: is associated with <strong>Acute Myeloid Leukemia (AML)</strong> with<strong> maturation </strong>but not Burkitt&#39;s lymphoma.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong> </span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Burkitt&#39;s lymphoma </strong>is most commonly associated with the <strong>translocation t(8;14)</strong>, involving the<strong> c-MYC gene on chromosome 8 and</strong> the <strong>immunoglobulin heavy chain gene on chromosome 14.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><em><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Ref: Robbins 10<sup>th</sup>/ 602) </span></span></em></strong></p>",
    "correct_choice_id": 61316,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual"
    ]
  },
  {
    "id": 15340,
    "choices": [
      {
        "id": 61320,
        "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">CD 23 </span></span></p>"
      },
      {
        "id": 61321,
        "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">CD 20 </span></span></p>"
      },
      {
        "id": 61322,
        "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">CD 5</span></span></p>"
      },
      {
        "id": 61323,
        "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">CD 43</span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mantle cell lymphomas are positive for all of the following, except:</span></span></span></p>",
    "unique_key": "Q8434155",
    "question_audio": null,
    "question_video": null,
    "map_id": 32015,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) CD 23 </span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Mantle cell lymphomas </strong>typically express the following markers:</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Mantle cell lymphomas are <strong>positive for CD20</strong>, a <strong>B-cell marker</strong>.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Mantle cell lymphomas are<strong> positive for CD5,</strong> a <strong>T-cell marker. </strong>This is a characteristic feature of <strong>mantle cell lymphomas</strong> and helps <strong>distinguish them from other B-cell lymphomas.</strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Mantle cell lymphomas are<strong> positive for CD43,</strong> a <strong>cell adhesion molecule</strong> and <strong>marker of T-lymphocytes</strong>. It is commonly expressed in mantle cell lymphomas.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Mantle cell lymphomas </strong>are typically <strong>negative for CD23</strong>, helping to distinguish them from other <strong>small B-cell lymphomas like CLL and</strong> <strong>follicular lymphoma.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><em><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Ref: Robbins 10<sup>th</sup>/602)</span></span></em></strong></p>",
    "correct_choice_id": 61320,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 15342,
    "choices": [
      {
        "id": 61328,
        "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">T-cell </span></span></p>"
      },
      {
        "id": 61329,
        "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">B-cell </span></span></p>"
      },
      {
        "id": 61330,
        "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">NK cell </span></span></p>"
      },
      {
        "id": 61331,
        "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Monocyte</span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Post transplant lymphoma occurs due to proliferation of which of the following cells:</span></span></span></p>",
    "unique_key": "Q8754696",
    "question_audio": null,
    "question_video": null,
    "map_id": 32016,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B. B-cell</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong>&nbsp;</strong></span></span><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">&lsquo;<strong>Post-transplant Lymphoproliferative Disorders&rsquo; (PTLDs) </strong>are lymphomas developing after <strong>solid or&shy;gan transplantation e.g. kidney, liver, heart or lung transplants</strong>. Since the <strong>immunosuppressive drugs </strong>destroy the<strong> T cells</strong>, the patients develop <strong>B cell neoplasms more frequently. </strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(B-cell):</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Post-transplant lymphoproliferative disorders (PTLDs)</strong> most frequently involve B-cells. This is due to the<strong> immunosuppressive therapy </strong>administered to <strong>transplant patients </strong>which primarily affects <strong>T-cell function</strong>, leading to a <strong>relative lack of T-cell regulation of B-cell growth </strong>and the subsequent development of <strong>B-cell neoplasms.</strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: (T-cell):</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> T-cell proliferative disorders <strong>post-transplant </strong>are<strong> less common</strong>. The immunosuppression used to <strong>prevent graft rejection </strong>often targets<strong> T-cells to a greater extent, </strong>which paradoxically may result in a<strong> lesser incidence of T-cell lymphomas</strong>.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: (NK cell):</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Natural Killer (NK) cell <strong>neoplasms </strong>are rare in the <strong>post-transplant setting</strong>. NK cells are a part of the <strong>innate immune system </strong>and are not typically involved in the pathogenesis of PTLDs.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: (Monocyte):</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Monocytes are<strong> not commonly </strong>the source of<strong> post-transplant neoplasms</strong>. While <strong>monocytes </strong>and <strong>other cells </strong>of the <strong>myeloid lineage</strong> can give <strong>rise to cancers,</strong> such as <strong>acute or chronic myeloid leukemias,</strong> they are <strong>not the typical cells </strong>implicated in <strong>PTLDs.</strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Post-transplant lymphoma, </strong>or <strong>PTLD, </strong>occurs most frequently due to the<strong> proliferation of B-cells</strong>, often as a result of <strong>reduced T-cell-</strong>mediated immune regulation due to <strong>immunosuppressive therapy</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><span style=\"color:black\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong><em><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Ref: Robbins 10<sup>th</sup> 1310) </span></span></em></strong> </span></span></span></span></p>",
    "correct_choice_id": 61329,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual"
    ]
  },
  {
    "id": 15350,
    "choices": [
      {
        "id": 61360,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Anaplastic large cell lymphoma</span></span></span></p>"
      },
      {
        "id": 61361,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Familial Medullary Carcinoma </span></span></span></p>"
      },
      {
        "id": 61362,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Familial Neuroblastoma </span></span></span></p>"
      },
      {
        "id": 61363,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lymphocyte predominance type Hodgkin&rsquo;s lymphoma </span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Histological presence of &ldquo;Hallmark Cells&rdquo; with horse shoe-like or embryoid like nuclei and voluminous cytoplasm are seen in:</span></span></span></p>",
    "unique_key": "Q6819893",
    "question_audio": null,
    "question_video": null,
    "map_id": 32022,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A. Anaplastic large cell lymphoma&nbsp; </span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Anaplastic large cell lymphoma):</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Anaplastic large cell lymphoma is characterized by<strong> hallmark cells </strong>with<strong> eccentric horseshoe-like </strong>or <strong>kidney-shaped nuclei </strong>and <strong>ample cytoplasm</strong>. Many of these lymphomas are associated with a<strong> chromosomal translocation </strong>that involves the<strong> ALK gene</strong>, leading to its expression in a subset of cases<strong> (ALK-positive ALCL).</strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: (Familial Medullary Carcinoma):</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Familial medullary carcinoma of the <strong>thyroid </strong>is a calcitonin-producing tumor that arises from<strong> parafollicular C cells </strong>of the thyroid. It is associated with mutations in the<strong> RET proto-oncogene </strong>but does not have hallmark cells as described in ALCL.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: (Familial Neuroblastoma):</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Familial neuroblastoma is a <strong>rare pediatric malignancy </strong>of the <strong>sympathetic nervous system</strong>. Histologically, it shows <strong>small, round, blue cells </strong>and is not characterized by hallmark cells with horseshoe-like nuclei.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: (Lymphocyte predominance type Hodgkin&rsquo;s lymphoma):</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This type of<strong> Hodgkin&rsquo;s lymphoma </strong>is characterized by the presence of<strong> popcorn cells (lymphocytic and histiocytic cells) </strong>and not by hallmark cells. It&#39;s different from the classic Reed-Sternberg cells seen in other subtypes of Hodgkin&#39;s lymphoma.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-family:Arial,sans-serif\"><span style=\"color:black\"><span style=\"font-size:12.0pt\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The presence of <strong>&ldquo;Hallmark Cells</strong>&rdquo; with <strong>horseshoe-like nuclei </strong>and <strong>abundant cytoplasm </strong>is characteristic of<strong> anaplastic large cell lymphoma.</strong></span></span><strong> </strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-family:Arial,sans-serif\"><span style=\"color:black\"><span style=\"font-size:12.0pt\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/24/picture3_gFdbepj.jpg\" style=\"height:228px; width:400px\" /></span></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><em><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Ref: Robbin 10<sup>th</sup> 606)</span></span></em></strong></p>",
    "correct_choice_id": 61360,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 15351,
    "choices": [
      {
        "id": 61364,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Follicular center lymphoma </span></span></span></p>"
      },
      {
        "id": 61365,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lymphocyte depleted Hodgkin&rsquo;s disease</span></span></span></p>"
      },
      {
        "id": 61366,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Nodular sclerosis Hodgkin&rsquo;s disease</span></span></span></p>"
      },
      {
        "id": 61367,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lymphocyte predominant Hodgkin&rsquo;s disease</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The lymphocytic and histiocytic variant of Reed- Sternberg cell is seen in:</span></span></span></p>",
    "unique_key": "Q4119184",
    "question_audio": null,
    "question_video": null,
    "map_id": 32023,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D. Lymphocyte predominant Hodgkin&rsquo;s disease</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Reed-Sternberg cells </strong>are<strong> large, abnormal cells </strong>that are characteristic of<strong> Hodgkin&#39;s lymphoma. </strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lymphocyte predominant Hodgkin&rsquo;s disease:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In lymphocyte-predominant Hodgkin&#39;s disease, the<strong> Reed-Sternberg cells </strong>have a <strong>popcorn-like appearance </strong>and are surrounded by a<strong> nodular and infiltrate of lymphocytes.</strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Follicular center lymphoma:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;<strong>Reed-Sternberg cells </strong>are <strong>not </strong>typically associated with <strong>follicular center lymphoma</strong>, which is a subtype of <strong>non-Hodgkin&#39;s lymphoma</strong>.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In the<strong> lymphocyte-depleted subtype of Hodgkin&#39;s disease</strong>, the<strong> Reed-Sternberg cells </strong>are surrounded by a<strong> small number of lymphocytes </strong>and a significant number o<strong>f histiocytes (macrophages). </strong>This variant is associated with a <strong>poorer prognosis </strong>compared to other subtypes of Hodgkin&#39;s lymphoma.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Nodular sclerosis Hodgkin&rsquo;s disease:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The nodular sclerosis <strong>subtype of Hodgkin&#39;s disease </strong>typically features <strong>Reed-Sternberg cells with a lacunar (empty) </strong>appearance, surrounded by <strong>fibrous bands.</strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The<strong> lymphocytic and histiocytic (L&amp;H) </strong>variant of<strong> Reed-Sternberg cells</strong>, often called <strong>&quot;popcorn cells,&quot; </strong>is characteristic of lymphocyte <strong>predominant Hodgkin&rsquo;s disease</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u>Ref</u>: Robbins 10<sup>th</sup> /613</strong></span></span></p>",
    "correct_choice_id": 61367,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 15354,
    "choices": [
      {
        "id": 61376,
        "text": "<p><span style=\"font-size:12pt;\">Lymphocyte predominant Hodgkin's lymphoma</span></p>"
      },
      {
        "id": 61377,
        "text": "<p><span style=\"font-size:12pt;\">Lymphocyte depleted Hodgkin's lymphoma</span></p>"
      },
      {
        "id": 61378,
        "text": "<p><span style=\"font-size:12pt;\">Nodular sclerosis Hodgkin's lymphoma</span></p>"
      },
      {
        "id": 61379,
        "text": "<p><span style=\"font-size:12pt;\">Mixed type Hodgkin's lymphoma</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">A 32-year-old female presents with painless swelling of a supraclavicular lymph node. Excisional biopsy reveals a nodular pattern with a predominance of lymphocytes, and characteristic large, atypical mononuclear or multinucleated cells with a \"popcorn\" appearance. Immunohistochemistry shows positive staining for CD20 and CD45. What subtype of Hodgkin's lymphoma is most likely to be diagnosed in this patient?</span></p>",
    "unique_key": "Q4118556",
    "question_audio": null,
    "question_video": null,
    "map_id": 32025,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ans. A. Lymphocyte predominant Hodgkin's lymphoma</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option A:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/24/picture4_6TMNz9L.jpg\" alt=\"\" width=\"1000\" height=\"360\"></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option B: (Lymphocyte depleted Hodgkin's lymphoma):</strong> This<strong> rare subtype </strong>is marked by a <strong>lack of lymphocytes </strong>and an abundance of <strong>classic Reed-Sternberg cells</strong>. It often presents in <strong>more advanced stages </strong>and has a <strong>worse prognosis. </strong>It does not typically contain popcorn cells.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option C: (Nodular sclerosis Hodgkin's lymphoma):</strong> The<strong> most common subtype, </strong>characterized by the <strong>presence of collagen bands </strong>dividing the <strong>lymph node into nodules </strong>and<strong> Reed-Sternberg cells </strong>within lacunar spaces. This subtype usually affects <strong>young adults</strong>, and it is not primarily associated with popcorn cells.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option D: (Mixed type Hodgkin's lymphoma):</strong> Also known as <strong>mixed cellularity Hodgkin's lymphoma</strong>, it is characterized by a<strong> mixed infiltrate </strong>that includes <strong>eosinophils, plasma cells, neutrophils, and Reed-Sternberg cells</strong>. It does not have a predominance of lymphocytes nor does it typically show popcorn cells.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">A biopsy showing a <strong>nodular pattern with a predominance of lymphocytes </strong>and characteristic \"<strong>popcorn\" cells </strong>that are positive for <strong>CD20 and CD45 </strong>is diagnostic of<strong> Lymphocyte Predominant Hodgkin's Lymphoma.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>(Ref: Robbins 10<sup>th</sup> /613)</strong></span></p>",
    "correct_choice_id": 61376,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual"
    ]
  },
  {
    "id": 15367,
    "choices": [
      {
        "id": 61428,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mycosis fungoides </span></span></p>"
      },
      {
        "id": 61429,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Follicular lymphoma </span></span></p>"
      },
      {
        "id": 61430,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Burkitt&rsquo;s lymphoma </span></span></p>"
      },
      {
        "id": 61431,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hodgkin lymphoma </span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient with lymphoma with CD10 and bcl2 marker is likely to be diagnosed with which of the following?</span></span></span></p>",
    "unique_key": "Q7718827",
    "question_audio": null,
    "question_video": null,
    "map_id": 32013,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B. Follicular lymphoma </span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Follicular lymphoma is a<strong> B-cell non-Hodgkin lymphoma</strong>. It is characterized by the<strong> t(14;18) translocation involving the bcl-2 gene,</strong> leading to the <strong>overexpression of bcl-2 protein.</strong> <strong>CD10 </strong>is often expressed in<strong> follicular lymphoma </strong>and is used as a<strong> diagnostic marker.</strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Mycosis fungoides</strong> is a type of <strong>cutaneous T-cell lymphoma</strong>, primarily involving the <strong>skin</strong>. <em>CD10 and bcl-2 </em>markers are not typically associated with mycosis fungoides.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Burkitt&#39;s lymphoma </strong>is an <strong>aggressive B-cell lymphoma, </strong>often associated with the <strong>Epstein-Barr virus.</strong> It is characterized by a <strong>high proliferation </strong>rate and a characteristic <strong>translocation involving the c-Myc gene</strong>.<strong> CD10 </strong>can be expressed in <strong>Burkitt&#39;s lymphoma,</strong> but<strong> bcl-2 is typically negative.</strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Hodgkin lymphoma</strong> is characterized by the<strong> presence of Reed-Sternberg cells</strong>. <strong>CD10 and bcl-2 are not t</strong>ypical markers for <strong>Hodgkin lymphoma</strong>. Classical Hodgkin lymphoma is more commonly associated with <strong>CD15 and CD30 expression.</strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A lymphoma with<strong> positive CD10 and bcl2 markers</strong> is likely to be diagnosed as<strong> follicular lymphoma.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><em><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Ref: Robbins 10th/e p468) </span></span></em></strong><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"> </span></span></span></p>",
    "correct_choice_id": 61429,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual"
    ]
  },
  {
    "id": 15355,
    "choices": [
      {
        "id": 61380,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lymphocyte predominance </span></span></span></p>"
      },
      {
        "id": 61381,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lyphocyte depletion </span></span></span></p>"
      },
      {
        "id": 61382,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Nodular sclerosis </span></span></span></p>"
      },
      {
        "id": 61383,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mixed cellularity</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lacunar cells are seen in which type of Hodgkin&rsquo;s lymphoma:</span></span></span></p>",
    "unique_key": "Q4248198",
    "question_audio": null,
    "question_video": null,
    "map_id": 32026,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C. Nodular sclerosis</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/24/picture5_RDkaQxW.jpg\" style=\"height:331px; width:1000px\" /></span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: (Lymphocyte Predominance):</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This <strong>subtype </strong>is characterized by the <strong>presence of Reed-Sternberg cell </strong>variants called <strong>popcorn cells</strong>, which are usually <strong>CD20 positive</strong>, and<strong> not by lacunar cells</strong>. It has a <strong>nodular pattern </strong>and <strong>an abundance of reactive lymphocytes</strong>.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: (Lymphocyte Depletion):</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This <strong>rare and aggressive </strong>subtype contains<strong> few lymphocytes and numerous Reed-Sternberg cells</strong>, often in a background that may include<strong> fibrosis</strong>, but<strong> not </strong>typically <strong>lacunar cells</strong>.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: (Mixed Cellularity):</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Mixed cellularity Hodgkin&#39;s lymphoma is noted for a<strong> diverse cellular composition </strong>that includes numerous classic<strong> Reed-Sternberg cells among inflammatory cells</strong>, but not specifically lacunar cells.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Lacunar cells </strong>are a characteristic feature of the <strong>nodular sclerosis subtype of Hodgkin&rsquo;s lymphoma</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><em><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Ref: Robbins 10<sup>th</sup> 618)</span></span></em></strong></p>",
    "correct_choice_id": 61382,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual"
    ]
  },
  {
    "id": 15372,
    "choices": [
      {
        "id": 61448,
        "text": "<p><span style=\"font-size:12pt;\">Progenitor B cell</span></p>"
      },
      {
        "id": 61449,
        "text": "<p><span style=\"font-size:12pt;\">Mature B cells</span></p>"
      },
      {
        "id": 61450,
        "text": "<p><span style=\"font-size:12.0pt;\">Na\u00efve B cells</span></p>"
      },
      {
        "id": 61451,
        "text": "<p><span style=\"font-size:12.0pt;\">Germinal centre</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt;\">Origin of Chronic Lymphocytic Leukemia/SLL is:</span></p>",
    "unique_key": "Q4434226",
    "question_audio": null,
    "question_video": null,
    "map_id": 32034,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C. Na\u00efve B cells</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ig genes </strong>of some CLL/SLL are somatically <strong>hypermutated, </strong>whereas others are not, suggesting that the <strong>cell of origin</strong> may be either a <strong>post-germinal center memory B cell </strong>or a <strong>naive B cell</strong>. It is <strong>not </strong>originating from<strong> progenitor B cell or mature B cell.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The<strong> cell </strong>of origin for<strong> CLL/SLL is the naive B cell</strong>, which may or may not undergo<strong> somatic hypermutation, </strong>suggesting that <strong>CLL/SLL </strong>can arise from a<strong> pre-germinal center B cell.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>(Ref: Robbins 10th/e p597)</strong></span></p>",
    "correct_choice_id": 61450,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 15332,
    "choices": [
      {
        "id": 61288,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chronic myelogenous leukemia </span></span></span></p>"
      },
      {
        "id": 61289,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chronic lymphocytic leukemia </span></span></span></p>"
      },
      {
        "id": 61290,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acute myelogenous leukemia </span></span></span></p>"
      },
      {
        "id": 61291,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acute lymphoblastic leukemia </span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">&ldquo;Smudge cells&rdquo; in the peripheral smear are characteristic of:</span></span></span></p>",
    "unique_key": "Q7429757",
    "question_audio": null,
    "question_video": null,
    "map_id": 32033,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B. Chronic lymphocytic leukemia</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Chronic Lymphocytic Leukemia (CLL) </strong>is a type of leukemia that affects<strong> lymphocytes, </strong>particularly<strong> B-cells</strong>. <strong>Smudge cells</strong>, also known as <strong>&quot;basket cells&quot; or &quot;Gumprecht shadows,&quot; </strong>are<strong> fragile, delicate lymphocytes </strong>that rupture during the<strong> blood smear preparation, </strong>leading to their characteristic appearance. CLL is often associated with<strong> smudge cells due to the fragility of the abnormal lymphocytes.</strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Chronic Myelogenous Leukemia (CML) </strong>is characterized by the presence of the <strong>Philadelphia chromosome </strong>and an<strong> increase in myeloid cells</strong>, particularly<strong> granulocytes</strong>. Smudge cells are not a typical feature of CML.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Acute Myelogenous Leukemia (AML) </strong>is characterized by the rapid proliferation of<strong> immature myeloid cells</strong>. <strong>Smudge cells </strong>are not a characteristic feature of <strong>AML.</strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Acute Lymphoblastic Leukemia (ALL) </strong>primarily affects<strong> lymphoid cells</strong>, and it is characterized by the<strong> presence of lymphoblasts </strong>in the peripheral blood. Smudge cells are not a typical finding in ALL.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective: </span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Smudge cells </strong>in the peripheral smear are characteristic of <strong>Chronic Lymphocytic Leukemia (CLL), due to the increased fragility of the abnormal lymphocytes encountered in this disease.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><em><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Ref: Robbins 7th/673, 9/e 593) </span></span></em></strong><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"><strong> </strong></span></span></span></span></p>",
    "correct_choice_id": 61289,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual"
    ]
  },
  {
    "id": 15329,
    "choices": [
      {
        "id": 61276,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acute myeloid leukemia </span></span></span></p>"
      },
      {
        "id": 61277,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acute lymphoblastic leukemia </span></span></span></p>"
      },
      {
        "id": 61278,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chronic myelogenous leukemia </span></span></span></p>"
      },
      {
        "id": 61279,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Myelodysplastic syndrome </span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">A peripheral smear with increased neutrophils, basophils, eosinophils, and platelets is highly suggestive of:</span></span></span></p>",
    "unique_key": "Q2152030",
    "question_audio": null,
    "question_video": null,
    "map_id": 32030,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C. Chronic myelogenous leukemia </span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Chronic Myelogenous Leukemia (CML):</strong> is characterized by the presence of the<strong> Philadelphia chromosome</strong>, resulting in the constitutive activation of the <strong>BCR-ABL1 tyrosine kinase</strong>. This leads to<strong> increased production of myeloid cells,</strong> including <strong>neutrophils,</strong> <strong>basophils, eosinophils, and platelets.</strong> The peripheral smear in CML often shows a <strong>&quot;left-shift,&quot; </strong>with <strong>increased mature and immature myeloid cells</strong>.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong> Acute Myeloid Leukemia (AML):</strong> is characterized by the <strong>rapid growth </strong>of <strong>abnormal myeloid cells </strong>in the bone marrow. While AML may show <strong>increased myeloid cells </strong>in the peripheral smear, it typically presents with<strong> blasts and a decrease in mature cells</strong>, unlike the broad spectrum of increased cells seen in the question.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong> Acute Lymphoblastic Leukemia (ALL):</strong> <strong>primarily affects lymphoid cells</strong>. It is characterized by the presence of <strong>lymphoblasts </strong>in the peripheral blood. The question describes an increase in myeloid cell lineages (neutrophils, basophils, eosinophils, and platelets), making ALL less likely.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Myelodysplastic Syndrome (MDS):</strong> is a<strong> group of disorders </strong>characterized by <strong>ineffective hematopoiesis</strong>. While MDS can present with<strong> cytopenias and dysplastic </strong>changes in blood cells, the specific pattern described in the question (increased neutrophils, basophils, eosinophils, and platelets) is more indicative of CML.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Chronic myeloid leukemia </strong>is a<strong> stem cell disease</strong> that is characterized by <strong><em>leukocytosis with granulocytic immaturities, basophilia, splenomegaly</em></strong> and distinct chromosomal abnormality<strong> Philadelphia chromosome</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><em><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Ref: Robbins 10<sup>th</sup>/ 622) </span></span></em></strong></p>",
    "correct_choice_id": 61278,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual"
    ]
  },
  {
    "id": 15369,
    "choices": [
      {
        "id": 61436,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">t (9; 22) </span></span></p>"
      },
      {
        "id": 61437,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">t (15; 17) </span></span></p>"
      },
      {
        "id": 61438,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">t (8; 14) </span></span></p>"
      },
      {
        "id": 61439,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">t (8; 21) </span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">An elderly male with dragging sensation in abdomen presents in the OPD. His cell count had elevated total leucocyte count and increased platelet count. His peripheral smear shows metamyelocytes, myelocytes, eosinophilia and basophilia (image given for reference). Which of the following is the likely genetic anomaly present in this individual? </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/24/picture7_WdmXOwZ.jpg\" style=\"height:194px; width:300px\" /></span></span></span></p>",
    "unique_key": "Q6747004",
    "question_audio": null,
    "question_video": null,
    "map_id": 32031,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A. t (9; 22)</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The<strong> increased cell count (leucocytes and platelets) </strong>with peripheral smear showing <strong>metamyelocytes, myelocytes, eosinophilia and basophilia (mixed myeloid lineage) </strong>is suggestive of a diagnosis of <strong>chronic myeloid leukemia</strong>. Two other features also fit in the diagnosis: </span></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Age of the patient (peak incidence in 5/6th decade of life) </span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The dragging sensation (can be due to splenomegaly seen in CML patients) </span></span></span></li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: t (15;17)</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: is associated with<strong> acute promyelocytic leukemia (APL).</strong> It involves the fusion of the<strong> PML (promyelocytic</strong> <strong>leukemia) gene on chromosome 15 with the RARA (retinoic acid receptor alpha) gene on chromosome 17</strong>, resulting in the <strong>PML-RARA fusion gene.</strong> This fusion gene plays a crucial role in the pathogenesis of APL.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: t (8;14)</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: is associated with <strong>Burkitt&#39;s lymphoma.</strong> It involves the<strong> c-MYC gene on chromosome 8 </strong>and the <strong>immunoglobulin</strong> <strong>heavy chain gene on chromosome 14</strong>. The dysregulation of <strong>c-MYC</strong>, a proto-oncogene, contributes to the <strong>rapid and uncontrolled</strong> <strong>proliferation of B cells</strong> in Burkitt&#39;s lymphoma.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: t (8;21)</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: is associated with <strong>acute myeloid leukemia (AML)</strong>, particularly the subtype known as <strong>AML with t(8;21), </strong>also called <strong>AML-M2. </strong>It involves the fusion of the <strong>AML1 (acute myeloid leukemia 1) gene on chromosome 21 with the ETO (eight-twenty-one) gene on chromosome 8, </strong>resulting in the <strong>AML1-ETO fusion gene.</strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The<strong> genetic anomaly </strong>likely present in an <strong>elderly male </strong>with an<strong> elevated leukocyte and platelet count</strong>, peripheral smear showing <strong>metamyelocytes, myelocytes, eosinophilia, and basophilia is t (9;22), </strong>which is associated with <strong>chronic myeloid leukemia (CML).</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><em><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Ref: Robbins 10th/e p622) </span></span></em></strong></p>",
    "correct_choice_id": 61436,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "ImageBased"
    ]
  },
  {
    "id": 15374,
    "choices": [
      {
        "id": 61456,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Whole body PET CT </span></span></p>"
      },
      {
        "id": 61457,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Leucocyte alkaline phosphatase </span></span></p>"
      },
      {
        "id": 61458,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Immunophenotyping</span></span></p>"
      },
      {
        "id": 61459,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">FISH in the peripheral blood smear </span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A male patient with splenomegaly with myeloid hyperplasia. What&rsquo;s is the next best investigation to be done?</span></span></span></p>",
    "unique_key": "Q2640566",
    "question_audio": null,
    "question_video": null,
    "map_id": 32032,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D. FISH in the peripheral blood smear</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong> </span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Fluorescence in situ hybridization (FISH) </strong>is a <strong>molecular cytogenetic </strong>technique that can be applied to detect <strong>specific genetic abnormalities </strong>and is invaluable for diagnosis of <strong>CML </strong>(more likely from the history given in the question). </span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Whole-body<strong> PET CT (Positron Emission Tomography with Computed Tomography) </strong>is a valuable imaging tool, particularly in the evaluation of <strong>lymphomas and solid tumors. </strong>However, it may <strong>not be the first-line investigation for myeloid hyperplasia </strong>or diseases<strong> primarily </strong>involving the <strong>bone marrow.</strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Leucocyte alkaline phosphatase (LAP) </strong>is an <strong>enzyme </strong>that can be measured <strong>to assess the activity of neutrophils</strong>. <strong>Low LAP </strong>scores may be associated with conditions like<strong> chronic myeloid leukemia (CML). </strong>However, this test alone might not provide a <strong>definitive diagnosis </strong>and is often used in conjunction with other tests.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Immunophenotyping </strong>is a crucial investigation in the context of<strong> hematological disorders</strong>. It involves the analysis of <strong>cell surface markers </strong>on <strong>blood or bone marrow cells </strong>but is more useful for other leukemias like <strong>ALL, AML or CLL. </strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">For a <strong>male </strong>patient with<strong> splenomegaly and myeloid hyperplasia</strong>, the next best investigation is <strong>Fluorescence in situ hybridization (FISH) </strong>in the peripheral blood smear, particularly to detect chromosomal abnormalities such as the<strong> Philadelphia chromosome </strong>in <strong>chronic myeloid leukemia (CML).</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong><em><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Ref: Robbins 10th/e p482) </span></span></em></strong></span></span></span></p>",
    "correct_choice_id": 61459,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "TreatmentBased"
    ]
  },
  {
    "id": 15364,
    "choices": [
      {
        "id": 61416,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tubular casts </span></span></span></p>"
      },
      {
        "id": 61417,
        "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Amyloidosis </span></span></p>"
      },
      {
        "id": 61418,
        "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Wire loop lesions </span></span></p>"
      },
      {
        "id": 61419,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Renal tubular necrosis </span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Q34. A 60-year-old male with a known history of multiple myeloma presents with worsening renal function. A renal biopsy is performed to assess the renal involvement. Which of the following findings would be considered atypical or not commonly associated with renal complications of multiple myeloma?</span></span></span></p>",
    "unique_key": "Q5304409",
    "question_audio": null,
    "question_video": null,
    "map_id": 32038,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C. Wire loop lesions </span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: </span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Wire loop lesions:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Wire loop lesions, seen on<strong> renal biopsy</strong>, are characteristic of<strong> lupus nephritis,</strong> a renal manifestation of <strong>systemic</strong> <strong>lupus erythematosus (SLE).</strong> This finding is <strong>not </strong>typically associated with <strong>multiple myeloma.</strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Tubular casts:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> These can result from the<strong> precipitation of light chains in the renal tubules</strong>, leading to <strong>cast</strong> formation. This is a common finding in<strong> multiple myeloma-associated renal disease.</strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Amyloidosis:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Amyloid deposition in the<strong> kidneys is a known complication of multiple myeloma,</strong> leading to <strong>renal</strong> <strong>impairment.</strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: Renal tubular necrosis:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Direct infiltration of myeloma cells</strong> into the <strong>renal tubules</strong> can cause<strong> tubular necrosis,</strong> contributing to renal dysfunction. </span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Wire loop lesions </strong>are<strong> not typically associated with multiple myeloma</strong> and are characteristic of<strong> lupus nephritis.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"><strong><em><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Ref: Robbins 10<sup>th</sup>/ 225) </span></span></em></strong> </span></span></span></p>",
    "correct_choice_id": 61418,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "Factual"
    ]
  },
  {
    "id": 15360,
    "choices": [
      {
        "id": 61400,
        "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Anemia </span></span></p>"
      },
      {
        "id": 61401,
        "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hyperviscosity </span></span></p>"
      },
      {
        "id": 61402,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bone pains </span></span></span></p>"
      },
      {
        "id": 61403,
        "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Infection </span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is the least common presentation of multiple myeloma?</span></span></span></p>",
    "unique_key": "Q7523497",
    "question_audio": null,
    "question_video": null,
    "map_id": 32036,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B. Hyperviscosity </span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Hyperviscosity):</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Hyperviscosity syndrome is<strong> less commonly </strong>a presenting feature of <strong>multiple myeloma.</strong> It results from the <strong>high</strong> <strong>protein </strong>content in the blood due to excessive production of<strong> monoclonal proteins by myeloma cells,</strong> but not all patients will experience this.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: (Anemia):</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong> Anemia is a common </strong>finding in multiple myeloma, <strong>typically normocytic and normochromic,</strong> caused by the replacement of <strong>bone marrow with myeloma cells</strong>, which impairs normal blood cell production.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: (Bone Pains):</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Bone pain, </strong>particularly in the <strong>back or chest</strong>, is a <strong>very common</strong> symptom of multiple myeloma. It results from <strong>bone destruction </strong>due to the<strong> infiltration and activation of osteoclasts by myeloma cells,</strong> leading to lytic lesions or fractures.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: (Infection):</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Patients with multiple myeloma have an<strong> increased risk of infections due to an impaired immune response</strong>, both from the disease itself and as a consequence of treatment, making infection a common presentation.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Hyperviscosity</strong> is the<strong> least common</strong> presentation of<strong> multiple myeloma compared to anemia, bone pains, and infection.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><em><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Ref: Robbins 10<sup>th</sup>/ 609)</span></em></strong></span></span></p>",
    "correct_choice_id": 61401,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 15362,
    "choices": [
      {
        "id": 61408,
        "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">IgG</span></span></p>"
      },
      {
        "id": 61409,
        "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">IgA</span></span></p>"
      },
      {
        "id": 61410,
        "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">IgD</span></span></p>"
      },
      {
        "id": 61411,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">IgM</span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 60-year-old male presents with fatigue, weakness, and recurrent infections. Flow cytometry analysis of bone marrow aspirate shows infiltration of small lymphocytes, plasma cells, and lymphoplasmacytoid cells. The patient is diagnosed with lymphoplasmacytoid lymphoma. Which immunoglobulin is most likely to be associated with this lymphoma subtype?</span></span></span></p>",
    "unique_key": "Q2256057",
    "question_audio": null,
    "question_video": null,
    "map_id": 32037,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) IgM </span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Lymphoplasmacytoid lymphoma </strong>(or <strong>Waldenstrom&rsquo;s macroglobulinemia) </strong>is a<strong> B cell neoplasm </strong>presenting in 6th or 7th decade of life having features similar to<strong> CLL/ SLL </strong>and <strong>multiple myeloma (MM). </strong>Like MM, there is presence of a <strong>&lsquo;M&rsquo; or monoclonal spike </strong>(caused due to IgM)</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">In <strong>multiple myeloma</strong>, the<strong> M spike </strong>is seen due to<strong> IgG.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: (IgG):</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> While<strong> IgG</strong> is the <strong>most </strong>common <strong>immunoglobulin </strong>produced in <strong>multiple myeloma</strong>, it is not typically associated with lymphoplasmacytoid lymphoma, also known as Waldenstr&ouml;m&rsquo;s macroglobulinemia.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: (IgA):</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong> IgA</strong> is another <strong>immunoglobulin </strong>that can be produced in <strong>multiple myeloma</strong> but is less commonly associated with lymphoplasmacytoid lymphoma.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: (IgD):</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>IgD paraproteinemia</strong> is very rare in <strong>plasma cell dyscrasias </strong>and is not commonly seen in lymphoplasmacytoid lymphoma.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Lymphoplasmacytoid lymphoma, </strong>known as <strong>Waldenstr&ouml;m&rsquo;s macroglobulinemia, </strong>is most commonly associated with the overproduction of<strong> monoclonal IgM</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong><em><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Ref: Robbins 10<sup>th</sup>/ 604) </span></span></em></strong></span></span></p>",
    "correct_choice_id": 61411,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 15366,
    "choices": [
      {
        "id": 61424,
        "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Beta 2 microglobulin </span></span></p>"
      },
      {
        "id": 61425,
        "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Creatine </span></span></p>"
      },
      {
        "id": 61426,
        "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Albumin </span></span></p>"
      },
      {
        "id": 61427,
        "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Anemia </span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 55-year-old male who is a diagnosed case of multiple myeloma has come up for follow-up. Elevated levels of which of the following is a poor prognostic factor in this patient?</span></span></span></p>",
    "unique_key": "Q1914126",
    "question_audio": null,
    "question_video": null,
    "map_id": 32039,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A. Beta 2 microglobulin </span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Elevated serum levels of <strong>Beta 2 microglobulin</strong> are associated with a <strong>poor prognosis</strong> in multiple myeloma. It is a marker of <strong>tumor</strong> <strong>burden and reflects</strong> the extent of tumor <strong>cell infiltration</strong>. Harrison writes &ldquo;<em><strong>Serum beta 2 microglobulin</strong> is the s<strong>in&shy;gle most powerful</strong> <strong>predictor of survival and can substitute for staging.</strong></em><strong>&rdquo;</strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong> Elevated creatinine levels</strong> can indicate <strong>impaired renal function</strong>, which is a common complication in multiple myeloma. However, it is not a specific prognostic factor on its own.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Low levels of albumin </strong>are associated with <strong>poor prognosis in various diseases,</strong> including multiple myeloma. However, an increase in albumin is not typically considered a poor prognostic factor in this context.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong> Anemia is a common</strong> feature of<strong> multiple myeloma</strong> and is associated with a <strong>poorer prognosis.</strong> However, the <strong>presence of</strong> <strong>anemia itself</strong> may not necessarily indicate a <strong>worsening prognosis </strong>without considering other factors.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Elevated serum levels of Beta 2 microglobulin </strong>are a <strong>powerful prognostic factor</strong> in multiple myeloma, reflecting tumor burden and the extent of<strong> tumor cell infiltration.</strong></span></span></span></span></span></p>",
    "correct_choice_id": 61424,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 15396,
    "choices": [
      {
        "id": 61544,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Idiopathic thrombocytopenia purpura </span></span></p>"
      },
      {
        "id": 61545,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Systemic lupus erythematosus </span></span></p>"
      },
      {
        "id": 61546,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Aplastic anemia </span></span></p>"
      },
      {
        "id": 61547,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Disseminated intravascular coagulation (DIC) </span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><span style=\"color:black\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">A 50-year-old male presents with fatigue and widespread purpura. Blood work reveals a marked decrease in platelets, with counts persistently below 20,000/&micro;L. The patient&#39;s history includes recurrent epistaxis and one instance of hematuria. Bone marrow biopsy reveals a hypocellular marrow with a markedly reduced number of megakaryocytes. </span></span></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">All of the following can cause megakaryocytic thrombocytopenia, except: </span></span></span></span></p>",
    "unique_key": "Q9054851",
    "question_audio": null,
    "question_video": null,
    "map_id": 31749,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ans. C) Aplastic anemia </span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><span style=\"color:black\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><span style=\"color:black\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Aplastic anemia </strong>involves the <strong>failure of bone marrow production </strong>leading to <strong>pancytopenia</strong>, including a <strong>severe reduction in megakaryocytes</strong>. This condition is characterized by a <strong>low number of all cell lines </strong>(including megakaryocytes) and is <strong>not associated with megakaryocytic thrombocytopenia </strong>but rather with hypoplastic or amegakaryocytic thrombocytopenia</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><span style=\"color:black\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Option A. Idiopathic thrombocytopenic purpura [ITP]:&nbsp;</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">ITP is characterized by <strong>autoimmune destruction of platelets</strong>. It typically presents with isolated thrombocytopenia and may show an increased number of megakaryocytes in the bone marrow due to compensatory production.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Option B. Systemic lupus erythematosus [SLE]:&nbsp;</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">SLE can <strong>cause thrombocytopenia </strong>due to <strong>autoantibody-mediated platelet destruction</strong>. Megakaryocytes may be increased in the bone marrow as the body tries to compensate for the peripheral platelet destruction.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Option D. Disseminated intravascular coagulation [DIC]:&nbsp;</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">DIC is a condition that <strong>leads to the systemic activation of the coagulation cascade</strong>, resulting in <strong>widespread microthrombi </strong>and <strong>secondary consumption of platelets </strong>and <strong>coagulation factors</strong>. This can also lead to a compensatory increase in megakaryocytes in the bone marrow.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Educational Objective:</span></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">In <strong>megakaryocytic thrombocytopenia</strong>, there is an <strong>increase in bone marrow megakaryocytes </strong>as a <strong>compensatory mechanism </strong>for <strong>peripheral platelet destruction</strong>, but in aplastic anemia, there is bone marrow failure and reduced megakaryocytes. </span></span></span></span></p>",
    "correct_choice_id": 61546,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 14087,
    "choices": [
      {
        "id": 56309,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Platelet functions and common pathway</span></span></span></p>"
      },
      {
        "id": 56310,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Extrinsic and common pathway</span></span></span></p>"
      },
      {
        "id": 56311,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Intrinsic and common pathway</span></span></span></p>"
      },
      {
        "id": 56312,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Vessel wall integrity and intrinsic pathway</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Activated Partial thromboplastin time correlates with which of the following?</span></span></p>",
    "unique_key": "Q5326750",
    "question_audio": null,
    "question_video": null,
    "map_id": 31752,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Intrinsic and common pathway</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The<strong> aPTT or activated Partial thromboplastin time </strong>best correlate with<strong> intrinsic and common pathway activity</strong>.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>PT or Prothrombin time </strong>best correlate with <strong>extrinsic and common pathway activity.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The<strong> aPTT test </strong>evaluates the integrity of the <strong>intrinsic and common pathways of coagulation</strong>. It involves factors<strong> XII, XI, IX, VIII (intrinsic pathway)</strong>, and factors<strong> X, V, II (prothrombin)</strong>, and <strong>I (fibrinogen) </strong>which are part of the common pathway.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A.&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Platelet function </strong>tests assess<strong> platelet aggregation and adhesion</strong>,<strong> </strong>which are <strong>not </strong>measured by the <strong>aPTT.</strong> The <strong>aPTT test </strong>measures factors in the <strong>intrinsic and common coagulation pathways </strong>but <strong>not platelet function.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B.&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The<strong> extrinsic pathway </strong>is assessed by the <strong>Prothrombin time (PT) test </strong>and involves factor<strong> VII. </strong>The aPTT does not evaluate the extrinsic pathway.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D.</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;<strong>Vessel wall integrity </strong>is <strong>not </strong>specifically assessed by the<strong> aPTT</strong>. The <strong>intrinsic pathway </strong>does involve <strong>endothelial interaction</strong>, but the aPTT test does not measure vessel wall function.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The<strong> activated Partial thromboplastin time (aPTT) </strong>test evaluates the factors of the<strong> intrinsic and common coagulation pathways </strong>and is used to <strong>monitor heparin therapy, </strong>diagnose <strong>coagulation factor deficiencies</strong>, and assess the<strong> potential presence of inhibitors</strong>. </span></span></span></p>",
    "correct_choice_id": 56311,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 15395,
    "choices": [
      {
        "id": 61540,
        "text": "<p><span style=\"font-size:12.0pt;\">Microangiopathic hemolytic anemia</span></p>"
      },
      {
        "id": 61541,
        "text": "<p><span style=\"font-size:12.0pt;\">Thrombocytopenia</span></p>"
      },
      {
        "id": 61542,
        "text": "<p><span style=\"font-size:12.0pt;\">Normal complement level</span></p>"
      },
      {
        "id": 61543,
        "text": "<p><span style=\"font-size:12.0pt;\">Grossly abnormal coagulation tests</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">All are true about thrombotic thrombocytopenic purpura except?</span></p>",
    "unique_key": "Q8046986",
    "question_audio": null,
    "question_video": null,
    "map_id": 31748,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ans. D) Grossly abnormal coagulation tests</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option D:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Thrombotic thrombocytopenic purpura </strong>(TTP) is a <strong>rare blood disorder </strong>characterized by the <strong>formation of microclots </strong>in <strong>small blood vessels throughout the body</strong>, leading to <strong>microangiopathic hemolytic anemia </strong>and <strong>thrombocytopenia</strong>. <strong>TTP </strong>is associated with a <strong>deficiency of ADAMTS13 </strong>(a disintegrin and metalloproteinase), an <strong>enzyme </strong>responsible for <strong>cleaving von Willebrand factor</strong>. TTP doesn't grossly affect the standard coagulation tests. So, the coagulation tests such as PT (prothrombin time) and APTT (activated partial thromboplastin time) are typically normal.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option A. Microangiopathic hemolytic anemia:</strong> <strong>True</strong>. <strong>TTP </strong>is associated with the formation of <strong>microclots that damage red blood cells</strong>, leading to<strong> hemolysis.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option B. Thrombocytopenia:</strong> <strong>True</strong>. <strong>TTP </strong>is characterized by<strong> low platelet counts </strong>due to the formation of <strong>platelet-rich microclots.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option C. Normal complement level:</strong> <strong>True</strong>. Unlike other conditions such as <strong>hemolytic uremic syndrome (HUS), TTP is not </strong>typically associated with<strong> complement activation, </strong>so complement levels are generally<strong> normal</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Educational objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>TTP doesn't </strong>grossly <strong>affect the standard coagulation tests</strong>. So, the <strong>coagulation tests </strong>such as <strong>PT </strong>(prothrombin time) and <strong>APTT </strong>(activated partial thromboplastin time) are typically <strong>normal</strong>. Direct lines from Robbins\u2026 \u201cIf<strong> coagulation tests </strong>indicate a <strong>major consumption of procoagulants, </strong>the diagnosis of <strong>TTP is doubtful</strong>\u201d.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p><span style=\"font-size:12.0pt;\">Mnemonic for TTP Clinical Features (Pentad):</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">FAT RN</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">Fever</span></li><li><span style=\"font-size:12.0pt;\">Anemia (microangiopathic hemolytic)</span></li><li><span style=\"font-size:12.0pt;\">Thrombocytopenia</span></li><li><span style=\"font-size:12.0pt;\">Renal dysfunction (mild to moderate)</span></li><li><span style=\"font-size:12.0pt;\">Neurologic symptoms</span></li></ul><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Ref</u>: Robbins 10<sup>th</sup>/ 665</strong></span></p>",
    "correct_choice_id": 61543,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "InvestigationBased"
    ]
  },
  {
    "id": 15389,
    "choices": [
      {
        "id": 61516,
        "text": "<p><span style=\"font-size:12.0pt;\">Factor X deficiency</span></p>"
      },
      {
        "id": 61517,
        "text": "<p><span style=\"font-size:12.0pt;\">Glanzmann\u2019s thrombasthenia</span></p>"
      },
      {
        "id": 61518,
        "text": "<p><span style=\"font-size:12.0pt;\">Von Willebrand disease&nbsp;</span></p>"
      },
      {
        "id": 61519,
        "text": "<p><span style=\"font-size:12.0pt;\">Bernard Soulier disease</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"color:black;font-size:12pt;\">A newborn baby presented with profuse bleeding from the umbilical stump after birth. Rest of the examination and PT, APTT are within normal limits. Most likely diagnosis is which of the following?</span></p>",
    "unique_key": "Q8220259",
    "question_audio": null,
    "question_video": null,
    "map_id": 31760,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ans. B) Glanzmann\u2019s thrombasthenia &gt; (d) Bernard Soulier disease</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option B:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Glanzmann\u2019s thrombasthenia </strong>is a <strong>rare genetic platelet disorder </strong>characterized by the <strong>lack of glycoprotein IIb/IIIa </strong>on the <strong>platelet surface</strong>, which is essential for <strong>platelet aggregation</strong>. Despite normal PT and aPTT, patients present with bleeding symptoms because the coagulation cascade is intact, but the platelet plug formation is impaired.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option A. Factor X deficiency:</strong> Factor X deficiency is a <strong>rare bleeding disorder </strong>where the <strong>clotting factor X </strong>is either <strong>deficient or not functioning properly</strong>. It typically presents with a <strong>prolonged prothrombin time </strong>(PT) and <strong>activated partial thromboplastin time </strong>(aPTT), which are not normal in this case.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option C. von Willebrand disease:</strong> Von Willebrand disease is the <strong>most common hereditary bleeding disorder </strong>and is caused by a <strong>qualitative or quantitative deficiency of von Willebrand factor </strong>(vWF). vWF is crucial for platelet adhesion; however, PT and aPTT can be normal in mild cases, but there's often an abnormal bleeding time or abnormal vWF assays.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option D. Bernard-Soulier disease:</strong> Bernard-Soulier syndrome is another <strong>rare platelet disorder</strong>, caused by a <strong>deficiency or dysfunction of the platelet glycoprotein Ib-IX-V complex</strong>, important for platelet adhesion to the vascular subendothelium. Similar to Glanzmann\u2019s thrombasthenia, PT and aPTT are normal, but the platelet function is impaired, leading to bleeding.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Educational Objective</u></strong><u>:</u></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">The <strong>presence of normal PT </strong>and <strong>aPTT despite bleeding symptoms </strong>points towards a <strong>platelet function disorder </strong>rather than a <strong>clotting factor deficiency</strong>. <strong>Glanzmann\u2019s thrombasthenia </strong>and <strong>Bernard-Soulier syndrome </strong>are both characterized by <strong>normal coagulation tests </strong>and <strong>abnormal platelet function</strong>; however, Glanzmann\u2019s thrombasthenia is generally considered more likely when these two conditions are indistinguishable based on clinical and laboratory findings.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p><span style=\"font-size:12.0pt;\">Factor XIII Deficiency and Umbilical Stump Bleeding</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Key Features of Factor XIII Deficiency:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">Autosomal recessive</span></li><li><span style=\"font-size:12.0pt;\">Rare, but classically causes delayed bleeding (e.g., 24\u201348 hours or later)</span></li><li><span style=\"font-size:12.0pt;\">Umbilical stump bleeding is one of the hallmark early signs</span></li><li><span style=\"font-size:12.0pt;\">Clot is formed but is unstable \u2014 leading to rebleeding</span></li><li><span style=\"font-size:12.0pt;\">PT, APTT, bleeding time, and platelet count are all normal</span></li><li><span style=\"font-size:12.0pt;\">Diagnosed by 5M urea clot solubility test or Factor XIII assay</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">But it\u2019s not in the option so the best option here is Glanzmann\u2019s thrombasthenia</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Ref</u>: Wintrobe\u2019s 12th/1365-1370</strong></span></p>",
    "correct_choice_id": 61517,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "InvestigationBased"
    ]
  },
  {
    "id": 15391,
    "choices": [
      {
        "id": 61524,
        "text": "<p><span style=\"font-size:12.0pt;\">Factor IX deficiency</span></p>"
      },
      {
        "id": 61525,
        "text": "<p><span style=\"font-size:12.0pt;\">Lupus anticoagulant</span></p>"
      },
      {
        "id": 61526,
        "text": "<p><span style=\"font-size:12.0pt;\">Factor VIII inhibitors</span></p>"
      },
      {
        "id": 61527,
        "text": "<p><span style=\"font-size:12.0pt;\">VWD \u2013 Type III</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">A 25 years old asymptomatic pregnant female underwent a pre-op coagulation test. Her bleeding time is 3 minutes, PT is 15/14sec, a PTT is 45/35 sec, platelet count is 2.5 lac/ mm</span><span style=\"color:black;font-size:5.0pt;\"><strong><sup>3</sup></strong></span><span style=\"font-size:12pt;\"> and factor VIII levels were 60IU/dL. What is her most likely diagnosis?</span></p>",
    "unique_key": "Q2512026",
    "question_audio": null,
    "question_video": null,
    "map_id": 31761,
    "difficulty_level": "difficult",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Ans. C) Factor VIII inhibitors</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Option C:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Acquired hemophilia</strong>, caused by <strong>autoantibodies against factor VIII</strong>, leads to a <strong>prolonged aPTT </strong>in the <strong>presence of a normal PT </strong>and <strong>bleeding time</strong>, which matches our patient\u2019s coagulation profile. It can occur in the absence of an underlying condition or be associated with conditions like pregnancy, as mentioned.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p><span style=\"font-size:16px;\">(3 minutes is the normal bleeding time)</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Option A. Factor IX deficiency:</strong> Factor IX deficiency, also known as <strong>Hemophilia B </strong>or <strong>Christmas disease</strong>, is a <strong>bleeding disorder </strong>caused by a <strong>deficiency of clotting factor IX</strong>. It is an <strong>X-linked recessive disorder</strong>, making it much <strong>less likely in females</strong>. It presents with a <strong>prolonged aPTT </strong>but <strong>normal PT </strong>and <strong>bleeding time</strong>, which does not fully match the patient's profile since her PT and bleeding time are within normal limits.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Option B. Lupus anticoagulant:</strong> The presence of lupus anticoagulant, an <strong>autoimmune inhibitor</strong>, is associated with <strong>prolonged aPTT </strong>and may also <strong>lead to a prolonged PT</strong>. It is part of the antiphospholipid syndrome and can cause both bleeding and thrombotic episodes. Patients often have thrombocytopenia, which is not the case here as the patient has a normal platelet count.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Option D. VWD \u2013 Type III:</strong> Von Willebrand Disease (VWD) Type III is the <strong>most severe form of VWD </strong>and is characterized by a <strong>markedly reduced </strong>or <strong>absent von Willebrand factor</strong>, leading to a significant <strong>bleeding tendency</strong>. Patients usually have a prolonged bleeding time and a decreased factor VIII activity, which is not consistent with this patient's normal bleeding time and near-normal factor VIII levels.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong><u>Educational Objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\">This patient\u2019s <strong>normal bleeding time </strong>and <strong>PT but prolonged aPTT, </strong>along with the <strong>presence of normal factor VIII activity</strong>, suggest the <strong>presence of an inhibitor against factor VIII </strong>rather than a deficiency, which is consistent with <strong>acquired hemophilia</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong><u>Ref</u>: Robbins 10<sup>th</sup> 672-3, Wintrobe 12th/1447-1453, Har\u00adrison 21<sup>st</sup>/980</strong></span></p>",
    "correct_choice_id": 61526,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual"
    ]
  },
  {
    "id": 15392,
    "choices": [
      {
        "id": 61528,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Immediate refrigeration to preserve factor viability </span></span></p>"
      },
      {
        "id": 61529,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Platelet-rich plasma is essential </span></span></p>"
      },
      {
        "id": 61530,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Done within 2 hours </span></span></p>"
      },
      {
        "id": 61531,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Activated with kaolin </span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">True about prothrombin time to:</span></span></span></p>",
    "unique_key": "Q8254468",
    "question_audio": null,
    "question_video": null,
    "map_id": 31745,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Done within 2 hours </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">Option C:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">Done within 2 hours:</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\"> <strong>PT testing </strong>should be performed within a <strong>specified time from sample collection</strong>, often <strong>within 2 hours</strong>, to ensure the <strong>viability of the coagulation factors</strong>, especially the <strong>labile factors V and VIII, </strong>which can deteriorate over time at room temperature.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">Explanation:</span></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">Option A. Immediate refrigeration to preserve factor viability:</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\"> While it&#39;s true that certain <strong>coagulation factors </strong>are <strong>temperature sensitive</strong>, <strong>prothrombin time </strong>(PT) <strong>testing </strong>typically requires the sample to be <strong>kept at room temperature </strong>to <strong>prevent the cold activation of factors </strong>and potential precipitation of fibrinogen. Immediate refrigeration is not required for PT.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">Option B. Platelet-rich plasma is essential:</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\"> <strong>PT </strong>is actually <strong>performed </strong>on <strong>platelet-poor plasma</strong>, not platelet-rich plasma. The presence of platelets can affect the test results by providing phospholipid surfaces that could artificially shorten the clotting time.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">Option D. Activated with kaolin:</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\"> <strong>PT </strong>is <strong>not activated with kaolin</strong>. Instead, <strong>thromboplastin </strong>(a combination of tissue factor and phospholipids) is used to <strong>activate the extrinsic pathway of coagulation</strong>. Kaolin is used as an activator in the activated partial thromboplastin time (aPTT) test, which evaluates the intrinsic pathway.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">Educational Objective:</span></span></u></strong> </span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">The <strong>PT test </strong>must be <strong>done on platelet-poor plasma </strong>and usually <strong>within 2 hours of sample collection </strong>to ensure <strong>accurate results</strong>, using <strong>thromboplastin for activation. </strong></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/10/picture1_R5zNr7B.jpg\" style=\"height:270px; width:500px\" /></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><span style=\"color:black\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Dacie and Lewis practical hematology 10th/392, 398</span></strong></span></span></span></p>",
    "correct_choice_id": 61530,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 15393,
    "choices": [
      {
        "id": 61532,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Normal platelet count and normal bleeding time </span></span></p>"
      },
      {
        "id": 61533,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Normal platelet count and increased bleeding time </span></span></p>"
      },
      {
        "id": 61534,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Decreased platelet count and increased bleeding time</span></span></p>"
      },
      {
        "id": 61535,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Normal platelet count and decreased bleeding time</span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Patient with bleeding due to platelet function defects has which of the following features?</span></span></span></p>",
    "unique_key": "Q2549306",
    "question_audio": null,
    "question_video": null,
    "map_id": 31746,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ans. B) Normal platelet count and increased </span></span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">bleeding time </span></span></strong><strong>&nbsp;</strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><span style=\"color:black\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><span style=\"color:black\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">This option is characteristic of <strong>platelet function defects. </strong>Although there is a <strong>normal quantity of platelets </strong>(platelet count), the <strong>quality or function of these platelets is compromised</strong>, which means they don&#39;t work as they should, leading to a prolonged bleeding time</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><span style=\"color:black\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Platelet function defects </strong>typically result in <strong>impaired platelet aggregation or adhesion</strong>, leading to <strong>increased bleeding time</strong>. However, the <strong>platelet count remains normal </strong>in these conditions because the <strong>number of platelets is adequate</strong>, but their function is compromised. Therefore, the features of bleeding due to platelet function defects include a normal platelet count and an increased bleeding time.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><span style=\"color:black\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><span style=\"color:black\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Normal platelet count and normal bleeding time:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This option would suggest <strong>no defect in platelet function </strong>or <strong>number</strong>, which would not typically be associated with a bleeding disorder.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><span style=\"color:black\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Decreased platelet count and increased bleeding time:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This suggests a <strong>quantitative defect of platelets</strong>, such as <strong>thrombocytopenia</strong>, rather than a functional defect. Although patients with thrombocytopenia will also have an increased bleeding time, the platelet count in functional defects remains normal.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><span style=\"color:black\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Normal platelet count and decreased bleeding time:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"> A <strong>decreased bleeding time </strong>indicates an <strong>efficient clotting process</strong>, which would not align with platelet function defects.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><span style=\"color:black\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><span style=\"color:black\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Platelet function defects </strong>present with a <strong>normal platelet count </strong>but <strong>impaired function</strong>, leading to an <strong>increased bleeding time</strong>, whereas <strong>quantitative disorders </strong>would show an <strong>altered platelet count</strong>. </span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ref</span></span></u></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">: Robbins 10<sup>th</sup>/ 655</span></span></strong></span></span></p>",
    "correct_choice_id": 61533,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual"
    ]
  },
  {
    "id": 15394,
    "choices": [
      {
        "id": 61536,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">Extrinsic pathway </span></span></span></p>"
      },
      {
        "id": 61537,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">Intrinsic pathway </span></span></span></p>"
      },
      {
        "id": 61538,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">Platelet function </span></span></span></p>"
      },
      {
        "id": 61539,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">Common pathway</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">A 9-year-old boy with no significant past medical history is brought to the pediatrician by his parents who are concerned about his recent onset of spontaneous bruising and a single episode of nose bleeding that took longer than expected to cease. The child has no known allergies, and there is no family history of bleeding disorders. On physical examination, the paediatrician notes several bruises of varying sizes on his legs and arms, as well as petechiae on his ankles. Initial laboratory tests reveal an elevated prothrombin time (PT) and an elevated activated partial thromboplastin time (aPTT), but a normal platelet count and bleeding time (BT). What is the most likely defect in this child&#39;s coagulation pathway?</span></span></span></span></p>",
    "unique_key": "Q3789526",
    "question_audio": null,
    "question_video": null,
    "map_id": 31747,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">Ans. D) Common pathway</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">Option D:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\"><strong>Defects </strong>in the <strong>common pathway affect factors </strong>that are involved in <strong>both the intrinsic </strong>and <strong>extrinsic pathways </strong>(such as factors X, V, II [prothrombin], and I [fibrinogen]) and would lead to <strong>elevations in both PT and aPTT</strong>, as seen in this patient.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">Explanation:</span></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">Option A. Extrinsic pathway:</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\"> A defect in the extrinsic pathway would typically <strong>lead to an isolated elevation of PT</strong>, as this pathway is evaluated by the PT test. This does not explain the elevated aPTT observed in the patient.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">Option B. Intrinsic pathway:</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\"> A defect in the intrinsic pathway would typically <strong>result in an isolated elevation of aPTT</strong>, as this pathway is evaluated by the aPTT test. This also does not explain the elevated PT observed in the patient.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">Option C. Platelet function:</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\"> Platelet function defects usually result in a <strong>prolonged bleeding time </strong>(BT) and <strong>normal coagulation tests </strong>(PT and aPTT). Since the patient has a normal BT, this is unlikely to be the correct diagnosis.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">Educational Objective: </span></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Defect in the <strong>extrinsic pathway </strong>causes elevation of <strong>PT </strong></span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Defect in the <strong>intrinsic pathway </strong>causes elevation of <strong>aPTT</strong>. </span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Defect in <strong>common pathway </strong>cause elevation of <strong>both PT and aPTT</strong>. </span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Platelet function defect </span></span></strong><span dir=\"ltr\" lang=\"EN-US\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">causes elevation of <strong>BT</strong>. </span></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ref</span></span></u></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">: Robbins 10<sup>th</sup>/ 120 </span></span></strong></span></span></p>",
    "correct_choice_id": 61539,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 15397,
    "choices": [
      {
        "id": 61548,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Idiopathic thrombocytopenia purpura (ITP)</span></span></p>"
      },
      {
        "id": 61549,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bernard Soulier syndrome </span></span></p>"
      },
      {
        "id": 61550,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Disseminated intravascular coagulation </span></span></p>"
      },
      {
        "id": 61551,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Wiskott Aldrich syndrome </span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">A 4-year-old boy is brought to the clinic with a history of recurrent ear infections, easy bruising, and severe eczema. On examination, the child has widespread petechiae and a weeping rash over his arms and legs. Laboratory tests reveal thrombocytopenia with an average platelet volume less than the reference range. The boy&#39;s immunoglobulin levels are also noted to be abnormally low. </span>The presence of small sized platelets on the peripheral smear is characteristic of:</span></span></span></p>",
    "unique_key": "Q2872580",
    "question_audio": null,
    "question_video": null,
    "map_id": 31750,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ans. D) Wiskott Aldrich syndrome </span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">Option D: </span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Wiskott Aldrich syndrome </span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">is characterized by the <strong>triad </strong>of: </span></span></span></span></p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><span style=\"color:black\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Severe eczema </span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><span style=\"color:black\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Thrombocytopenia </span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><span style=\"color:black\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Recurrent infections </span></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\"><strong>Wiskott-Aldrich syndrome </strong>is characterized by the<strong> triad of eczema, thrombocytopenia (with small platelets), and immunodeficiency, </strong>which corresponds to the clinical presentation of this patient.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><span style=\"color:black\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">Option A. Idiopathic thrombocytopenic purpura [ITP]:</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\"> ITP is characterized by <strong>autoimmune destruction of platelets</strong>, typically leading to<strong> thrombocytopenia with normal-sized platelets </strong>and no associated eczema or immunodeficiency.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">Option B. Bernard-Soulier syndrome:</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\"> Bernard-Soulier syndrome is a <strong>platelet function disorder </strong>due to a deficiency in<strong> glycoprotein Ib,</strong> the platelet receptor for <strong>von Willebrand factor</strong>. Patients may have <strong>thrombocytopenia </strong>with large platelets and no associated eczema or immunodeficiency.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">Option C. Disseminated intravascular coagulation [DIC]:</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\"> DIC is a secondary condition resulting from another <strong>underlying disease</strong>. It is characterized by widespread <strong>activation of coagulation</strong>, which can lead to the <strong>consumption of platelets and coagulation factors</strong>. Platelet size is typically not affected, and it is not associated with eczema or immunodeficiency.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">Educational Objective:</span></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">The characteristic features of <strong>Wiskott-Aldrich syndrome</strong>, include<strong> thrombocytopenia with small platelets, eczema, and recurrent infections </strong>due to immunodeficiency. </span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ref</span></span></u></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">: Robbins 10<sup>th</sup>/ 243 </span></span></strong></span></span></p>",
    "correct_choice_id": 61551,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 15398,
    "choices": [
      {
        "id": 61552,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">Defect platelet function</span></p>"
      },
      {
        "id": 61553,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">Reduced factor VIII in plasma</span></p>"
      },
      {
        "id": 61554,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">Defective platelet adhesion</span></p>"
      },
      {
        "id": 61555,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">All of the above</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"color:black;font-size:12pt;\">A 28-year-old female presents with easy bruising and prolonged bleeding after minor injuries. She has a family history of bleeding disorders. Which of the following is caused by VWF factor deficiency?</span></p>",
    "unique_key": "Q9710633",
    "question_audio": null,
    "question_video": null,
    "map_id": 31751,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify;\"><span style=\"color:black;font-size:12pt;\"><strong>Ans. D) All of the above</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"color:black;font-size:12pt;\"><strong>Option D:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Von Willebrand factor (VWF) deficiency </strong>can lead to several effects on the <strong>coagulation process:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option A. Defect platelet function:</strong> <strong>True</strong>. VWF plays a crucial role in <strong>platelet adhesion by binding to platelets </strong>and stabilizing the interaction between <strong>platelets and the damaged blood vessel wall</strong>. Its <strong>reduced levels lead to reduced platelet functioning</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option B. Reduced factor VIII in plasma:</strong> <strong>True</strong>. VWF serves as a <strong>carrier protein for factor VIII</strong>, protecting it from rapid <strong>clearance and degradation</strong>. Therefore, a deficiency in VWF can result in <strong>decreased levels of factor VIII </strong>in the plasma.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option C. Defective platelet adhesion</strong>:<strong> True</strong>. VWF is essential for the initial <strong>adhesion of platelets to the damaged blood vessel wall</strong>, facilitating the formation of a <strong>stable plug at the site of injury.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">So, the correct answer is (d) All of the above. <strong>Von Willebrand factor deficiency </strong>affects both<strong> platelet function and factor VIII levels in the plasma</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Educational objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;color:#0d0d0d;font-size:12pt;\">VWF deficiency impairs <strong>platelet adhesion and aggregation </strong>at the site of <strong>vascular injury, </strong>and <strong>reduces the plasma level of factor VIII </strong>by<strong> decreasing its stability </strong>in circulation.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"color:black;font-size:12pt;\"><strong><u>Ref</u>: Robbins 10<sup>th</sup>/ 660</strong></span></p>",
    "correct_choice_id": 61555,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 15399,
    "choices": [
      {
        "id": 61556,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bernard Soulier syndrome </span></span></p>"
      },
      {
        "id": 61557,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Glanzmann disease </span></span></p>"
      },
      {
        "id": 61558,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Von willebrand disease </span></span></p>"
      },
      {
        "id": 61559,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Gray platelet syndrome </span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 22-year-old male presents with a history of recurrent nosebleeds, easy bruising, and prolonged bleeding after minor injuries. He has a deficiency of glycoprotein IIb-IIIa complex. </span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Glycoprotein IIb-IIIa complex is deficient in which of the following conditions? </span></span></span></p>",
    "unique_key": "Q2348333",
    "question_audio": null,
    "question_video": null,
    "map_id": 31753,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ans. B) Glanzmann disease </span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><span style=\"color:black\">&nbsp;&nbsp; </span></span></span><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><span style=\"color:black\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Glanzmann disease </strong>is a <strong>congenital platelet disorder </strong>characterized by a deficiency or dysfunction of the <strong>glycoprotein IIb-IIIa complex </strong>on the surface of platelets. This complex is essential for <strong>platelet aggregation by binding fibrinogen </strong>and facilitating <strong>platelet-platelet interaction</strong>. In Glanzmann disease, i<strong>mpaired platelet aggregation </strong>leads to a tendency for <strong>prolonged bleeding.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A.</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Bernard Soulier syndrome</strong> is associated with a deficiency of<strong> glycoprotein Ib-IX-V complex</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C.</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>von Willebrand disease</strong> is associated with deficiencies or dysfunction of <strong>von Willebrand factor</strong>, not the glycoprotein IIb-IIIa complex.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D.</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Gray platelet syndrome</strong> is a <strong>rare platelet disorder </strong>characterized by <strong>grayish platelets and a deficiency of alpha-granules.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><span style=\"color:black\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></u></strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><span style=\"color:black\"><strong>&nbsp;</strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Glycoprotein IIb-IIIa complex </strong>is deficient in <strong>Glanzmann&rsquo;s disease</strong>.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><span style=\"color:black\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Robbins 10<sup>th</sup> /120</span></strong></span></span></span></p>",
    "correct_choice_id": 61557,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 15400,
    "choices": [
      {
        "id": 61560,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Most of the patients respond to immunosuppressive doses of glucocorticoids</span></span></p>"
      },
      {
        "id": 61561,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Relapse is rare </span></span></p>"
      },
      {
        "id": 61562,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Splenectomy is the treatment of choice for relapse </span></span></p>"
      },
      {
        "id": 61563,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Minority have refractory forms of ITP and difficult to treat </span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"background-color:white\"><span style=\"color:#0d0d0d\">A 32-year-old woman with a diagnosis of chronic immune thrombocytopenic purpura (ITP) returns for a follow-up visit. She previously responded well to a course of glucocorticoids but presented again with petechiae and a platelet count of 25,000/&mu;L. She has no splenomegaly on examination. </span></span>All the following statements are correct about treatment in chronic immune thrombocytopenic purpura except:</span></span></span></p>",
    "unique_key": "Q4434540",
    "question_audio": null,
    "question_video": null,
    "map_id": 31754,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ans. B) Relapse is rare </span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This statement is <strong>incorrect </strong>because <strong>relapses after initial treatment with glucocorticoids </strong>are common in<strong> chronic ITP.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Explanation:</span></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">. While initial treatment with<strong> glucocorticoids </strong>can be effective, many patients with <strong>chronic ITP </strong>may <strong>not </strong>achieve sustained <strong>remission and can experience relapses.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C.</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong> Splenectomy </strong>is typically considered <strong>after glucocorticoids and other medical therapies have failed</strong>, making it not a first-line treatment, but rather a treatment for <strong>relapsed or refractory cases</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D.</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Some patients with<strong> chronic ITP </strong>do not respond to <strong>conventional therapies or relapse following initial therapy</strong>, which may suggest a<strong> refractory form of the disease</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Direct quote&hellip;. &ldquo;Almost all patients<strong> respond to gluco&shy;corticoids </strong>(which inhibit phagocyte function), but<strong> many eventually relapse</strong>.&rdquo; </span></span></span></span></p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><span style=\"color:black\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">In individuals with <strong>severe thrombocytopenia, sple&shy;nectomy normalizes</strong> the <strong>platelet counts. </strong></span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><span style=\"color:black\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Immunomodulatory agents</strong> such as <strong>intravenous immunoglobulin or anti-CD20 antibody (rituximab) </strong>are often effective in patients who <strong>relapse after splenectomy </strong>or for whom <strong>splenectomy is contraindicated. </strong></span></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><span style=\"color:black\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Robbins 10<sup>th</sup>/ 659</span></strong></span></span></span></p>",
    "correct_choice_id": 61561,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "TreatmentBased"
    ]
  },
  {
    "id": 15404,
    "choices": [
      {
        "id": 61576,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Heparin</span></span></p>"
      },
      {
        "id": 61577,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">EDTA</span></span></p>"
      },
      {
        "id": 61578,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sodium oxalate </span></span></p>"
      },
      {
        "id": 61579,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">3.2% trisodium citrate </span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">The anticoagulant of choice for anticoagulation testing:</span></span></span></p>",
    "unique_key": "Q7889064",
    "question_audio": null,
    "question_video": null,
    "map_id": 31757,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ans. D) 3.2% trisodium citrate </span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><span style=\"color:black\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><span style=\"color:black\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Trisodium citrate</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"> is a <strong>calcium chelator </strong>and is commonly used as the <strong>anticoagulant of choice for coagulation </strong>testing particularly for tests like<strong> prothrombin time (PT) and activated partial thromboplastin time (APTT)</strong></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><span style=\"color:black\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Heparin</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> is an <strong>anticoagulant </strong>that acts by potentiating the<strong> activity of antithrombin III, </strong>thereby <strong>inhibiting thrombin and</strong> <strong>other coagulation factors. </strong>While heparin is commonly <strong>used in clinical settings </strong>for<strong> anticoagulation,</strong> it is <strong>not the anticoagulant of choice for anticoagulation testing, </strong>as it can interfere with clotting assays.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. EDTA</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> is an <strong>anticoagulant </strong>that <strong>chelates calcium ions</strong>, <strong>preventing the coagulation </strong>process by <strong>inhibiting clotting factors </strong>that depend on<strong> calcium</strong>. EDTA is commonly used for<strong> collecting blood samples for hematology studies, </strong>such as<strong> complete blood counts</strong>. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Sodium oxalate</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> also <strong>chelates calcium ions</strong>, similar to<strong> EDTA</strong>, and is used for collecting blood samples for<strong> glucose testing (enolase acting as a glycolysis inhibitor).</strong></span></span></span></p>\r\n\r\n<p style=\"margin-left:24px; text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><span style=\"color:black\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></u></strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><span style=\"color:black\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>anticoagulant of choice for anticoagulation </strong>testing is <strong>3.2% trisodium citrate.</strong></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><span style=\"color:black\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Question Id-15404 Unique Key-Q7889064</span></strong></span></span></span></p>",
    "correct_choice_id": 61579,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "InvestigationBased"
    ]
  },
  {
    "id": 15405,
    "choices": [
      {
        "id": 61580,
        "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">EDTA</span></span></p>"
      },
      {
        "id": 61581,
        "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Heparin</span></span></p>"
      },
      {
        "id": 61582,
        "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Potassium oxalate + sodium fluoride </span></span></p>"
      },
      {
        "id": 61583,
        "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tri Sodium citrate </span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"background-color:white\"><span style=\"color:#0d0d0d\">As a primary healthcare worker, you collect blood samples to measure fasting blood glucose levels in a population screening for diabetes. To ensure accurate results, which anticoagulant should be used to prevent glycolysis in the sample during transport to the laboratory</span></span>? </span></span></span></p>",
    "unique_key": "Q6653533",
    "question_audio": null,
    "question_video": null,
    "map_id": 31758,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ans. C) Potassium oxalate + sodium fluoride</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">Option C:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">Potassium oxalate + sodium fluoride:</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\"> Sodium fluoride <strong>inhibits glycolysis </strong>by inhibiting the<strong> enolase enzyme in the glycolytic pathway</strong>, ensuring <strong>glucose levels remain stable</strong> after blood collection. <strong>Potassium oxalate </strong>acts as an <strong>anticoagulant. </strong>This combination is<strong> ideal for glucose estimation in blood samples.</strong></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><span style=\"color:black\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">Option A. EDTA:</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\"> <strong>Ethylenediaminetetraacetic acid </strong>(EDTA) is commonly used as an <strong>anticoagulant in hematology </strong>for<strong> complete blood</strong> <strong>count testing </strong>but not for glucose estimation because it does not prevent glycolysis.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">Option B. Heparin:</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\"> Heparin is an<strong> anticoagulant </strong>that prevents blood clotting by<strong> inhibiting thrombin </strong>but does not prevent glycolysis, so it is not the best choice for glucose testing.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">Option D. Tri Sodium citrate:</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\"> Trisodium citrate is used mainly for<strong> coagulation tests </strong>and <strong>does not inhibit glycolysis</strong>, making it unsuitable for glucose estimation.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><span style=\"color:black\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></u></strong> </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><span style=\"color:black\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Direct quote &lsquo;<strong>enolase enzyme in the glycolysis is inhibited by fluoride</strong>, and when <strong>blood samples </strong>are taken for measurement of <strong>glucose</strong>, it is<strong> collected in tubes </strong>containing<strong> fluoride to inhibit glycolysis.&rsquo;</strong></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ref</span></span></u></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">: Henry&rsquo;s 21<sup>st</sup> /188, Harper 27th/152 </span></span></strong></span></span></p>",
    "correct_choice_id": 61582,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "InvestigationBased"
    ]
  },
  {
    "id": 15418,
    "choices": [
      {
        "id": 61632,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Prolonged PTT </span></span></p>"
      },
      {
        "id": 61633,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Prolonged PT </span></span></p>"
      },
      {
        "id": 61634,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Low platelet count </span></span></p>"
      },
      {
        "id": 61635,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Abnormal BT </span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"background-color:white\"><span style=\"color:#0d0d0d\">A 23-year-old male presents to the clinic with recurrent, spontaneous joint hemarthroses. Family history is significant for similar symptoms in his maternal uncles. Laboratory evaluation reveals a specific factor deficiency. Which laboratory finding is most consistent with a diagnosis of Hemophilia A? </span></span></span></span></span></p>",
    "unique_key": "Q7080398",
    "question_audio": null,
    "question_video": null,
    "map_id": 31759,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Prolonged PTT </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Option A:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">PTT </span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">is prolonged by <strong>deficiency </strong>of factors <strong>XII, XI, IX, III, X, V, prothrombin and fibrinogen</strong></span> <span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">and drugs like <strong>hep&shy;arin </strong></span>&nbsp;</span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hemophilia A </span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">is characterized by the deficiency of <strong>factor 8 </strong>and decreased activity of intrinsic pathway. This is associated with prolongation of <strong>partial thromboplastin time</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Prolonged PTT:</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"> This is the correct answer. <strong>Hemophilia A </strong>is caused by a <strong>deficiency in factor VIII</strong>, which is part of the <strong>intrinsic coagulation pathway</strong>. The <strong>activated partial thromboplastin time (PTT) test </strong>evaluates the <strong>intrinsic and common coagulation pathways </strong>and will be <strong>prolonged in Hemophilia A.</strong></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Explanation:</span></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Option B. Prolonged PT:</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"> The prothrombin time (PT) test evaluates the <strong>extrinsic and common pathways</strong>. </span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Option C. Low platelet count:</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"> Hemophilia A <strong>does not </strong>affect the <strong>platelet count</strong>; it is a <strong>coagulation factor deficiency </strong>and does not involve <strong>quantitative platelet defects.</strong></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Option D. Abnormal BT</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">: Bleeding time tests <strong>primary hemostasis</strong>, which includes <strong>platelet function</strong>. </span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Educational Objective: </span></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"><strong>Hemophilia A</strong>, a genetic disorder characterized by <strong>factor VIII deficiency </strong>leads to<strong> impaired </strong>function of the<strong> intrinsic coagulation pathway</strong>. This manifests clinically with a<strong> prolonged activated partial thromboplastin time (PTT) and a normal prothrombin time (PT) and bleeding time (BT).</strong></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Robbins 10<sup>th</sup> 668</span></strong></span></span></p>",
    "correct_choice_id": 61632,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 15427,
    "choices": [
      {
        "id": 61668,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Anti-platelet antibodies </span></span></p>"
      },
      {
        "id": 61669,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bone marrow examination </span></span></p>"
      },
      {
        "id": 61670,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">WASP gene study </span></span><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> </span></span></p>"
      },
      {
        "id": 61671,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Platelet function analyzer </span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A young boy presented with recurrent episodes of melena. The physician also found presence of dermatitis like rashes and multiple petechiae. His platelet count was low but red cell and white blood cell counts were normal. Which of the following is the diagnostic investigation in this case?</span></span></span></p>",
    "unique_key": "Q1645499",
    "question_audio": null,
    "question_video": null,
    "map_id": 31755,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) WASP gene study</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Option C:</span></span></strong> </span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"><strong>WASP gene </strong>study refers to the<strong> genetic analysis of the Wiskott-Aldrich syndrome protein (WASP) gene</strong>. Wiskott-Aldrich syndrome is a <strong>rare X-linked recessive disorder </strong>characterized by <strong>thrombocytopenia, recurrent infections, and eczema</strong>. Given the clinical presentation described in the question, which includes<strong> low platelet count, dermatitis-like rashes, and petechiae, </strong>along with a<strong> young male patient</strong>, the possibility of <strong>Wiskott-Aldrich syndrome is high</strong>. Therefore, genetic analysis of the<strong> WASP gene </strong>is the appropriate <strong>diagnostic investigation </strong>in this case.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/10/picture4.jpg\" style=\"height:346px; width:1000px\" /></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Explanation:</span></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Option A.</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"> <strong>Anti-platelet antibodies</strong> are <strong>antibodies </strong>produced by the immune system<strong> against platelets, </strong>which can result in conditions like<strong> immune thrombocytopenic purpura (ITP</strong>). While it could be considered in cases of thrombocytopenia, the clinical presentation described in the question is <strong>more indicative of a specific underlying genetic disorder</strong> rather than an autoimmune cause.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Option B.</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"> <strong>Bone marrow examination</strong> is a valuable diagnostic tool in cases of<strong> unexplained thrombocytopenia </strong>to assess for <strong>abnormalities in platelet production or destruction</strong>. However, in this case, the clinical presentation and history strongly suggest a <strong>specific genetic disorder </strong>rather than a primary bone marrow disorder.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Option D</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">. <strong>Platelet function analyzers</strong> are used to assess<strong> platelet function </strong>in various <strong>bleeding disorders</strong>. While they may be useful in certain contexts, the clinical presentation described in the question suggests a<strong> genetic disorder </strong>rather than a <strong>primary platelet dysfunction</strong>.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Educational objective: </span></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">The <strong>clinical presentation </strong>described, including<strong> thrombocytopenia, recurrent infections, and eczema</strong>, is suggestive of <strong>Wiskott-Aldrich syndrome</strong>, a <strong>rare X-linked recessive disorder</strong>. Genetic analysis of the<strong> WASP gene </strong>is the <strong>diagnostic investigation of choice </strong>to confirm the<strong> diagnosis.</strong></span></span></span></span></p>",
    "correct_choice_id": 61670,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "InvestigationBased"
    ]
  },
  {
    "id": 15370,
    "choices": [
      {
        "id": 61440,
        "text": "<p><span style=\"font-size:12pt;\">TRALI</span></p>"
      },
      {
        "id": 61441,
        "text": "<p><span style=\"font-size:12pt;\">HLA alloimmunisation</span></p>"
      },
      {
        "id": 61442,
        "text": "<p><span style=\"font-size:12pt;\">Graft versus host disease</span></p>"
      },
      {
        "id": 61443,
        "text": "<p><span style=\"font-size:12pt;\">Immunomodulation</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Irradiation of blood prior to transfusion prevents which of the following complications?</span></p>",
    "unique_key": "Q2173974",
    "question_audio": null,
    "question_video": null,
    "map_id": 31756,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C. Graft versus host disease</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>(Graft versus Host Disease - GVHD):</strong> GVHD occurs when <strong>donor T cells attack the recipient's body</strong>. <strong>Irradiation of blood products deactivates these T cells</strong>, thereby <strong>preventing GVHD,</strong> which is especially important in <strong>immunocompromised recipients.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A: (TRALI - Transfusion-Related Acute Lung Injury):</strong> TRALI is a serious complication characterized by <strong>acute respiratory distress </strong>following<strong> transfusion. </strong>It is thought to be caused by <strong>donor antibodies against recipient leukocytes</strong>. Irradiation does not prevent TRALI.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B: (HLA alloimmunization):</strong> HLA alloimmunization can occur when a<strong> patient develops antibodies against HLA antigens from transfused blood</strong>. While leukoreduction can reduce the risk, irradiation of blood products does not prevent HLA alloimmunization.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D: (Immunomodulation):</strong> Immunomodulation refers to the<strong> potential immune system </strong>changes in <strong>transfusion recipients,</strong> potentially leading to an increased risk of <strong>postoperative infections </strong>and <strong>malignancy recurrence</strong>. <strong>Irradiation\u2019s </strong>role in preventing <strong>immunomodulation </strong>is not clearly established.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Irradiation of white </strong>and <strong>red blood cells prior </strong>to transfusion is primarily used to<strong> prevent graft versus host disease.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">What happens in Transfusion associated-GVHD?</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">Donor T cells attack recipient tissues.</span></li><li><span style=\"font-size:12.0pt;\">Occurs particularly in immunocompromised patients (e.g., post-transplant, chemotherapy).</span></li><li><span style=\"font-size:12.0pt;\">It is often fatal.</span></li><li><span style=\"font-size:12.0pt;\">Irradiation (typically with 25\u201330 Gy gamma rays) prevents T-cell proliferation.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>(Ref: Robbins 10th/e p671-2)</strong></span></p>",
    "correct_choice_id": 61442,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "InvestigationBased"
    ]
  },
  {
    "id": 15428,
    "choices": [
      {
        "id": 61672,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Wiskott Aldrich syndrome </span></span></span></p>"
      },
      {
        "id": 61673,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Henoch Schonlein purpura </span></span></span></p>"
      },
      {
        "id": 61674,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Immune thrombocytopenia </span></span></span></p>"
      },
      {
        "id": 61675,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Dengue fever</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Normal platelet count is found in:</span></span></span></span></p>",
    "unique_key": "Q1633947",
    "question_audio": null,
    "question_video": null,
    "map_id": 31999,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ans. B) Henoch Schonlein purpura </span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Explanation:</span></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"><strong>All other options </strong>have<strong> decreased platelet count </strong>except<strong> Henoch Schonlein purpura</strong>. Though it&nbsp;</span></span></span></span><span style=\"color:black; font-family:Calibri,sans-serif; font-size:12pt\">has the word pur&shy;pura in its name, but the </span><strong>platelet count in this condition is normal</strong><span style=\"color:black; font-family:Calibri,sans-serif; font-size:12pt\">. Th<strong>e&nbsp;</strong></span><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"><strong>skin manifestations in HSP </strong>are due to <strong>small vessel vasculitis</strong>.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ref</span></span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">: Robbins 10<sup>th</sup>/ 526-527 </span></span></strong></span></span></p>",
    "correct_choice_id": 61673,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual"
    ]
  },
  {
    "id": 15407,
    "choices": [
      {
        "id": 61588,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Febrile non-hemolytic transfusion reaction </span></span></p>"
      },
      {
        "id": 61589,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hemolysis</span></span></p>"
      },
      {
        "id": 61590,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Transmission of infections </span></span></p>"
      },
      {
        "id": 61591,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Electrolyte imbalance </span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Most common blood transfusion reaction is:</span></span></span></p>",
    "unique_key": "Q3760812",
    "question_audio": null,
    "question_video": null,
    "map_id": 31993,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ans. A) Febrile non-hemolytic transfusion reaction </span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">FNHTR is the <strong>most common</strong> type of transfusion reaction. It is characterized by <strong>fever, chills, and rigors without</strong> evidence of <strong>hemolysis. </strong>It is usually caused by a reaction between the<strong> recipient&#39;s immune system and leukocytes </strong>in the transfused blood.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><span style=\"color:black\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Hemolysis: </span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">it </span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">is a<strong> serious but less common </strong>transfusion reaction. It occurs when <strong>red blood cells are destroyed, </strong>leading to the release of<strong> hemoglobin into the bloodstream</strong>. Hemolysis can be caused by <strong>various factors, </strong>including <strong>ABO incompatibility, improper storage</strong>, or<strong> bacterial contamination</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Transmission of Infections: </span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">While the transmission of infections is a<strong> serious concern in blood transfusions, </strong>it is <strong>not the most common </strong>transfusion reaction.<strong> Stringent screening and testing procedures for donated blood </strong>have significantly <strong>reduced </strong>the risk of<strong> transmitting infections, </strong>making FNHTR more common.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D.</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Electrolyte Imbalance: </strong>Electrolyte imbalances are <strong>not </strong>a common transfusion reaction. However, in some cases, <strong>transfusions with large volumes of blood or specific blood components </strong>can lead to <strong>electrolyte disturbances</strong>. This is <strong>not the primary </strong>or most common transfusion reaction.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;Most common<strong> blood transfusion </strong>reaction is <strong><span style=\"color:black\">Febrile non-hemolytic transfusion reaction.</span></strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ref:</span></span></u></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"> Robbins 10<sup>th</sup> 667 </span></span></strong></span></span></p>",
    "correct_choice_id": 61588,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual"
    ]
  },
  {
    "id": 15409,
    "choices": [
      {
        "id": 61596,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Metabolic alkalosis</span></span></span></p>"
      },
      {
        "id": 61597,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Metabolic acidosis </span></span></span></p>"
      },
      {
        "id": 61598,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Respiratory alkalosis </span></span></span></p>"
      },
      {
        "id": 61599,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Respiratory acidosis</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">A 40-year-old male involved in a motor vehicle collision requires a massive transfusion due to severe hemorrhagic shock. He receives 15 units of packed red blood cells within a 24-hour period. </span></span></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Which of the following complications is likely to result after several units of blood have been transferred?</span></span></span></span></p>",
    "unique_key": "Q3823748",
    "question_audio": null,
    "question_video": null,
    "map_id": 31994,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ans. A) Metabolic alkalosis </span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">Option A:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\"><strong>Metabolic alkalosis </strong>is a common complication after a <strong>massive transfusion due to the metabolism of citrate,</strong> which is used as an <strong>anticoagulant in stored blood</strong>, into<strong> bicarbonate</strong>.<strong> Lactate</strong>, which may accumulate in <strong>stored blood due to hypoperfusion and anaerobic metabolism</strong>, is also <strong>converted to bicarbonate </strong>when<strong> normal perfusion is restored</strong>.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">Explanation:</span></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">Option B. Metabolic acidosis:</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\"> While metabolic acidosis can be present initially <strong>due to hypoperfusion and lactic acidosis</strong>, the administration of several units of blood typically results in the correction of the acidosis, <strong>potentially overshooting into alkalosis </strong>due to the reasons mentioned above.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">Option C. Respiratory alkalosis:</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\"> Respiratory alkalosis typically results from <strong>hyperventilation, </strong>which may occur in patients in<strong> pain or with anxiety</strong>, but it is not directly related to the transfusion of blood products.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">Option D. Respiratory acidosis:</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\"> Respiratory acidosis is caused by <strong>hypoventilation and the accumulation of carbon dioxide </strong>in the blood. It is not a common complication associated with blood transfusion itself, unless there are<strong> underlying respiratory issues or transfusion-related complications affecting lung function.</strong></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">Educational Objective:</span></span></u></strong><strong> </strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Massive Transfusion </span></span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">is defined as the need to transfuse from<strong> one to two times the patient&rsquo;s normal blood vol&shy;ume</strong>. In a normal adult, this is equivalent to <strong>10-20 units</strong>. Most common abnormality is <strong>metabolic alkalosis</strong>. It re&shy;sults from conversion of<strong> citrate (present in stored blood) and lactate (accumulated due to hypoperfusion) to bicar&shy;bonate.</strong></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ref:</span></span></u></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"> Robbins 10<sup>th</sup>/ 668 </span></span></strong></span></span></p>",
    "correct_choice_id": 61596,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 15410,
    "choices": [
      {
        "id": 61600,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Fresh frozen plasma </span></span></span></p>"
      },
      {
        "id": 61601,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Platelet rich plasma </span></span></span></p>"
      },
      {
        "id": 61602,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Single donor platelets </span></span></span></p>"
      },
      {
        "id": 61603,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Cryoprecipitate</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">A 58-year-old man with a history of hemophilia A requires a blood product transfusion during a surgical procedure. </span></span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">ABO incompatibility is not seen with:</span></span></span></span></p>",
    "unique_key": "Q8641153",
    "question_audio": null,
    "question_video": null,
    "map_id": 31995,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ans. D) Cryoprecipitate </span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Option D:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Cryoprecipitate is prepared from <strong>FFP by cold precipitation </strong>and contains a<strong> high concentration </strong>of specific coagulation factors like <strong>fibrinogen, factor VIII, factor XIII, and von Willebrand factor. </strong>It has minimal <strong>plasma and ABO antigens</strong>, <strong>reducing the risk of ABO incompatibility reactions.</strong></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Explanation:</span></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Option A. Fresh frozen plasma:</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"> FFP contains all<strong> coagulation factors</strong>, including soluble <strong>ABO antigens</strong>. <strong>ABO incompatibility </strong>can lead to <strong>hemolytic reactions</strong>; thus, it should be <strong>matched </strong>with the <strong>recipient&#39;s blood group</strong>.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Option B. Platelet-rich plasma:</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"> PRP is derived from <strong>whole blood and retains the ABO antigens</strong>. Transfusion with<strong> incompatible PRP </strong>can also lead to<strong> hemolytic reactions.</strong></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Option C. Single donor platelets:</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"> Single donor platelets carry the<strong> donor&#39;s ABO antigens</strong>, and while the risk is <strong>lower compared to red cell transfusion, ABO compatibility </strong>is still preferred to minimize the risk of reaction.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Educational Objective:</span></span></u></strong> </span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">While <strong>ABO matching </strong>is ideal for all <strong>blood components</strong>, <strong>cryoprecipitate </strong>is the least likely to cause an<strong> ABO incompatibility reaction </strong>due to its<strong> low content of plasma </strong>and <strong>ABO antigens</strong>. </span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Wintrobes 12<sup>th</sup> /850</span></strong></span></span></p>",
    "correct_choice_id": 61603,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual"
    ]
  },
  {
    "id": 15412,
    "choices": [
      {
        "id": 61608,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">RBC corresponding to his red cell group and colloids/ crystalloid </span></span></span></p>"
      },
      {
        "id": 61609,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Whole blood corresponding to his plasma group </span></span></span></p>"
      },
      {
        "id": 61610,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">O positive RBC and colloids/crystalloid </span></span></span></p>"
      },
      {
        "id": 61611,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">AB negative whole blood</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">A 55 years old male accident victim in casualty urgently needs blood. The blood bank is unable to determine his ABO group, as his red cell group and plasma group do not match. Emergency transfusion of the patient should be with:</span></span></span></span></p>",
    "unique_key": "Q5809961",
    "question_audio": null,
    "question_video": null,
    "map_id": 31996,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ans. C) O positive RBC and colloids/crystalloid </span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Option C:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Selection of blood for emergency transfusion </span></span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">If patient&rsquo;s blood group is known, </span></span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">unmatched blood group of the same group may be used. </span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">If the patient&rsquo;s blood cannot be determined, </span></span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"><strong>Group O red blood cells </strong>should be chosen. The use of such<strong> unmatched blood should be Rh (&ndash;ve) </strong>when used in woman of child-bearing age in whom we do not want sensitization to Rh antigen. As Rh-negative blood is often in limited supply, <strong>Rh positive blood </strong>is used in the<strong> emergency transfusion of older females and males of unknown blood group</strong>. In such cases <strong>sensitization may occur </strong>but the<strong> risk of an immediate hemolytic reaction is low</strong>. <strong>O blood group </strong>is the <strong>universal donor </strong>and therefore, should be given to this patient. </span></span></span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">positive RBCs and colloids/crystalloid:</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"> In emergencies where the blood type is unknown or cannot be confirmed, it is standard to use <strong>O positive RBCs for males and older females </strong>because of the<strong> availability and lower risk </strong>of causing an <strong>immediate hemolytic reaction</strong>.<strong> Colloids or crystalloids </strong>can be used to<strong> maintain volume</strong>.</span></span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><span style=\"color:black\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Option A. RBCs corresponding to his red cell group and colloids/crystalloid:</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"> While it might seem intuitive to use RBCs corresponding to his red cell group, in cases where there is a <strong>discrepancy and the patient&#39;s blood group cannot be confirmed, </strong>it is <strong>safer to use group O RBCs, </strong>which are considered <strong>universal donors</strong>.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Option B. Whole blood corresponding to his plasma group:</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"> When the ABO group cannot be determined, using whole blood of a specific group is<strong> not recommended </strong>due to the risk of an<strong> ABO incompatibility reaction</strong>.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Option D. AB negative whole blood:</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"> AB negative blood is considered the<strong> universal plasma donor</strong>, <strong>not the universal RBC donor</strong>. This option could result in an<strong> ABO incompatibility reaction if the patient is not AB negative.</strong></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Educational Objective:</span></span></u></strong> </span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"><strong>O positive RBCs </strong>can be used in <strong>males and non-childbearing potential females, with colloids or crystalloid solutions </strong>to manage volume, as this approach<strong> minimizes </strong>the risk of<strong> hemolytic transfusion reactions</strong>. </span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ref:</span></span></u></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"> Wintrobes 12<sup>th</sup> 836</span></span></strong></span></span></p>",
    "correct_choice_id": 61610,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "TreatmentBased"
    ]
  },
  {
    "id": 15420,
    "choices": [
      {
        "id": 61640,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">2&ndash;6 &deg;C </span></span></span></p>"
      },
      {
        "id": 61641,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">&ndash;2 to&ndash;4 &deg;C </span></span></span></p>"
      },
      {
        "id": 61642,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">37 &deg;C </span></span></span></p>"
      },
      {
        "id": 61643,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">20&ndash;25&deg;C </span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A medical student working in a blood bank is tasked with handling stored red blood cells (RBCs) for transfusion purposes. What is the recommended storage temperature for preserving the viability and function of RBCs?</span></span></span></p>",
    "unique_key": "Q9515739",
    "question_audio": null,
    "question_video": null,
    "map_id": 31997,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) 2&ndash;6 &deg;C</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><span style=\"color:black\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><span style=\"color:black\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/10/picture2.jpg\" style=\"height:181px; width:1000px\" /></span></u></strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></u></strong><strong> </strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The recommended<strong> storage temperature </strong>for preserving the <strong>viability and function of RBCs </strong>is <strong>2-6 degree Celsius</strong>.</span></span></span></p>\r\n\r\n<p style=\"margin-left:29px; text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Robbins 10<sup>th</sup>/; Essentials of Hematology 2nd/500 </span></strong></span></span></p>",
    "correct_choice_id": 61640,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "InvestigationBased"
    ]
  },
  {
    "id": 15422,
    "choices": [
      {
        "id": 61648,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">With a 16&ndash;18 G needle </span></span></p>"
      },
      {
        "id": 61649,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">With a 18&ndash;20 G needle </span></span></p>"
      },
      {
        "id": 61650,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">With a 20&ndash;22 G needle </span></span></p>"
      },
      {
        "id": 61651,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">With a 22&ndash;24 G needle </span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 55-year-old male is scheduled for a red blood cell transfusion due to severe anemia. To optimize the transfusion process, which of the following needle sizes is recommended for the administration of red blood cells?</span></span></span></p>",
    "unique_key": "Q3865152",
    "question_audio": null,
    "question_video": null,
    "map_id": 31998,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) With a 18&ndash;20 G needle </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><span style=\"color:black\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><span style=\"color:black\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/10/picture3.jpg\" style=\"height:336px; width:1000px\" /></span></u></strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Educational Objective:</span></span></u></strong> </span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">A needle gauge of<strong> 18-20 G </strong>is recommended for <strong>transfusion to minimize hemolysis </strong>and allow for an<strong> adequate flow rate</strong>. </span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Essentials of Hematology 2nd/500</span></strong></span></span></p>",
    "correct_choice_id": 61649,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "InstrumentsBased"
    ]
  },
  {
    "id": 15425,
    "choices": [
      {
        "id": 61660,
        "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Malaria</span></span></p>"
      },
      {
        "id": 61661,
        "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hep B</span></span></p>"
      },
      {
        "id": 61662,
        "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">HIV </span></span></p>"
      },
      {
        "id": 61663,
        "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dengue </span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 30-year-old individual is scheduled to donate blood for a local blood drive. To ensure the safety of the blood supply, the donor&#39;s blood will be screened for various infectious diseases. Among the following options, which one is typically NOT included in the routine screening for donated blood?</span></span></span></p>",
    "unique_key": "Q4897867",
    "question_audio": null,
    "question_video": null,
    "map_id": 31992,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Dengue </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Option D:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Dengue fever is a <strong>viral illness </strong>transmitted by <strong>Aedes mosquitoes. </strong>Unlike some of the other diseases listed, routine screening for Dengue in donated blood is not typically performed. This is because<strong> Dengue is primarily transmitted by mosquitoes rather </strong>than through<strong> blood transfusions.</strong></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Option A.</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"><strong> Malaria </strong>is routinely screened for in <strong>donated blood </strong>because it is caused by <strong>parasites transmitted through the bite of infected mosquitoes</strong>. <strong>Screening helps </strong>prevent<strong> </strong>the transmission of<strong> malaria </strong>through <strong>blood transfusions</strong>.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Option B.</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">&nbsp; <strong>Hepatitis B </strong>is a<strong> viral infection </strong>that can be transmitted through <strong>blood transfusions. </strong>Screening for <strong>Hepatitis B surface antigen (HBsAg) </strong>is essential to prevent the transmission of the<strong> virus to recipients of donated blood</strong>.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Option C.</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"><strong> Screening for HIV </strong>is crucial in <strong>donated blood to prevent the transmission of the virus to recipients</strong>. HIV screening typically involves testing for<strong> antibodies to HIV-1 and HIV-2</strong>, ensuring the<strong> safety of the blood supply</strong>.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Educational objective: </span></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">While diseases such as <strong>HIV, Hepatitis B, and Malaria </strong>are routinely screened for in <strong>donated blood to ensure the safety of the blood supply</strong>,<strong> Dengue is not </strong>typically included in routine <strong>screening protocols </strong>as it is primarily transmitted by<strong> mosquitoes rather than through blood transfusions</strong>.</span></span></span></span></p>",
    "correct_choice_id": 61663,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "InvestigationBased"
    ]
  }
];
        let quizName = 'Heamatology';
        let hierarchy = ["Cerebellum", "qBank", "Pathology"];
        
        // Handle Custom Quiz Loading
        if (window.location.pathname.endsWith('custom_quiz.html')) {
            const customData = JSON.parse(localStorage.getItem('customQuizData'));
            if (customData) {
                questionsData = customData.questions;
                quizName = customData.name;
                hierarchy = customData.hierarchy;
                document.title = quizName + ' - Brain And Scalpel';
                document.getElementById('totalQuestions').textContent = questionsData.length;
                document.getElementById('quizHierarchy').textContent = hierarchy.join(' > ');
            }
        }

        let currentQuestionIndex = 0;
        let selectedOption = null;
        let currentMode = 'study';
        let timer = null;
        let timeRemaining = 0;
        let questionStartTime = Date.now();
        let quizStartTime = Date.now();
        let isQuizCompleted = false;
        
        let questionStates = new Array(questionsData.length).fill(null).map(() => ({
            status: 'not_attempted',
            bookmarked: false,
            markedForReview: false,
            selectedAnswer: null,
            timeSpent: 0
        }));
        
        let stats = {
            correctAnswers: 0,
            incorrectAnswers: 0,
            totalAttempted: 0,
            totalTime: 0,
            notAttempted: questionsData.length
        };

        const urlParams = new URLSearchParams(window.location.search);
        currentQuestionIndex = Math.min(parseInt(urlParams.get('startAt')) || 0, questionsData.length - 1);

        function goBack() {
            if (isQuizCompleted || confirm('Are you sure you want to leave the quiz? Your progress will be lost.')) {
                window.history.back();
            }
        }

        function selectMode(mode) {
            currentMode = mode;
            document.getElementById('modeModal').style.display = 'none';
            initializeQuiz();
        }

        function initializeQuiz() {
            quizStartTime = Date.now();
            
            const bookmarkBtn = document.getElementById('bookmarkBtn');
            const markReviewBtn = document.getElementById('markReviewBtn');
            const testModeReviewLegend = document.getElementById('testModeReviewLegend');
            const isTestMode = currentMode === 'test' || currentMode === 'timed_exam';
            
            document.getElementById('statsBar').style.display = isTestMode ? 'none' : 'block';
            document.getElementById('studyModeLegend').style.display = isTestMode ? 'none' : 'block';
            document.getElementById('testModeLegend').style.display = isTestMode ? 'block' : 'none';
            document.getElementById('submitSection').style.display = isTestMode ? 'block' : 'none';
            bookmarkBtn.style.display = isTestMode ? 'none' : 'flex';
            markReviewBtn.style.display = isTestMode ? 'flex' : 'none';
            testModeReviewLegend.style.display = isTestMode ? 'flex' : 'none';
            
            if (currentMode === 'timed_study' || currentMode === 'timed_exam') {
                document.getElementById('timerContainer').classList.remove('hidden');
            }
            
            loadBookmarkedQuestions();
            generateQuestionNav();
            updateStats();
            displayQuestion();
        }

        function generateQuestionNav() {
            const nav = document.getElementById('questionNav');
            nav.innerHTML = '';
            
            for (let i = 0; i < questionsData.length; i++) {
                const btn = document.createElement('button');
                btn.textContent = i + 1;
                btn.className = 'w-8 h-8 text-sm font-medium rounded transition-all duration-200';
                btn.onclick = () => jumpToQuestion(i);
                btn.id = `navBtn_${i}`;
                nav.appendChild(btn);
            }
            
            updateQuestionNav();
        }

        function updateQuestionNav() {
            for (let i = 0; i < questionsData.length; i++) {
                const btn = document.getElementById(`navBtn_${i}`);
                const state = questionStates[i];
                let className = '';
                
                if (i === currentQuestionIndex) {
                    className = 'nav-btn-current';
                } else if (state.bookmarked) {
                    className = 'nav-btn-bookmarked';
                } else if (state.markedForReview) {
                    className = 'nav-btn-marked-review';
                } else if (currentMode === 'study' || currentMode === 'timed_study') {
                    if (state.status === 'correct') className = 'nav-btn-correct';
                    else if (state.status === 'incorrect') className = 'nav-btn-incorrect';
                    else className = 'nav-btn-not-attempted hover:bg-white hover:bg-opacity-20';
                } else {
                    if (state.selectedAnswer !== null) className = 'nav-btn-answered';
                    else className = 'nav-btn-not-attempted hover:bg-white hover:bg-opacity-20';
                }
                btn.className = `w-8 h-8 text-sm font-medium rounded ${className}`;
            }
        }

        function jumpToQuestion(index) {
            if (index >= 0 && index < questionsData.length) {
                if (questionStartTime) {
                    questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
                }
                
                currentQuestionIndex = index;
                displayQuestion();
            }
        }

        function updateStats() {
            if (currentMode === 'study' || currentMode === 'timed_study') {
                document.getElementById('correctCount').textContent = stats.correctAnswers;
                document.getElementById('incorrectCount').textContent = stats.incorrectAnswers;
                document.getElementById('totalAttempted').textContent = stats.totalAttempted;
                
                const accuracy = stats.totalAttempted > 0 
                    ? Math.round((stats.correctAnswers / stats.totalAttempted) * 100)
                    : 0;
                document.getElementById('accuracy').textContent = accuracy + '%';
                
                stats.totalTime = questionStates.reduce((acc, state) => acc + state.timeSpent, 0);
                const timeSpent = Math.floor(stats.totalTime / 1000);
                const minutes = Math.floor(timeSpent / 60);
                const seconds = timeSpent % 60;
                document.getElementById('timeSpent').textContent = 
                    minutes + ':' + seconds.toString().padStart(2, '0');
            }
        }

        function setupVideo(videoElement, url) {
            if (Hls.isSupported()) {
                const hls = new Hls();
                hls.loadSource(url);
                hls.attachMedia(videoElement);
            } else if (videoElement.canPlayType('application/vnd.apple.mpegurl')) {
                videoElement.src = url;
            }
        }

        function displayQuestion() {
            if (!questionsData || questionsData.length === 0) {
                document.getElementById('questionText').innerHTML = 'No questions available for this quiz.';
                return;
            };
            
            const question = questionsData[currentQuestionIndex];
            questionStartTime = Date.now();
            
            selectedOption = questionStates[currentQuestionIndex].selectedAnswer;
            
            const progress = ((currentQuestionIndex + 1) / questionsData.length) * 100;
            document.getElementById('progressBar').style.width = progress + '%';
            document.getElementById('currentQuestion').textContent = currentQuestionIndex + 1;
            updateQuestionNav();
            
            document.getElementById('prevBtn').disabled = currentQuestionIndex === 0;
            
            document.getElementById('solutionContainer').classList.add('hidden');
            
            document.getElementById('questionText').innerHTML = question.text || 'No question text available';
            
            let mediaHtml = '';
            if (question.question_audio) mediaHtml += `<div class="glass-light p-4 mb-4"><audio src="${question.question_audio}" controls class="w-full"></audio></div>`;
            if (question.question_video) mediaHtml += `<div class="glass-light p-4 mb-4"><video src="${question.question_video}" controls class="w-full rounded-lg"></video></div>`;
            if (question.question_images) {
                question.question_images.forEach(imgSrc => {
                    if (imgSrc) mediaHtml += `<div class="glass-light p-4 mb-4"><img src="${imgSrc}" alt="Question Image" class="w-full rounded-lg"></div>`;
                });
            }
            document.getElementById('questionMedia').innerHTML = mediaHtml;
            
            const optionsContainer = document.getElementById('optionsContainer');
            optionsContainer.innerHTML = '';
            optionsContainer.classList.remove('answered');
            
            if (question.choices && Array.isArray(question.choices)) {
                question.choices.forEach((choice, index) => {
                    const optionLetter = String.fromCharCode(65 + index);
                    const isSelected = selectedOption === index;
                    
                    const optionDiv = document.createElement('div');
                    optionDiv.innerHTML = `
                        <button type="button" class="option-button ${isSelected ? 'selected' : ''}" data-option-index="${index}">
                            <div class="option-letter">${optionLetter}</div>
                            <div class="option-text">${choice.text || 'Option ' + (index + 1)}</div>
                        </button>
                    `;
                    optionsContainer.appendChild(optionDiv);
                });
                
                optionsContainer.addEventListener('click', function(e) {
                    const optionButton = e.target.closest('.option-button');
                    if (optionButton) {
                        const optionIndex = parseInt(optionButton.getAttribute('data-option-index'));
                        selectOption(optionIndex);
                    }
                });
            }
            
            updateBookmarkButton();
            updateMarkReviewButton();

            if ((currentMode === 'timed_study' || currentMode === 'timed_exam') && !isQuizCompleted) {
                startTimer();
            }
        }

        function selectOption(index) {
            const optionsContainer = document.getElementById('optionsContainer');
            if (optionsContainer.classList.contains('answered')) return;

            if (questionStartTime) {
                questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
                questionStartTime = Date.now();
            }
            
            selectedOption = index;
            questionStates[currentQuestionIndex].selectedAnswer = index;
            
            document.querySelectorAll('.option-button').forEach((btn, i) => {
                btn.classList.toggle('selected', i === index);
            });
            
            if (currentMode === 'study' || currentMode === 'timed_study') {
                setTimeout(processAnswer, 300);
            } else {
                if (questionStates[currentQuestionIndex].status === 'not_attempted') {
                    questionStates[currentQuestionIndex].status = 'answered';
                    stats.totalAttempted++;
                    stats.notAttempted--;
                }
                updateQuestionNav();
            }
        }

        function processAnswer() {
            const question = questionsData[currentQuestionIndex];
            const correctChoiceId = question.correct_choice_id;
            
            if(selectedOption === null) return;

            const selectedChoice = question.choices[selectedOption];
            const isCorrect = selectedChoice.id === correctChoiceId;
            
            if (questionStates[currentQuestionIndex].status === 'not_attempted') {
                stats.totalAttempted++;
                stats.notAttempted--;
                if(isCorrect) stats.correctAnswers++; else stats.incorrectAnswers++;
            }
            questionStates[currentQuestionIndex].status = isCorrect ? 'correct' : 'incorrect';
            
            updateStats();
            showInlineFeedback(isCorrect);
            updateQuestionNav();
        }

        function showInlineFeedback(isCorrect) {
            if (currentMode !== 'study' && currentMode !== 'timed_study') return;

            const optionsContainer = document.getElementById('optionsContainer');
            const optionButtons = optionsContainer.querySelectorAll('.option-button');
            const question = questionsData[currentQuestionIndex];
            const correctChoiceId = question.correct_choice_id;
            let correctOptionIndex = question.choices.findIndex(c => c.id === correctChoiceId);

            optionsContainer.classList.add('answered');

            optionButtons.forEach((btn, index) => {
                btn.classList.remove('selected');
                if (index === correctOptionIndex) btn.classList.add('correct');
                else if (index === selectedOption && !isCorrect) btn.classList.add('incorrect');
            });

            setTimeout(showSolution, 1500);
        }


        function showSolution() {
            if (currentMode !== 'study' && currentMode !== 'timed_study') return;
            
            const question = questionsData[currentQuestionIndex];
            document.getElementById('solutionText').innerHTML = question.solution || 'No solution provided';
            
            const videoContainer = document.getElementById('solutionVideo');
            const videoPlayer = document.getElementById('explanationVideoPlayer');
            const explanationVideo = question.explanation_video;
            
            if (explanationVideo) {
                videoContainer.classList.remove('hidden');
                if (explanationVideo.includes('.m3u8')) setupVideo(videoPlayer, explanationVideo);
                else videoPlayer.src = explanationVideo;
            } else {
                videoContainer.classList.add('hidden');
            }
            
            document.getElementById('solutionContainer').classList.remove('hidden');
        }

        function submitQuiz() {
            if (timer) clearInterval(timer);
            if (!confirm('Are you sure you want to submit the quiz?')) return;
            
            isQuizCompleted = true;
            let correct = 0, incorrect = 0;
            const totalTime = Date.now() - quizStartTime;
            
            questionsData.forEach((question, index) => {
                const state = questionStates[index];
                if (state.selectedAnswer !== null) {
                    if (question.choices[state.selectedAnswer].id === question.correct_choice_id) {
                        correct++;
                        state.status = 'correct';
                    } else {
                        incorrect++;
                        state.status = 'incorrect';
                    }
                }
            });
            
            // Save performance data
            const performanceData = JSON.parse(localStorage.getItem('quizPerformanceData')) || [];
            performanceData.push({
                quizName: quizName,
                hierarchy: hierarchy,
                timestamp: Date.now(),
                totalTime: totalTime,
                stats: {
                    correct: correct,
                    incorrect: incorrect,
                    notAttempted: questionsData.length - (correct + incorrect)
                }
            });
            localStorage.setItem('quizPerformanceData', JSON.stringify(performanceData));

            showPerformanceAnalysis(correct, incorrect, questionsData.length - (correct + incorrect), totalTime);
        }

        function showPerformanceAnalysis(correct, incorrect, notAttempted, totalTime) {
            const modal = document.getElementById('performanceModal');
            const accuracy = (correct + incorrect) > 0 ? Math.round((correct / (correct + incorrect)) * 100) : 0;
            
            const circumference = 2 * Math.PI * 65;
            const scoreCircle = document.getElementById('scoreCircle');
            scoreCircle.style.strokeDasharray = `${circumference} ${circumference}`;
            scoreCircle.style.strokeDashoffset = circumference - (accuracy / 100) * circumference;
            
            document.getElementById('accuracyScore').textContent = `${accuracy}%`;
            document.getElementById('totalQuestionsResult').textContent = questionsData.length;
            document.getElementById('correctResult').textContent = correct;
            document.getElementById('incorrectResult').textContent = incorrect;
            document.getElementById('notAttemptedResult').textContent = notAttempted;
            
            const totalMinutes = Math.floor(totalTime / 60000);
            const totalSeconds = Math.floor((totalTime % 60000) / 1000);
            document.getElementById('totalTimeResult').textContent = `${totalMinutes}:${totalSeconds.toString().padStart(2, '0')}`;
            
            const avgTime = totalTime / questionsData.length;
            const avgMinutes = Math.floor(avgTime / 60000);
            const avgSeconds = Math.floor((avgTime % 60000) / 1000);
            document.getElementById('avgTimeResult').textContent = `${avgMinutes}:${avgSeconds.toString().padStart(2, '0')}`;
            
            modal.classList.remove('hidden');
        }

        function closePerformanceModal() { document.getElementById('performanceModal').classList.add('hidden'); }

        function reviewQuestions() {
            document.getElementById('questionReviewSection').classList.remove('hidden');
            const container = document.getElementById('reviewQuestionsContainer');
            container.innerHTML = '';
            
            questionsData.forEach((question, index) => {
                const state = questionStates[index];
                const correctChoiceId = question.correct_choice_id;
                
                let statusClass = 'not-attempted', statusText = 'Not Attempted';
                if (state.selectedAnswer !== null) {
                    const selectedChoice = question.choices[state.selectedAnswer];
                    if (selectedChoice.id === correctChoiceId) { statusClass = 'correct'; statusText = 'Correct'; }
                     else { statusClass = 'incorrect'; statusText = 'Incorrect'; }
                }
                
                const reviewDiv = document.createElement('div');
                reviewDiv.className = `review-question ${statusClass}`;
                
                let optionsHtml = (question.choices || []).map((choice, choiceIndex) => {
                    const isSelected = state.selectedAnswer === choiceIndex;
                    const isCorrect = choice.id === correctChoiceId;
                    let borderClass = 'border-gray-600';
                    if(isCorrect) borderClass = 'border-green-500';
                    else if(isSelected) borderClass = 'border-red-500';
                    
                    return `<div class="p-3 rounded-lg border ${borderClass}"><span class="font-bold mr-3">${String.fromCharCode(65 + choiceIndex)}</span><span>${choice.text}</span></div>`;
                }).join('');

                const videoHtml = question.explanation_video ? `<div class="mt-4"><video id="review-video-${index}" data-src="${question.explanation_video}" class="w-full rounded-lg" controls></video></div>` : '';

                reviewDiv.innerHTML = `
                    <div class="mb-4">
                        <div class="flex justify-between items-center mb-3">
                            <h4 class="text-lg font-bold text-white">Question ${index + 1}</h4>
                            <span class="text-sm px-3 py-1 rounded-full bg-${statusClass === 'correct' ? 'green' : statusClass === 'incorrect' ? 'red' : 'gray'}-600 text-white">${statusText}</span>
                        </div>
                        <div class="text-white mb-4">${question.text}</div>
                    </div>
                    <div class="space-y-2 mb-4">${optionsHtml}</div>
                    <div class="bg-green-900 bg-opacity-20 p-4 rounded-lg border border-green-700">
                        <h5 class="text-green-400 font-bold mb-2">Explanation:</h5>
                        <div class="text-white text-opacity-90">${question.solution || 'No solution available.'}</div>
                        ${videoHtml}
                    </div>`;
                container.appendChild(reviewDiv);
            });
            initializeReviewVideos();
        }

        function initializeReviewVideos() {
            document.querySelectorAll('video[data-src]').forEach(videoEl => {
                const src = videoEl.dataset.src;
                if (src && src.includes('.m3u8')) {
                    setupVideo(videoEl, src);
                } else if (src) {
                    videoEl.src = src;
                }
            });
        }

        function retakeQuiz() {
            if (confirm('Are you sure you want to retake the quiz? This will reset all your answers.')) {
                if (window.location.pathname.endsWith('custom_quiz.html')) {
                    localStorage.removeItem('customQuizData');
                }
                location.reload();
            }
        }

        function loadBookmarkedQuestions() {
            const bookmarks = JSON.parse(localStorage.getItem('bookmarkedQuestions')) || [];
            bookmarks.forEach(bookmark => {
                if (bookmark.quizFile.includes(quizName.toLowerCase().replace(/ /g, '-'))) {
                    if (bookmark.questionIndex < questionsData.length) {
                        questionStates[bookmark.questionIndex].bookmarked = true;
                    }
                }
            });
        }

        function toggleBookmark() {
            const isBookmarked = !questionStates[currentQuestionIndex].bookmarked;
            questionStates[currentQuestionIndex].bookmarked = isBookmarked;
            
            let bookmarks = JSON.parse(localStorage.getItem('bookmarkedQuestions')) || [];
            
            if (isBookmarked) {
                const bookmarkData = {
                    quizName: quizName,
                    quizFile: window.location.pathname.split('/').pop(),
                    questionIndex: currentQuestionIndex,
                    question: questionsData[currentQuestionIndex],
                    hierarchy: hierarchy,
                    timestamp: Date.now()
                };
                bookmarks.push(bookmarkData);
            } else {
                bookmarks = bookmarks.filter(b => 
                    !(b.quizFile.includes(quizName.toLowerCase().replace(/ /g, '-')) && b.questionIndex === currentQuestionIndex)
                );
            }
            
            localStorage.setItem('bookmarkedQuestions', JSON.stringify(bookmarks));
            updateBookmarkButton();
            updateQuestionNav();
        }

        function updateBookmarkButton() {
            const btn = document.getElementById('bookmarkBtn');
            const text = document.getElementById('bookmarkText');
            const isBookmarked = questionStates[currentQuestionIndex].bookmarked;
            
            btn.className = isBookmarked ? 'gradient-yellow px-6 py-3 text-white transition-all duration-300 flex items-center' : 'glass-light px-6 py-3 text-white hover:bg-yellow-500 hover:bg-opacity-20 transition-all duration-300 flex items-center';
            text.textContent = isBookmarked ? 'Bookmarked' : 'Bookmark';
        }
        
        function toggleMarkForReview() {
            questionStates[currentQuestionIndex].markedForReview = !questionStates[currentQuestionIndex].markedForReview;
            updateMarkReviewButton();
            updateQuestionNav();
        }

        function updateMarkReviewButton() {
            const btn = document.getElementById('markReviewBtn');
            const text = document.getElementById('markReviewText');
            const isMarked = questionStates[currentQuestionIndex].markedForReview;
            
            btn.className = isMarked ? 'gradient-purple px-6 py-3 text-white transition-all duration-300 flex items-center' : 'glass-light px-6 py-3 text-white hover:bg-purple-500 hover:bg-opacity-20 transition-all duration-300 flex items-center';
            text.textContent = isMarked ? 'Marked' : 'Mark for Review';
        }

        function previousQuestion() {
            if (currentQuestionIndex > 0) {
                if (questionStartTime) {
                    questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
                }
                
                currentQuestionIndex--;
                displayQuestion();
            }
        }

        function nextQuestion() {
            if (questionStartTime) {
                questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
            }
            
            if (currentQuestionIndex < questionsData.length - 1) {
                currentQuestionIndex++;
                displayQuestion();
            } else {
                if (currentMode === 'test' || currentMode === 'timed_exam') {
                    if (confirm('You have reached the end of the quiz. Would you like to submit your answers now?')) {
                        submitQuiz();
                    }
                } else {
                    if (confirm('You have completed all questions. Would you like to review from the beginning?')) {
                        currentQuestionIndex = 0;
                        displayQuestion();
                    }
                }
            }
        }

        function startTimer() {
            if (timer) clearInterval(timer);
            timeRemaining = 120; // 2 minutes per question
            updateTimerDisplay();
            
            timer = setInterval(() => {
                timeRemaining--;
                updateTimerDisplay();
                
                if (timeRemaining <= 0) {
                    clearInterval(timer);
                    if (currentMode === 'timed_exam') {
                        submitQuiz();
                    } else {
                        nextQuestion();
                    }
                }
            }, 1000);
        }

        function updateTimerDisplay() {
            const minutes = Math.floor(timeRemaining / 60);
            const seconds = timeRemaining % 60;
            document.getElementById('timeDisplay').textContent = 
                minutes + ':' + seconds.toString().padStart(2, '0');
        }

        document.addEventListener('DOMContentLoaded', () => {
             if (!window.location.pathname.endsWith('custom_quiz.html')) {
                document.getElementById('modeModal').style.display = 'flex';
             } else {
                initializeQuiz();
             }
        });
        
        document.addEventListener('keydown', function(e) {
            if (document.getElementById('modeModal').style.display !== 'none') return;
            if (document.getElementById('performanceModal').classList.contains('hidden') === false) return;
            
            if (e.key >= '1' && e.key <= '4') {
                const optionIndex = parseInt(e.key) - 1;
                const options = document.querySelectorAll('.option-button');
                if (optionIndex < options.length) selectOption(optionIndex);
            } else if (e.key === 'ArrowLeft') {
                previousQuestion();
            } else if (e.key === 'ArrowRight' || e.key === ' ') {
                e.preventDefault();
                nextQuestion();
            } else if (e.key.toLowerCase() === 'b' && (currentMode === 'study' || currentMode === 'timed_study')) {
                toggleBookmark();
            } else if (e.key.toLowerCase() === 'm' && (currentMode === 'test' || currentMode === 'timed_exam')) {
                toggleMarkForReview();
            } else if (e.key.toLowerCase() === 's' && (currentMode === 'test' || currentMode === 'timed_exam')) {
                submitQuiz();
            }
        });
    </script>
</body>
</html>